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Summary
ATP release from the surface of the ventro-lateral medulla (VLM) is integral
to the hypercapnic response in vivo and can be seen in vitro. By employing horizontal
slices of the ventral medulla containing the ventral chemosensitive nuclei, I have
developed a model that consistently evokes hypercapnia-induced ATP release in vitro.
Using this preparation I have studied CO2-triggered ATP release by means of
microelectrode biosensors. I conclude that it is the change in PCO2 itself, and not
associated pH changes that accompany it, that is directly responsible for eliciting ATP
release from the surface of the VLM. In addition ATP release from this region may
have a role in the response to hypocapnia as well as hypercapnia. Using
pharmacological agents I have demonstrated that gating of connexin hemichannels
mediates ATP release. The dorso-ventral distribution of Cx26 ascertained via
quantitative PCR and immunofluorescence makes this hemichannel the most likely
candidate. Dye loading the cells responsible for ATP release with carboxyfluorescein,
which co-localised with Cx26, revealed these cells reside in the pia mater and sub-
pial astrocytes. Application of gap-junction antagonists, with selectivity towards
connexin 26, greatly reduced ATP release in response to elevated CO2 in vitro and in
vivo and reduced the tone of ATP at the VLM surface. Moreover, by loading Cx26
expressing HeLa cells with ATP, I was able to recapitulate the entire in vivo response.
Therefore I propose that ATP is released from sub-pial astrocytes and leptomeningeal
cells through connexin 26 hemichannels in response to alterations in PCO2. Here
Cx26 performs a dual role, as both the chemosensory transducer and the conduit for
ATP release.
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Chapter 1: Introduction
1.1 Respiratory regulation
Generation and control of respiratory rhythm is one of the most important
functions performed by the brain. This rhythm is generated by pacemaker cells, whose
activity can be modulated to meet metabolic demands. The vital regulation of this
function is controlled by the medulla oblongata, which is situated rostral to the spinal
cord and ventral to the cerebellum at the base of the skull. There are several nuclei
within this brain region which communicate, control and modulate respiratory output
(Berne and Levy, 1998). The respiratory cycle is incessant, and perturbations in its
control can have profound effects; dysregulation of this system often leads to the
cessation of life. The two most widely studied diseases of the autonomic control of
respiration are congenital central hypoventilation syndrome (CCHS) and sudden
infant death syndrome (SIDS).
1.1.1 Congenital central hypoventilation syndrome (CCHS)
CCHS was first described in 1970, and is predominantly defined by
cardiorespiratory dysregulation (Weese-Mayer et al., 2008). It is characterised by an
intact respiratory system and neural network but with an absence of chemoreception,
leading to hypoventilation and apnoeas particularly during sleep (Gallego and Dauger,
2008). It is associated with over 20 genetic mutations, however it is now accepted that
the major cause of this disease is abnormalities in the homeobox gene Phox2b
(Weese-Mayer et al., 2008, Gallego and Dauger, 2008). Phox2b is expressed in many
respiratory and chemosensory areas; the area postrema, nucleus tractus solitarius
(NTS), dorsal motor nucleus of the vagus, the dorsomedial portion of the spinal
trigeminal tract, intermediate reticular nucleus, nucleus ambiguus (NA),
retrotrapezoid nucleus (RTN), parabrachial nucleus (PBN), the carotid bodies (Kang
et al., 2007) and the locus coeruleus (LC) (Gallego and Dauger, 2008). There are also
implications that Phox2b mutations may also lead to abnormalities in the
hypothalamus, though it is not expressed there. CCHS patients often present with
thermoregulatory control deficits, a function performed by this brain region (Gallego
and Dauger, 2008). It is required for the development of most neural cell types in the
central and peripheral nervous system and thus a heterozygotic Phox2b knockout
phenotype, where one allele of the gene is replaced the human mutation which carries
a 7 polyalanine repeat, is embryonic lethal (Gallego and Dauger, 2008).
Phox2b co-localises with VGlut-2 in the RTN, though cited by the authors as a
neuronal marker it is not exclusive to this cell type. Thus there may be a role for
Phox2b in non-neuronal cells as well. Despite its expression in many areas, Phox2b
mutations cause a 77% loss of RTN/pFRG (parafacial respiratory group) neurons with
an apparently otherwise intact respiratory network (Dubreuil et al., 2008, Guyenet,
2008). This loss causes gasping or reduced and haphazard breathing eventually
leading to death shortly after birth (Dubreuil et al., 2008). This led to the hypothesis
that at birth breathing and chemoreception is entirely dependent on RTN neurons
(Guyenet, 2008). However it cannot be ruled out that the RTN is the major site of
integration for all peripheral and medullary chemoreceptors and therefore its loss
removes all chemoreception by indirect as well as direct means (Guyenet, 2008).
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or due to the nature of the mutation (Gallego and Dauger, 2008). Humans have a
polyalanine repeat whilst mice are null mutants, thus human proteins may still bind to
their targets without inducing their intracellular pathway, effectively antagonising
them which cannot happen in the mouse model (Gallego and Dauger, 2008). The
addition of this polyalanine repeat may also lead to incorrect trafficking of
intracellular proteins, which could have downstream effects. In either case the neurons
may appear morphologically normal, but the network may not be intact. In other
words neurons in other brain regions may appear normal but Phox2b mutations cause
a loss or gain of function causing them to act abnormally. If this were true then it
would appear that only the RTN is affected, whilst in truth the loss of Phox2b would
have much further reaching effects. This would appear a more logical conclusion as
the chemosensitivity of RTN neurons alone cannot account for the full hypercapnic
ventilatory response.
1.1.2 Sudden infant death syndrome (SIDS)
Sudden infant death syndrome (SIDS) is characterised by a perverse
chemosensitive response during sleep, which results in apnoea. It has been linked to
the dysregulation of the serotonergic system (Richerson, 2004) particularly mutations
in the serotonin transporter protein (Weese-Mayer et al., 2008). Interestingly as with
CCHS patients many SIDS patients present with mutations in Phox2b, these
mutations lead to abnormal differentiation of serotonergic neurons (Weese-Mayer et
al., 2008). Therefore Phox2b mutations do not with the exception of the loss of RTN
neurons have an otherwise intact respiratory network as has been previously stated
(Dubreuil et al., 2008, Guyenet, 2008). Therefore the Phox2b containing neuronal
pathway may be a common pathway altered in all sleep apnoea related disorders
(Weese-Mayer et al., 2008).
SIDS like CCHS has been causally related to the loss of many chemosensitive
and respiratory nuclei, particularly the medullary raphé (see section 1.4.3), the pre-
Bötzinger complex and the arcuate nucleus. The pre-Bötzinger complex is the
respiratory rhythm central pattern generator in rats (Smith et al., 1991) and has been
identified in humans (Lavezzi and Matturri, 2008). Thus any mutations leading to a
loss of, or abnormal function in, these neurons will result in apnoea. In one study
abnormalities in the pre-Bötzinger complex were identified in 41% of sudden death
patients (Lavezzi and Matturri, 2008).
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There are several hypothesises as to which chemosensitive areas in the VLM
of lower order mammals (see section 1.3) relate to their human counterparts (figure 2),
though all agree that the human arcuate nucleus is a key central chemosensitive site.
Some believe that there is no homologue to the rostral chemosensitive sites, area M
and the RTN (Filiano et al., 1990), whereas others believe that it is the arcuate nucleus
(Mulkey et al., 2004, Okada et al., 2001). If there is no rostral homologue the arcuate
nucleus may be the caudal chemosensitive area, area L, and the raphé complex of cats
and rats; as the cells of these regions are identical in description and cover similar
areas (Filiano et al., 1990). By contrast those who have implicated the arcuate nucleus
as the rostral homologue implicate the nucleus conterminalis as the human homologue
of the cat and rat area L (Okada et al., 2001). There is an area S homologue, which is
also opposed to the sub-pial space. Also both humans and lower order mammals have
raphé pallidi (Filiano et al., 1990). There is also a thickened marginal glial layer
(MGL) in the human which is comparable to that of lower order mammal (Filiano et
al., 1990) as they cover similar areas upon 3D reconstruction.
Figure 2: Human chemosensitive and respiratory nuclei.
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In any case arcuate nucleus abnormalities are commonly seen in SIDS
patients (Lavezzi and Matturri, 2008), these include low neural density, volume and
number of neurons (Matturri et al., 2002, , Biondo et al., 2003). Since these areas in
humans as well as the human pre-Bötzinger complex homologue (Lavezzi and
Matturri, 2008), have all been implicated in the pathology of sudden infant death
syndrome (Matturri et al., 2002, , Biondo et al., 2003, Lavezzi and Matturri, 2008),
any progress made in chemoreception and respiration in lower order mammals could
advance our understanding of human diseases.
1.2 Chemosensitivity
Chemoreception is the body’s ability to detect specific chemical changes. In
terms of respiration chemoreception is the ability of the brain to detect changes in
blood gases (oxygen and carbon dioxide) and to alter breathing to keep their levels
within tightly controlled parameters. The O2 sensitive chemoreceptors are external to
the brain in the carotid bodies. CO2/pH sensitive cells are also in the carotid bodies
(Peers and Buckler, 1995), but major sites are also within the brain (Feldman et al.,
2003). Of the two gases it appears that CO2 provides the most powerful drive to
breath (Haldane and Priestley, 1905). Hypercapnia from re-breathing expired air
causes similar increases in respiratory rate to exercise and does not affect physiology.
In contrast hypoxia (low O2) causes cyanosis (blueing of the lips and fingertips etc.),
which is not seen during physical exertion. As athletes do not become cyanotic before
their breathing rate increases, this was interpreted to mean that CO2 is the primary
drive to breathe (Haldane and Priestley, 1905). In support of this, it has been shown
that mean arterial PCO2 (PaCO2) does not change with exercise (Forster et al., 1986).
In conjunction PCO2 in arterial blood is not different well below, above or at sea
level, until extreme altitudes (>2500ft) are reached or prolonged periods of time are
spent at altitude (Haldane and Priestley, 1905, Catron et al., 2006). In contrast PO2
varies dramatically during short term exposure to moderate altitude (Haldane and
Priestley, 1905). Therefore PCO2 is tightly regulated even at the expense of PO2, as it
is at rest (Haldane and Priestley, 1905). In fact an increase in arterial PCO2 by as little
as 1mmHg leads to a 20-30% increase in ventilation (Feldman et al., 2003) and
increasing inspired CO2 to 4% increases ventilation (177%) (Haldane and Priestley,
1905). As CO2 levels rise, depth of breathing increases as does total ventilation
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(Haldane and Priestley, 1905). In contrast inspired O2 must fall to 13% before
changes in respiration occur (Haldane and Priestley, 1905).
The central CO2 chemoreceptors, which are responsible for detecting changing
levels of CO2, are situated close to the respiratory centres and provide a powerful
driving force for respiration (Thomas et al., 1999). Moreover it is changes in the
partial pressure of carbon dioxide (PCO2) of arterial blood that provides this powerful
drive for respiratory rhythm (Haldane and Priestley, 1905), and causes the changes in
ventilation that serves to alter clearance of CO2 via the lungs (Berne and Levy 1998).
This is also true during exercise where increased ventilation is proportional to
increased CO2 produced by the work, so increased breathing serves to clear the extra
CO2 and keep blood levels constant (Haldane and Priestley, 1905). Therefore there
must be an underlying homeostatic process that serves to detect levels of systemic
CO2 and changes respiratory frequency, in order to return levels of CO2 to the norm.
The fact that CCHS patients are able to manage their PCO2 during wakefulness has
led to the hypothesis that chemoreception is only functional during sleep. However
there are many more factors that contribute to respiratory control during wakefulness
as compared to sleep, it may be the contribution of these additional factors that allows
them this compensation (see section 1.8)
Once in the extracellular fluid (ECF) CO2 is converted to bicarbonate ions and
protons. Although this process occurs it does so at a very slow rate. This can however
be dramatically increased by carbonic anhydrase, which catalyses the reaction (figure
3). Thus there are three possible signalling molecules that could act as chemosensory
signals.
CO2 + H2O ↔ HCO3- + H+
CA
Figure 3: The conversion of carbon dioxide to hydrogen ions under the influence of carbonic
anhydrase (CA). Possible chemosensory signals are highlighted in black.
In order to be classified as a chemosensitive neuron certain characteristics
must be displayed. Neurons must respond to CO2 or pH intrinsically, project to the
respiratory centres and once stimulated must lead to alterations in ventilation (Putnam
et al., 2004, Guyenet et al., 2005b, Richerson, 2004). A neuron that responds
intrinsically to CO2 must contain a protein that directly binds CO2, causing a change
in conformation, leading to an alteration in the neurons excitability. It must be
remembered that neurons inhibited by CO2 are as important as those excited by it
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(Putnam et al., 2004). The anatomical connections between the pre-Bötzinger
complex and chemosensitive neurons means that NK1R (neurokinin 1 receptor: a
marker of pacemaker cells in this region) ablation in the pre-Bötzinger complex leads
to the loss of the hypercapnic and hypoxic responses (Feldman et al., 2003). There are
several areas that have been implicated in chemoreception and they will be discussed
here.
1.3 The Ventrolateral medulla
The surface of the ventro-lateral medulla has a denser capillary network than
the surrounding tissue (Göbel et al., 1990). The penetrating vessels of the medulla are
surrounded by a perivascular space (Okada et al., 2001), and lead to elongated and
labryrinthic invaginations of the sub-arachnoid space which form cisternae at the
surface of the medulla (Okada et al., 2001). This leads to a higher blood flow than is
seen in the surrounding tissue which is followed by higher glucose utilisation in adult
rats (Göbel et al., 1990). This allows for greater blood gas sampling by the cells of the
medulla, making the arterial branches perfusing the rostral ventrolateral medulla
(RVLM) the most important in chemoreception (Okada et al., 2001). Importantly
there is an intimate relationship between CO2 excitable cells and surface and
penetrating vessels in the ventral medulla, the basal lamina of these vessels have
neuronal axon terminals and somata abutted to them (Okada et al., 2001). These cells
often displayed a concave shape and a surface indentation is associated with fine
vessels (Okada et al., 2002).
1.3.1 Chemosensitive sites of the VLM surface
The importance of the medulla in chemosensory signalling has long been
known and the first major site that responds to inspired CO2 was discovered on the
VLM surface 45 years ago (Mitchell et al., 1963). Increasing the PCO2 or hydrogen
ion (H+) concentration at a discrete locus on the surface of the VLM dramatically
increased breathing. This area of the rostral VLM was designated area M after its
founder (Mitchell et al., 1963). Interestingly the effect of changes in H+ alone on
respiration were slower than the effects of changing CO2/H+ simultaneously (Mitchell
et al., 1963). In conjunction application of acetylcholine (ACh) or nicotine (which acts
at nicotinic ACh receptors) to the sub-arachnoid space around 8th and 9th cranial nerve
rootlets increased tidal volume and frequency (Mitchell et al., 1963).
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Application of sodium cyanide (NaCN) and lobeline (an AChR antagonist) to
area M depressed respiration (Mitchell et al., 1963). In conjunction cooling of this
area leads to a pronounced apnoea in both adult and neonate goats (Forster et al., 1997)
and adult cats (Mitchell et al., 1963). Repeated applications of ACh agonists led to a
desensitisation of the response and cauterising it diminished it dramatically (Mitchell
et al., 1963). Procaine (a local anaesthetic) depressed tidal volume and did not
penetrate more than 0.35mm into the medulla (Mitchell et al., 1963).
They concluded that the neurons or their dendrites creating this response must
be close to the surface since hydrogen and bicarbonate ions diffuse slowly through
neural tissue and poorly penetrate the cellular membrane if at all (Mitchell et al.,
1963). The neurons of area M thought to participate in this response are located dorsal
to the ventral surface and consist of thin unmyelinated dendrites running parallel to
the pial surface (Okada et al., 2001). The conclusions of these experiments were that
the VLM contributes approximately 40% of the total hypercapnic ventilatory response
(Mitchell et al., 1963).
The discovery of this chemosensitive area on the surface of the ventral
medulla led to investigations to locate other areas that may participate in the
hypercapnic ventilatory response. A second series of experiments by the same group
identified a separate area at a more caudal location, designated as area L (Loeschcke
et al., 1970). This area was located in and around the hypoglossal nerve rootlets, and
electrical stimulation of this area caused an increase in respiratory rate (Loeschcke et
al., 1970). However cooling of this area in goats had an effect only in neonates
(Forster et al., 1997). The neurons of area L are located between 80-200µm from the
surface of the medulla (Okada et al., 2001). Acetylcholinergic cells of this region
importantly have close contact with penetrating vessels, ideally locating them to sense
changes in blood chemistry (Okada et al., 2001). A third intermediate area was
located between area M and L, designated area S. This region though apparently not
chemosensitive itself contains neurons of passage vital to the chemosensitive response
(Loeschcke, 1982). The neurons of area S are located 30-50µm from the ventral
surface which were more dense than area L (Okada et al., 2001).
The stimulation or inhibition of breathing by the rostral (area M), intermediate
(area S) and caudal (area L) chemosensitive loci, may have been due to a direct effect
on the respiratory central pattern generator. To determine this, a series of ventral
surface cooling experiments were conducted. Cooling of any area was never able to
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eliminate breathing in goats (Forster et al., 1997). Therefore neurons near the VLM
surface are not essential to sustain breathing in the awake goat (Forster et al., 1997).
However it did have a profound effect on the response to hypercapnia and hypoxia
(Forster et al., 1997). Greater effects of cooling were seen in the response to
hypercapnia than hypoxia and during exercise; thus the effects of cooling are due to
the inactivation of CO2 sensitive neurons (Forster et al., 1997). As respiration was
reduced across all parameters tested, it appears that chemosensitive neurons of the
VLM provide a facilitatory effect on more dorsal areas independent of
chemoreception (Forster et al., 1997). Although the experiments described so far
show that sites on the VLM surface do in fact contribute to the ventilatory response to
hypercapnia, they do not distinguish whether these are intrinsic responses or due to
the integration of the peripheral chemoreceptors. Cooling of the ventral surface was
without effect on peripheral chemosensory stimulation; thus the VLM does not
integrate peripheral chemoreceptors (Forster et al., 1997).
1.3.2 Cell types involved in CO2 chemosensation
The medulla has a thickened marginal glial layer, which extends from the
surface of the medulla to a depth of 150µm. The MGL of the rostral VLM contains
numerous neurons, although only few neurons are seen in the MGL of many other
brainstem regions (Okada et al., 2001). Many c-Fos studies have been undertaken to
identify chemosensitive neurons of the VLM. c-Fos is a proto-oncogene that becomes
active when neurons fire, and thus is a marker of neuronal excitability. There are
however some limitations to its use and data collected by these studies must be
carefully interpreted. In order to increase levels of c-Fos to a detectable level, neurons
must be activated for a sustained period of time; typically animals are put into CO2
rich environments (>9%) for at least 1 hour. This is a very unphysiological stimulus
and could lead to the activation of neurons that do not typically respond to
hypercapnia. It must also be noted that not all neurons express c-Fos and so may be
misinterpreted as non-chemosensitive. Conversely, c-Fos is expressed in all neurons
that express it and are active, whether they participate in the response to a given
stimulus or not; thus some neurons will be misconstrued as chemosensitive when they
are not. Finally c-Fos studies are unable to distinguish between neurons that are
intrinsically sensitive to a given stimulus (primary order neurons) and those
stimulated by synaptic transmission (second order neurons).
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As one would expect c-Fos studies have shown CO2-induced positive cells in
the ventral medulla (Belegu et al., 1999, Sato et al., 1992, Wickström et al., 1999).
Most c-Fos positive cells lie predominantly within a few hundred micrometers of the
ventral surface, but some are seen at deeper levels when 21% CO2 was inhaled for 1
hour (Belegu et al., 1999) or 10% for 3 hours (Okada et al., 2002). In contrast
exposure to lower CO2 levels, 13-15% for 1 hour, c-Fos immunoreactivity in deeper
structures was not different to controls (Sato et al., 1992). Neurons embedded within
the MGL are typically of small diameter and surround fine vessels, whereas those
seen in deeper structures have a larger diameter (Okada et al., 2001, Okada et al.,
2002). These c-Fos studies have shown that 67-75% of c-Fos positive cells reside
within the first 50µm of the surface of the VLM (Sato et al., 1992, Okada et al.,
2002), which constitutes approximately 29% of all superficial cells (Okada et al.,
2002). Interestingly c-Fos expression in small diameter neurons within the MGL is
unaffected by the blockade of synaptic activity with either low calcium/high
magnesium or Tetrodotoxin (TTX) (Okada et al., 2002). On the other hand larger
diameter neurons showed almost no c-Fos reactivity in either of the synaptic block
solutions (Okada et al., 2001). The topology of c-Fos staining in the VLM closely
resembles that of areas M, L and S (Sato et al., 1992). Intriguingly shortly after birth
the VLM is the only location in which c-Fos can be induced by hypercapnia
(Wickström et al., 1999). In conjunction injections of HCl, creating a fall in pH of
0.2pH units (a chemosensory stimulus in the absence of CO2), a similar drop to that
seen in arterial pH during hypercapnia, increased c-Fos staining in all surface regions
of the medulla (Douglas et al., 2001).
1.3.3 The marginal glial layer of the VLM may contribute to CO2 chemosensory
transduction
It is important to remember that although neurons are present at the surface of
the VLM, the primary cell type that resides here are astrocytes. Therefore one cannot
discount their participation in the hypercapnic ventilatory response. In fact it has been
speculated (Okada et al., 2001, Filiano et al., 1990) that the primary chemoreceptor
cells may be a kind of neuroglia which process hypercapnia and release chemical
messengers. Thus the significance of glia near the medullary surface in central
chemoreception needs to be further studied.
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The first indication that glia may participate in the adaptive changes in
breathing to alteration in PCO2 was that presumed glia cells within the MGL
depolarise in response to hypercapnia (Fukuda et al 1978, Ritucci et al 2005). In one
study this was shown to be a direct interaction with H+ as they depolarise in response
to changes in pHe without concomitant changes in PCO2 (Fukuda et al., 1978).
However this study did not distinguish whether this is a direct effect of H+ on these
cells, or a secondary effect of H+ acting on neurons of this region, which in turn
influence these cells. Nevertheless the reason for this depolarisation and the exact role
they play is a yet an unanswered question.
Importantly perfusion of the rostral VLM with fluorocitrate, a glial toxin,
reduced the hypercapnic ventilatory response by 10% in anaesthetised rats (Erlichman
et al., 1998). However these studies are by no means conclusive, fluorocitrate only
inhibits the tricarboxylic acid cycle but does not affect the ribose shunt pathway. Thus
under these experiments it may still be possible for glia to produce adenosine
triphosphate (ATP) and may leave other intracellular processes intact. Importantly the
animals were not treated with isocitrate, which could bypass the effects of
fluorocitrate on astrocytes and thus recover the animals to act as an important control.
In addition glia are closely associated with blood vessels in the medulla (Bradley et al.,
2002). It is therefore possible that this association exists so they may sample the PCO2
content of arterial blood. In addition a small proportion of SIDS patients present with
a low GFAP (glial fibrillary acidic protein; a marker of glia) density (Biondo et al.,
2003); thus loss of glia in humans may lead to sleep apnoeas in a subset of patients.
Therefore though their involvement has not been conclusively proven, it cannot be
ruled out.
1.3.4 Evolutionary origins of chemosensitive sites on the surface of the VLM
CO2 chemosensitivity of the VLM surface may have arisen from our
amphibian ancestors. There are discrete nuclei on the surface of the medulla of frogs
adjacent to cranial nerve (CN) 5 and CN 10 which are chemosensitive (Tayor et al.,
2003). Although the Frog chemosensitive sites are not homologous to the previously
described mammalian sites, they share many important similarities (Tayor et al.,
2003). Unilateral injections of CO2 rich solutions into each chemosensitive site causes
an increase in ventilation (Tayor et al., 2003). Lesions of either the CN 5 or CN 10
regions removes the hypercapnic ventilatory response and these sites are within
100µM of the surface (Tayor et al., 2003). Intriguingly lesions of the caudal site but
not the rostral site reduced resting ventilation, showing that some chemosensitive sites
in the bull frog also provide facilitatory drive to the respiratory rhythm generator
(Tayor et al., 2003).
1.4 Chemosensitive neurons of the VLM
Although the VLM is undoubtedly important it does not consist of a
homogenous pool of neurons and is comprised of several chemosensitive nuclei.
1.4.1 Primary and secondary chemosensitive neurons
Not all primary chemosensitive neurons feed directly into the respiratory
rhythm generator (figure 4). For instance glomus cells of the carotid body stimulate
the carotid sinus nerve (Spyer et al., 2003), which synapse in the nucleus tractus
solitarius, which innervates the retrotrapezoid nucleus (Moreira et al., 2007). These
neurons excite the pre-Bötzinger complex (Mulkey et al., 2004) which project to
motor neurons that control respiratory muscles (Duffin et al., 2000).
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Thus it is important that, when performing experiments, we distinguish
between whether we are affecting first or second order chemosensory cells. If
experiments are performed which remove cells that have an identified chemosensory
transducer then we can be sure we have removed a primary chemosensor.
Alternatively cells can be identified as primary chemosensors by using a cocktail of
antagonists for all known neuro- and gliotransmitters, though this has the risk that an
unknown transmitter may play a role. Several types of lesioning studies can be
performed to disrupt a reflex arc. By lesioning different aspects of the arc we can
evaluate its involvement in the physiological reflex. However these studies must be
interpreted carefully.
Electrolytic lesions and cauterisation aimed at destroying the cells of a
chemosensitive nucleus, could cause a reduction in the ventilatory response to
hypercapnia. However electrolytic lesions do not just destroy the somata of neurons in
a specific region, they will also destroy neurons of the passage. If the axons of
neurons that pass through an area are destroyed it may remove the reflex, but this will
appear to be due to the removal of the somata in this area.
Genetic lesioning, such as the removal of genes in the form of knockout mice
will remove a genetic component from a cell type of the reflex arc. This can be in the
form of a neurotransmitter such as serotonin which will remove serotonergic
signalling and thus test the participation of serotonergic neurons in a reflex.
Alternatively it could remove a chemosensory transducer, the removal of this
molecule could remove a specific subset of neurons or many neurons in the pathway.
However even if serotonergic signalling is removed, the pathway may still remain
intact but employ a different transmitter such as acetylcholine. Hence it would appear
that this neurotransmitter does not participate in the response providing a false
negative. Alternatively animals with a constitutive lesion from conception may show
developmental compensation for this loss, thus creating the illusion this gene is not
important.
Finally there is pharmacological lesioning. The use of pharmacological agents
to antagonise a receptor removes the influence of a neurotransmitter and thus can
provide evidence for its involvement in the reflex. However a pharmacological agent
may have non-specific effects; thus it will affect neurons in a way which is not
intended. Therefore it may also provide a false positive.
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1.4.2 Respiratory neurons
Respiratory (increased CO2/H+) and metabolic acidosis (increased H+ at
constant PCO2) increase frequency in neonatal rat ‘en bloc’ preparations (Kawai et al.,
2006). Though the responses to metabolic and respiratory acidosis may cause similar
changes in ventilation, they are mediated by different channels (Kawai et al., 2006).
A rise of CO2 from 2-8% increases phrenic nerve discharge (PND) by 70%
(Kawai et al., 1996), due to a reduced burst length and expiratory interval in mice
(Kawai et al., 1996, Infante et al., 2003), whereas burst amplitude stays unchanged in
the rat (Kawai et al., 2006). Alterations in PND are a result of the effect that moderate
shifts in pH or PCO2 have on membrane excitability (Kawai et al., 1996).
Hypercapnic (respiratory) acidosis depolarises inspiratory neurons resulting in their
discharging, whereas hypocapnic alkalosis has the opposite effect (Kawai et al., 2006).
When solutions are switched from hypocapnic alkalosis to hypercapnic
acidosis pre-inspiratory (pre-I) neurons increased firing during all phases of their
bursting (Kawai et al., 2006). In contrast to inspiratory related neurons post-
inspiratory (post-I) and expiratory neurons hyperpolarised in response to hypercapnia
and decreased discharge (Kawai et al., 1996). In the presence of TTX or in calcium
free solutions to stop synaptic activity, both post-I and expiratory neurons retained
their hyperpolarising response but in the absence of discharge (Kawai et al., 1996),
whereas inspiratory neurons depolarised (Kawai et al., 1996).. As well as bursting
neurons that respond to hypercapnia there are tonically firing neurons that are
sensitive to it, these neurons were either excited by CO2 or depressed by it. Tonically
excited neurons depolarised in response to hypercapnia and increased their discharge,
these neurons also depolarised in TTX and low calcium (Kawai et al., 1996).
Tonically depressed neurons hyperpolarised and decreased discharge in response to
increased PCO2, and maintained their change in membrane polarity in synaptic block
(Kawai et al., 1996). Thus during hypercapnia there is reduced firing of expiratory
neurons and an increase in firing in inspiratory related neurons. The maintenance of
membrane potential changes in synaptic block has been thought to show that
respiratory neurons are intrinsically chemosensitive (Kawai et al., 2006).
The cell bodies of respiratory neurons reside between 90-400µm from the
surface with dendrites projecting to within 50µm of the VLM surface regardless of
cell body depth (Kawai et al., 2006). Cell body depth was independent of response
time and not deep enough to elicit the fast responses seen with hypercapnia; hence it
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is the dendrites that are likely to be chemosensitive (Kawai et al., 1996). In
conjunction neurons that lack dendrites but whose cell bodies are at the same depth as
hypercapnia modulated respiratory neurons are insensitive to CO2 (Kawai et al., 1996).
As well as neurons of the Bötzinger and pre-Bötzinger complex, pre-I
neurons are intrinsically and synaptically chemosensitive (Kawai et al., 2006).
Excitation of these neurons by hypercapnia increased both the frequency and
amplitude of drive potential (Kawai et al., 2006). As hypercapnic (respiratory)
acidosis caused greater responses than isocapnic (metabolic) acidosis and isohydric
hypercapnia (increased CO2, at a constant pH) it appears that CO2 itself has an effect
(Kawai et al., 2006). Though it must be stated that the respiratory neurons of the adult
in vivo have been shown to be unresponsive to H+ (Ribas-Salgueiro et al., 2003). Even
if they are not chemosensitive, they must at least be second order neurons, but which
transmitters affect them?
1.4.3 Medullary raphé neurons
The medullary raphé neurons are serotonergic neurons that either have their
cell bodies in the marginal glia layer or if their cell bodies are in deeper structures and
have dendrites that run parallel to the surface (Ribas-Salgueiro et al., 2005). In
conjunction with their close proximity to the VLM surface serotonergic neurons are
closely associated with arteries. These arteries perfuse the medulla before the rest of
the brain, thus enabling serotonergc neurons to sense blood gases before they are
affected by brain metabolism (Richerson, 2004). Phenylethanolamine N-
methyltransferase (PNMT), a marker of adrenergic cells also co-localises with
markers of serotoninergic cells. These PMNT positive cells were often in direct
apposition to the basal lamina of small capillaries, intraparenchymal blood vessels and
neighbouring astrocytic processes (Okada et al., 2001). Other studies have also shown
that neurons expressing serotonergic markers are tightly apposed to both surface and
penetrating large arteries of the VLM (Bradley et al., 2002, Severson et al., 2003), and
that only glial end feet separate these neurons from large blood vessels (Bradley et al.,
2002).
These cells have been shown to be highly sensitive to fluctuations in pHi in
vitro (Ribas-Salgueiro et al., 2005, Wang et al., 2002) and to some extent in vivo
(Mulkey et al., 2004, Ribas-Salgueiro et al., 2003, Veasey et al., 1995). Their
chemosensitivity has been shown to vary with age, during the first two postnatal
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weeks there was an increase in responsive neurons (3-18%) in vivo (Wang and
Richerson, 1999), and an increase in the strength of the response in both neurons that
are inhibited and excited by hypercapnia in cultured raphé neurons (Wang and
Richerson, 1999). After the second postnatal week, the response remains unchanged
with 22% (Veasey et al., 1995) to 27% of cells in midline raphé being excited by
hypercapnia (Okada et al., 2002). An increase in inspired CO2 increases ventilation by
increasing inspiratory burst amplitude in conscious cats (Veasey et al., 1995). In
conjunction exercise which increases arterial CO2 also increases activity in raphé
neurons of cats in vivo (Veasey et al., 1995). The increase in firing of these neurons
will lead to increase in respiration, which will reduce PaCO2 back to resting levels.
Raphé neurons are also either highly or mildly responsive to isocapnic acidosis, and
displayed an increased firing frequency of burst patterning in anaesthetised rats
(Ribas-Salgueiro et al., 2003).
It appears that the serotonin 1a receptor (5-HT1a) is an important receptor in
these neurons. A 5-HT1a receptor antagonist 8-hydroxy-2-(di-n-propylamino) tetralin
(8-OH DPAT) reduced firing in raphé neurons when injected intravenously (IV) or
subcutaneously (Veasey et al., 1995). Blockade of 5-HT using methysergide (a 5-
HT1/2 receptor antagonist) not only reduces respiratory rate but also reduces c-Fos
staining in these areas, both in vivo and in vitro (Bodineau et al., 2004).
1.4.3.1 Alterations of pHi is the chemosensory stimuli of raphé neurons
Raphé neurons in vitro responded equally to all forms of chemosensory
stimuli, isohydric hypercapnia (IH), hypercapnic acidosis (HA) and isocapnic acidosis
(IA) (Wang et al., 2002). However the increase in firing did differ between these
chemosensory stimuli so that IH>IA>HA (Wang et al., 2002). These responses were
unaffected by application of the carbonic anhydrase inhibitor acetazolamide (AZ),
leaving the conclusion that it is in fact alterations in pHi that are primarily responsible
for the change in firing rate (Wang et al., 2002). It has also been shown that their
intrinsic chemosensitivity to pHe comes from the presence of TASK (tandem-pore
acid sensing channels) 1 and 3 channels (Mulkey et al., 2007b). These channels are
highly sensitive to certain anaesthetics such as halothane (Mulkey et al., 2007b),
which may provide a reason for their low CO2 sensitivity in anaesthetised animals in
vivo (Mulkey et al., 2004). The fact that TASK knockouts show no deficiency in their
CO2 response has left doubt over whether serotonergic neurons are functional
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chemosensors (Mulkey et al., 2007b). However since these mice have lacked these
channels since birth it is possible that they have compensated for this somehow.
Although their intrinsic chemosensitivity has been called into question, it is
still certain that they participate in the response to hypercapnia; as animals seem to be
unable to compensate for the loss of serotonergic neurons (Li and Nattie, 2008b).
Therefore it is highly likely the TASK channels are not the primary chemosensory
transducer for serotonergic neurons. Thus serotonergic neurons appear to be second
order neurons, responding to the release of a transmitter from primary chemoreceptors.
The remaining questions therefore are which transmitter is influencing these neurons
and why are they so closely associated with blood vessels?
Their close association with blood vessels has always been assumed to be to
increase their ability to detect changes in arterial PCO2. Importantly serotonergic
neurons are not directly apposed to blood vessels, instead they are actually associated
with glial end feet that surround the artery (Bradley et al., 2002). Thus it may be that
it is their association with glia that is important and the proximity of these neurons to
arteries is due to the necessity of glial contact with arteries. In other words, glia are in
close contact with arteries, as they are responsible for sensing arterial PCO2, they then
release a transmitter to signal alterations in arterial PCO2 which is detected by
serotonergic neurons. Therefore serotonergic neurons are closely associated with glial
end feet around blood vessels, so that they may detect this signal.
1.4.3.2 Anatomical connections of the raphé nuclei
Anterograde tracers injected into the caudal VLM, looking for efferent
projections revealed connections with: the rostral VLM, lateral reticular formation and
the nucleus tractus solitarus of the medulla; the parabrachial nucleus, locus coeruleus
and the A5 region of the pons; the motorneurons of the cranial nerves in the cat
(Stocker et al., 1997). Once stimulated the medullary raphé exert their influence over
the hypercapnic ventilatory response by innervating respiratory and other
chemosensory centres (Ribas-Salgueiro et al., 2005, Mulkey et al., 2007a).
1.4.3.3 Serotonergic neurons influence over the drive to breathe
Serotonergic neurons are a source of tonic drive for respiration (Richerson,
2004, Hodges et al., 2008). Inhibition of the raphé obscurus inhibits the persistent
sodium current (INaP) in the pre-Bötzinger complex (Pace et al., 2007). INaP currents
provide a depolarising current when pacemaker neurons are hyperpolarised stabilising
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their Vm (Tryba and Ramirez, 2004). This keeps the pacemakers Vm within a range
where bi-stable properties can be expressed (e.g., regenerative plateau formation),
which is vitally important to their function (Tryba and Ramirez, 2004). Thus raphé
neurons project to the pre-Bötzinger complex and increase excitability (Pace et al.,
2007). A second source of tonic input is derived from the raphé magnus (RM) (Li et
al., 2006). Inhibition of the medullary raphé in a location that include raphé pallidus
(RP) and raphé obscurus (RO) causes hypoventilation (Li et al., 2006), thus they
provide a facilitatory drive to respiration. However they are not essential for rhythm
generation (Hodges et al., 2008). Thus any excitation or inhibition here will lead to
alterations in respiratory rate. The exact nature of their participation is unclear as there
are differential reports as to how these neurons influence breathing. Serotonin
transporter knock out mice exhibit higher breathing rates than wild types of both
sexes (Li and Nattie, 2008b), however ablation of medullary raphé with 5,7-
dihydroxytryptamine (5,7-DHT) did not affect basal respiration (Penatti et al., 2006).
1.4.3.4 Serotonergic neurons influence over chemoreception
They may also influence adaptive breathing to alterations in CO2, through the
release of substance P, TRH (tyrosine hydroxylase) and serotonin which are co-
expressed in raphé neurons, and known to excite chemosensory neurons (Mulkey et
al., 2007a, Richerson, 2004). The absence of serotonergic neurons by genetic (cre-lox)
re-combination causing the removal of the homeobox gene Lmx1b only in
serotonergic neurons leads to a reduced response to CO2 challenges (~50%) (Hodges
et al., 2008). These mice show a developmental compensation with greater emphasis
on peripheral receptors; importantly the hypercapnic ventilatory response could be
rescued by intracerebroventricular injections of 5-HT (Hodges et al., 2008). The fact
that the hypercapnic ventilatory response could be rescued by the addition of the
neurotransmitter released by the cells that were removed indicates that the rest of the
respiratory network is intact in these animals and that this is not due to a non-specific
effect of the removal of the gene.
Serotonin transporter knockout mice have increased 5-HT in their extracellular
fluid (ECF), which leads to a desensitisation of their receptors, and a decrease in their
respiratory response to CO2 (Li and Nattie, 2008b): approximately 48-68% in males
and 15-38% in females (Li and Nattie, 2008b). Though in pigs it has been shown that
lesions of 5-HT neurons with 8-OH DPAHT leads only to a decrease in the CO2
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response in males and only during NREM (non-rapid eye movement) sleep (Penatti et
al., 2006) as there are sex differences in the ability to compensate for medullary
lesions (Penatti et al., 2006). The differences between these studies may also be
because CO2 sensitivity does not change during post-natal life in pigs as it does with
rats. The idea that chemosensitivity differs between these two species is further
supported by the fact that aberrations in serotonergic neurons do not affect hypoxia in
rodents (Hodges et al., 2008, Li and Nattie, 2008b), but do affect hypoxic responses
during NREM in piglets (Penatti et al., 2006).
1.4.3.5 Effects of different raphé nuclei on respiration
Although serotonergic neurons are usually grouped together it must be said
that the raphé consist of three nuclei; RM, RP and the RO, which all contain
serotonergic neurons in adult rats (Connelly et al., 1989). It is important to note that
these areas provide differential responses on respiration when electrically stimulated;
the RM is associated with inhibition of respiratory drive, whilst the RP provides a
facilitatory role and the RO causes both inhibitory and excitatory responses (Cao et al.,
2006). Stimulation of the RM depressed the inspiratory phase and ceased respiratory
movements at the end of the expiratory phase, thus slowing respiration (Cao et al.,
2006); it should also be noted that this area inhibits the response to hypoxia (Penatti et
al., 2006). Thus the RM could provide a GABAergic (gamma aminobutyric acid)
input into the respiratory system and the RP a serotonergic one (Cao et al., 2006). c-
Fos studies have revealed that during hypercapnia greater activity is seen in the caudal
nuclei of the raphé, in the RP and RO, the raphé neurons known to facilitate
respiration (Belegu et al., 1999). This mediation may arise from raphé spinal
projections (Cao et al., 2006, Weston et al., 2004) in conjunction with those to other
medullary nuclei (Cao et al., 2006).
It must also be noted that as well as differential responses between nuclei,
there are differential responses between neurons in the same locale, such that some
are inhibited by hypercapnia and others excited by it: chemosensory inhibited cells act
oppositely to chemosensory activated cells (Wang et al., 2002). Although the strength
of inhibition on breathing varies dramatically, depending on the location within the
medullary raphé (Li et al., 2006). These neurons were also stimulated by all forms of
chemosensory stimuli so that the magnitude of inhibition was HA=IH>IA (Wang et
al., 2002).
35
1.5 The retrotrapezoid nucleus
The RTN is located ventral to the facial (VII) nucleus and contains
glutamatergic Phox2b positive neurons (Mulkey et al., 2004, Kang et al., 2007) which
do not contain serotonin (Connelly et al., 1989). The neurons are located at 130-
230µm from the ventral surface, with a few cell bodies located in the MGL (Mulkey
et al., 2004). Their dendrites project ventrally with extensive secondary dendrites
located within the MGL (Mulkey et al., 2004). Since 67% of c-Fos positive cells lie
within the first 200µm of the ventral surface and 60% c-Fos positive cells lie rostral to
the midline (Sato et al., 1992), a vast proportion of the cells stained in this study are
RTN neurons. This location enables the dendrites to sample CSF in close proximity to
the basilar artery, and thus sense CO2 of the blood before it is affected by cellular
metabolism (similar to the medullary raphé). These cells are exquisitely sensitive to
CO2 when levels are above 4% in vivo (Mulkey et al., 2004, Hewitt et al., 2004) and
in vitro (when it leads to hypercapnic acidosis) (Mulkey et al., 2004), and from
injections of AZ (resulting in decreased pH) directly into this nuclei (Hewitt et al.,
2004). Though their pH sensitivity in vitro is half of that in vivo, as the temperature
difference between these preparations significantly alters their pH sensitivity
(Guyenet et al., 2005a). This discrepancy may also be due to the large pH changes
used in the in vitro preparation (~0.5 pH units) which could not be achieved in vivo
(~0.15 pH units see section 1.9.4). Their CO2 sensitivity is preserved in the presence
of blockers of excitatory transmission both in the RTN and the pre-Bötzinger complex;
and it has been shown that the central pattern generator (CPG) activity during
hypercapnia is secondary to RTN firing (Mulkey et al., 2004). Thus during
hypercapnia increased firing in RTN neurons causes increased discharge in pre-
Bötzinger neurons.
1.5.1 Intrinsic chemosensitive properties of RTN neurons
Their intrinsic pH sensitivity has been shown to be linked to a background K+
current (Mulkey et al., 2004), it appears that hypercapnia blocks outward rectifying
potassium channels (figure 5(i)) (Wellner-Kienitz et al., 1998). Unlike serotonergic
neurons this effect is not dependent on TASK channels (Mulkey et al., 2007a). The
RTN contains over 2000 glutamatergic neurons that are activated by acidification via
reductions in potassium conductance (Guyenet, 2008). Although they are intrinsically
chemosensitive, it has not been ruled out that respiratory acidosis could release an
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unknown substance from neighbouring glia or blood vessels and this substance could
activate receptors located on the RTN neurons causing the modulation of their
potassium conductance (Guyenet et al., 2005b). Although these authors have ruled out
serotonergic and purinergic modulation of their pH sensitivity in neonates (Mulkey et
al., 2004, Mulkey et al., 2007a), this has not been done in adult preparations or in vivo;
thus their modulation by these transmitters in the mature hypercapnic response cannot
be ruled out. However although serotonin does not affect the intrinsic pH sensitivity
of these neurons, it is not without effect; serotonin and pH are additive showing
different mechanisms in RTN neurons (Mulkey et al., 2007a). Therefore it has been
hypothesised that serotonin could bring RTN neurons close to their firing threshold,
magnifying their response to pH changes and thus increasing central chemosensitive
reflex gain (Mulkey et al., 2007a). Since at least one other transmitter affects these
neurons, it may be a yet overlooked transmitter that performs a similar role.
1.5.2 Influences on RTN neurons
The RTN provides the major drive to breathe, as it is the major site of CO2
sensing and CO2 is the major drive to breathe, but it also comes under the influence of
many feed forward inputs and reflexes (Guyenet, 2008). Activity of RTN neurons is
unregulated by descending inputs from the hypothalamus involved in respiration
(Guyenet, 2008). The RTN receives convergent inputs from lung mechanoreceptors,
peripheral chemoreceptors and cardiopulmonary C-fibre afferents which first synapse
in the NTS (Moreira et al., 2007, Takakura et al., 2006). Though peripheral
denervation does not affect their response to hypercapnia (Mulkey et al., 2004). It also
receives direct inputs from the NTS (a known chemosensitive site), particularly
glutamatergic neurons of the commissural NTS as activity here causes spiking in the
RTN (Takakura et al., 2006, Bodineau et al., 2000). It also receives inputs from the
ventrolateral NTS but whether these are chemo- or baro- receptors was not elucidated
(Bodineau et al., 2000), however it is most likely that that these are slow adapting
pulmonary stretch receptors (Moreira et al., 2007).
The RTN also receives inputs from the medullary raphé and injections of 5-
HT, TRH and substance P (neurotransmitters released by serotonergic neurons) all
increased PND and single cell firing rate of neurons in the RTN (Mulkey et al.,
2007a). There is an implication that the serotonergic neurons of the raphé obscurus
provide a tonic drive to the RTN (Li et al., 2006) as it does for the pre-Bötzinger
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complex (see section 1.4.3.3). Inhibition of serotonergic neurons in the caudal
medullary raphé markedly potentiates the effect of inhibition in the RTN (Li et al.,
2006). Inhibition of these areas causes a hypoventilation and a substantial reduction in
CO2 response (Li et al., 2006). The extensive afferent projections to the RTN has led
to the proposal that the RTN could be a chemosensory integrator (Takakura et al.,
2006), as other respiratory reflexes probably modify respiration by altering
chemoreceptor drive (Moreira et al., 2007). However some believe that this is not the
final common pathway (Guyenet, 2008), as cooling the VLM in the vicinity of the
RTN did not affect the response to carotid nerve stimulation (Forster et al., 1997). The
fact that the RTN receives inputs from peripheral CO2 sensors and is itself pH
sensitive may explain why lesions here reset the accepted arterial CO2 to above
normal levels and may explain why it is so important in the drive to breathe (Nattie,
2006). Thus this region appears to be both a primary and secondary chemosensory
nucleus.
1.5.3 Connections between the RTN and the VRG
Glutamatergic neurons of the VLM (RTN) project ipsilaterally to the VRG
and pontine respiratory group (PRG) (Mulkey et al., 2004, Connelly et al., 1989), pre-
Bötzinger complex and Bötzinger complex (Weston et al., 2004) but not the spinal
cord (Weston et al., 2004, Kang et al., 2007). The latency in the response from
stimulation of these areas shows the projections to be unmyelinated neurons. RTN
neurons are poised to provide a tonic excitatory drive to the CPG (Guyenet et al.,
2005b, Nattie, 2000), as well as chemosensory information (Nattie, 2000). Cooling of
the VLM, which affects the RTN, has shown that the RTN has a facilitatory function
on breathing (Forster et al., 1997). However there are discrepancies between the
effects of lesions on room air breathing, having either no effect (Akilesh et al., 1997)
or causing hypoventilation (Li et al., 2006). A hypoventilation would appear more
plausible due to the fact the RTN provides a tonic drive to the pre-Bötzinger complex
(Li et al., 2006). The RTN neurons receive inhibitory inputs from the CPG and, when
blocked, the intensity of firing in the RTN rises with PCO2 until saturated (Guyenet et
al., 2005a). In conjunction, after CPG blockade their firing becomes tonic (Guyenet et
al., 2005a).
Although the RTN is involved in the hypercapnic ventilatory response, these
neurons are not activated until CO2 levels increase to 5%. At low levels of inspired
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CO2 below the RTN activation point, frequency changes occur indicating that more
than just this nucleus is involved (Li and Nattie, 2002).
Nucleus pHe pHi CO2 HCO3- TTX/ low Ca2+ Excitatory block
RTN + + ? + +
NTS + +
Raphé + + ?
pre-Bötzinger complex ? ? + +
Table 1: Summary of features of areas involved in the hypercapnic adaptive ventilatory response.
+ represent what is known, ? represent what is hypothesised and blank squares represent what is
unknown.
1.6 Distributed versus specialised theory of chemosensitivity
At present there are two theories as to how the medulla oblongata detects
changes in arterial CO2; the specialised chemosensitivity theory, which states that
there are a few dedicated cells which monitor pH and send information to the
respiratory centres: and the distributed chemosensitivity theory, which states that all
brainstem neurons are chemosensitive and it is a summation of the effects on the
medulla as a whole that causes the change in CPG output (Guyenet et al., 2005b,
Guyenet, 2008). Although many brainstem neurons are pH sensitive, some neurons
(i.e. RTN) are dramatically more chemosensitive (Guyenet et al., 2005b), though their
chemosensitivity is determined using extremely unphysiological changes in
extracellular pH. TASK channels confer intrinsic pH-sensitivity to most neurons
(Mulkey et al., 2007b) and TASK knock outs show no alterations in the hypercapnic
ventilatory response, thus the intrinsic chemosensitivity of most medullary neurons is
not required for the chemoreceptive response (Mulkey et al., 2007b). In conjunction
after excitatory block, the RTN remains chemosensitive, but the CPG does not
(inferring that it is not intrinsically chemosensitive) (Guyenet et al., 2005b). Since the
pH sensitivity of the majority of medullary neurons is not necessary for the full
hypercapnic ventilatory response, and there are apparent intrinsically sensitive
neurons in discrete nuclei which are essential for adaptive breathing to hypercapnia,
chemosensitivity is most likely conveyed by specialised groups of neurons within the
brain.
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1.7 The peripheral nervous system
In the 1930s a series of experiments in anaesthetised dogs, led to the search for
the role of the carotid body in respiratory control (Heymans and Bouckaert, 1930).
Though it was known that respiration could be altered by the peripheral nervous
system, this was the first time it had been shown to be due to activation of the carotid
body (Heymans and Bouckaert, 1930). They observed that by removing the carotid
body they were able to remove respiratory related apnoeas to intravenous adrenaline
and that increasing pressure within the carotid body increased breathing (Heymans
and Bouckaert, 1930). Glomus cells are chemosensors of the carotid body and are the
principle peripheral chemoreceptors (Peers and Buckler, 1995). Heeringa et al 1979
estimate their input to be 20-50% of the total hypercapnic ventilatory response (Nattie,
2000).
In these cells a rise in intracellular Ca2+ leads to neurosecretion (Peers and
Buckler, 1995). During hypoxia this is due to the inhibition of K+ channels hypoxia
(Peers and Buckler, 1995), whereas for CO2 transduction it is through alterations in
pHi (Peers and Buckler, 1995).
1.8 Complexity of chemosensitivity
Though chemosensitivity is determined by specialised groups of neurons,
these neurons appear to be present in multiple nuclei throughout the brain (Mulkey et
al., 2004, Filosa et al., 2002, Wang et al., 2002, Nattie and Li, 2002a). What is the
reason for such complexity and the necessity of multiple sites? It has been
hypothesised that one set of chemosensors could be the primary set, but other areas
compensate for its loss (Richerson, 2005). Although redundancy is likely to occur in
such an important function as breathing, this is not likely to be the only reason.
Conditions placed on the respiratory system are constantly changing, increased
CO2 during exercise will be accompanied by lactic acid formation, whereas re-
breathing expired air will not. Thus as conditions change, the influence of individual
chemoreceptors changes, which would increase the adaptability/flexibility of the
system (Richerson, 2005). In support of this there are many physiological reflexes
associated with hypercapnia and different areas perform different functions (Nattie,
2000). There are many stimuli that cause chemosensitive cells to discharge; in
neurons this is primarily pHe (as in the RTN) and pHi (as in the raphé). Thus different
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regions sense different signals and the summation of these signals induces the
appropriate response to the appropriate physiological conditions (Nattie, 2000, Su et
al., 2007). There may also be some temporal specificity, in which some areas respond
to acute and others to chronic conditions (Nattie, 2000). The response to hypercapnia
is also not universal at all sites, they respond to different chemicals (i.e. pH, CO2 etc)
and do so at different levels (i.e. <5% or >5% CO2) and thus may represent functional
subdivisions, so some may mediate small changes and others more pathophysiological
conditions.
Whatever the reason it is apparent that multiple systems are required (Su et al.,
2007, Putnam et al., 2004, Li and Nattie, 2008a). The robust nature of the response to
CO2 depends on additive or greater interactions of inputs from multiple locations
(Nattie, 2000) and some tonic baseline input is required from all chemoreceptors to
allow full expression of the systemic response (Nattie, 2000). It is sure that the
sensitivity of neuronal processing of hypercapnia is enhanced if all of the neurons in
the pathway are chemosensitive (Su et al., 2007). This may provide a reason for the
widespread chemosensitivity in the medullary neurons conferred by TASK channels,
and why these channels, though present are not essential. Finally many sites involved
in CO2 detection provide stability in a closed loop (Li and Nattie, 2008a), and allow
for corrections of regional imbalances of blood flow and metabolism, and provide
redundancy and malleability (Li and Nattie, 2008a).
1.8.1 Complexity of chemosensitivity and arousal state
During wakefulness respiratory control is determined by behavioural and
arousal related influences and their integration with chemoreceptive feedback (Shea,
1997). The integration of descending voluntary and involuntary and rhythmic and
non-rhythmic respiratory drives which act on both the respiratory rhythm generator
and the spinal motorneurons, determine our basal ventilatory rate (Shea, 1997). When
we are in rapid eye movement (REM) sleep however there is a loss of voluntary
inputs and a change in chemoreflexes so that the complexity (a measure of the inputs
to a physiological signal) of respiratory pattern decreases (Dragomir et al., 2008). This
change in complexity during arousal states may explain why CCHS patients show
little perturbation in CO2 regulation whilst awake. If given no physiological
stimulants (i.e. air re-breathing, exercise etc), CCHS shows little qualitative difference
in respiratory adaptation to the altered behavioural conditions (Shea, 1997). Patients
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might learn behavioural cues which replace intrinsic responses (Shea, 1997), for
instance they may increase breathing during exercise because they have learnt to do so
and not through involuntary reflexive control.
This reduction in complexity may be due to enhancement of the GABAergic
system during REM sleep, and muscimol (a GABAA agonist) injections reduce the
complexity of breathing during NREM as well as REM sleep (Dragomir et al., 2008).
This reduction in complexity during REM sleep will partly be due to independence of
breathing on VLM chemoreception (Forster et al., 1997). During NREM sleep
breathing can be made more dependent on VLM chemoreception if animals are
peripherally denervated (Forster et al., 1997): Thus following carotid body
denervation, cooling of the ventral surface during NREM and wakefulness led to
apnoeas, whereas breathing in intact animals recovered (Ohtake et al., 1996).
Further support for this comes from studies in conscious rats where the RTN
and raphé were remarkably immunoreactive for c-Fos after hypercapnia when
compared to other arousal states (Okada et al., 2002). Though other studies have
suggested that RTN and not the raphé are important in the conscious animal (Nattie,
2001). A study in humans has seen that the sensitivity to changes in end tidal (expired)
CO2 were higher during wakefulness (Trinder et al., 2006). Interestingly the increase
in ventilation at arousal is not due to a shift from sleeping chemoreception to waking;
it is due to an increase in the behavioural and arousal related inputs to the system
(Trinder et al., 2006). Although GABAergic enhancement explains the alterations
during REM sleep it does not however explain the alterations in chemosensitivity
during NREM sleep. Studies into non-respiratory (cortical) related chemoreception,
from the olfactory system and trigeminal reflex, may provide some insights. Cortical
chemosensory inputs also alter during sleep stages, for instance olfactory responses
are lost during NREM and REM sleep whereas trigeminal responses are lost only
during REM sleep (Stuck et al., 2006). However cortical event related potentials are
still seen during sleep, thus chemosensory stimuli are processed during sleep, but are
processed differently (Stuck et al., 2006).
1.8.2 Anaesthesia and chemosensitivity
There is also a dramatic difference in the hypercapnic ventilatory response
during anaesthesia and either wakefulness and sleep states. Contrary to what one
would expect conscious rats exhibited more restricted c-Fos than anaesthetised ones
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(Okada et al., 2002). This is due to the unequal suppression of chemosensitive nuclei,
such that nuclei whose activities are low during consciousness can exert greater
influence during anaesthesia. Also, as in conscious animals, chemoreception during
anaesthesia is more dependent on structures of the VLM, such as the RTN, lateral
reticular nucleus, RP and MGL (Okada et al., 2002). Under anaesthesia the influence
of the NTS, which normally contributes 20-30% of the total hypercapnic ventilatory
response in both sleep and wakefulness (Nattie and Li, 2002a), increases to 39%
(Nattie, 2001) and the input of medullary raphé doubles (Nattie, 2001). Though these
measurements provide a useful guide as to the contribution of these sites one must
remember that if a site is acidified, hyperventilation can occur and cause an
alkalisation at other sites that may counteract the effects of the original stimulus and
so they can only be used as guidelines (Li and Nattie, 2002).
1.8.3 RTN and arousal state
Under anaesthesia the RTN plays a massive role in the CO2 response and the
drive to breathe (Nattie, 2006). Anaesthesia differs from sleep, it depresses other
chemoreceptive sites more than the RTN thus increasing its influence on the total
response (Li et al., 1999). Lesions here create a 39% decrease in the response to CO2
during wakefulness and 52% reduction during anaesthesia, but do not affect room air
breathing (Li and Nattie, 2002). In conjunction the tonic facilitatory role of the RTN
alters with anaesthesia, cooling of area M where many of the RTN dendritic
projections are found, shows differences between wakefulness and sleep and
anaesthesia; during wakefulness and sleep there was a decrease in respiration which
recovered, but in anaesthetised animals there was persistent apnoea (Forster et al.,
1997, Ohtake et al., 1996). The facilitatory role of the RTN may also differ between
sleep and wakefulness. Bilateral injections into the RTN of substance P conjugated to
saporin, a ribosome-inactivating protein, (SP-SAP; which resulted in cell death in this
nuclei) reduced induced hypoventilation during wake but not sleep (Nattie and Li,
2002b), whereas inhibition of the RTN causes hypoventilation during wakefulness
and NREM sleep (Li et al., 2006, Nattie and Li, 2002b).
The chemosensitive response of these neurons does not seem dependent on
arousal state. CO2 dialysis (25%: which causes tissue pH changes equivalent to 7%
inspired CO2) into the RTN causes a change in the amplitude of PND by 20% and
accounts for 25% of the total response in anaesthetised animals and an increase in
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tidal volume of 17-24% during wakefulness (Li et al., 1999). However the relative
contribution of this area does not seem to be affected in NREM sleep; 24% during
wakefulness and 27% during NREM sleep (Li et al., 2006). In conjunction both uni-
and bi- lateral injections of SP-SAP reduced the CO2 response by 51% during
wakefulness and 52% during NREM sleep. One study seems to contradict this: in
awake rats 50-100% CO2 dialysis increased ventilation by 10-30% during
wakefulness but not when asleep, though this may be due to failure to distinguish
between NREM and REM sleep (Li et al., 1999).
1.8.4 Arousal state and serotonergic neurons
Hypercapnia induced changes in breathing decrease when 8-OH DPAT lesions
are applied to the RM and RP, due to tidal volume changes during sleep and
wakefulness (Taylor et al., 2005). Though reductions in their CO2 response was
higher during wakefulness (22%) than sleep (10%) at lower concentrations of 8-OH
DPAT, interestingly at high concentrations the responses were not different (Taylor et
al., 2005). A similar result was seen in vivo though the number of raphé neurons that
increased firing in response to hypercapnia remained constant (22%) the magnitude
being much lower during sleep (Veasey et al., 1995). Thus hypoventilation and
reduced chemoreception during sleep may be due to a loss of chemosensitivity of
raphé neurons during sleep (Richerson, 2005). Interestingly inhibition of the
medullary raphé causes hypoventilation during wakefulness and NREM sleep (Li et
al., 2006, Nattie and Li, 2002b). 8-OH DPAT also altered room air breathing only
during wakefulness implying a tonic drive to breathe exists only during wakefulness
(Taylor et al., 2005).
Due to the drastic changes in the influence of different chemosensitive areas
with arousal state, experiments need to be performed to determine exactly which areas
are and are not active during each stage of the sleep-wake cycle. This may be
achieved using established methods for obtaining functional connections in the
respiratory network (Duffin et al., 2000).
1.9 pH regulation
1.9.1 pH regulation and chemosensitive neurons
In early postnatal life neurons from non-chemosensitive areas such as the
hypoglossal (XII) nucleus show pHi recovery from acidification caused by
hypercapnic acidosis (Nottingham et al., 2001), whereas neurons from chemosensitive
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areas such as the RTN do not (Nottingham et al., 2001, Ritucci, 2005 #194, Ritucci et
al., 2005). The fall in pHi associated with hypercapnic acidosis in younger animals
was significantly greater in the RTN compared to the XII nucleus (Nottingham et al.,
2001). The pHi changes in acute tissue slices from younger animals exposed to high
CO2 was more profound than older animals in the RTN (Nottingham et al., 2001).
Thus the RTN had a lower internal buffering power than the XII nucleus, but for both
nuclei internal buffering increased with age (Nottingham et al., 2001). This leads to
similar profiles in pHi regulation in both nuclei whether they are chemosensitive or
not after P11 (Nottingham et al., 2001).
RTN neurons respond to hypercapnic acidosis (fall in pHe) in a similar way to
isohydric hypercapnia (constant pHe) (Ritucci et al., 2005). However animals of all
ages were able to regulate their pHi in isohydric hypercapnia (no pHe change)
(Nottingham et al., 2001, Ritucci et al., 2005). This tells us two things, firstly changes
of pHi are more significant than changes of pHe in chemosensory signalling in RTN
neurons (Ritucci et al., 2005, Chesler, 2003). Secondly decreases in pHe has an
inhibitory effect on recovery, and must inhibit transporters responsible for
rectification of pHi in response to an acid load (Nottingham et al., 2001) and indicates
Na+/H+ exchangers (NHE transporters). To further support this, amiloride, a known
inhibitor of NHE transporters (Paris and Pouyssegur, 1983) reduces pHi recovery in
the RTN (Nottingham et al., 2001). Whereas DIDS (4,4'-diisothiocyano-2,2'-stillbene-
disulfonic acid) a bicarbonate transporter inhibitor was without effect (Nottingham et
al., 2001). This indicates that brain stem neurons use NHE antiporters (figure 5(ii))
that are more readily inhibited by pHe in chemosensitive neurons than non-
chemosensitive neurons, implying chemosensitive and non-chemosensitive cells
express different isoforms (Chesler, 2003). Nevertheless it must be noted at this point
that amiloride has many non-specific effects and so one must be careful when
attributing its effects solely to blockade of NHE transporters.
The RTN is exposed to a continuous acid load offset by extrusion of H+ by
NHE (Nottingham et al., 2001). Since chemosensitive neurons can regulate pHi if pHe
is constant, NHE in the medulla allows pHi recovery in IH but not HA (Putnam, 2001).
Importantly 90% of RTN neurons have a maintained fall in pHi, but only 50%
respond to hypercapnic acidosis, thus maintained pHi is not a marker of
chemosensitive neurons (Ritucci et al., 2005). Therefore chemosensitive neurons must
have a fall in pHi and a molecular transducer sensitive to it (Ritucci et al., 2005).
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These experiments also do not distinguish where the pHi regulation takes place and
have left a need for dendritic pHi recording (Putnam, 2001). Since pHi recovers it has
been hypothesised that increases in intracellular HCO3- may play a role (as it does in
glomus cells) as it will increase in IH (Ritucci et al., 2005). In addition the Cl-/HCO3-
exchanger is present in the VLM and is also inhibited by pHe, whereas it is not in non-
chemosensitive cells or the NTS (Chesler, 2003).
Figure 5: pH regulation of neurons in chemosensitive areas of the medulla. Carbonic anhydrase
converts CO2 to H+ in the extracellular fluid and neuron.
1.9.2 pH regulation and glia
Glial mechanisms of pHi regulation include NHE (for acid extrusion: figure 6
(i)) (Dietmar and Rose, 1996, Chesler, 2003); sodium driven and non-sodium driven
Cl-/ HCO3- exchanger for (for HCO3- extrusion) (Chesler, 2003, Dietmar and Rose,
1996); sodium bicarbonate cotransporter (NBC: for HCO3- extrusion: figure 6(ii)) at
resting membrane potential are especially prevalent in glial cells (Chesler, 2003).
In cortical glia, 20mM NH4+ caused a biphasic intracellular pH change (basic-
acidic), which glia were able to recover from (Faff et al., 1996). Removal of sodium
from the perfusate caused an intracellular acidification, implying a loss of pHi
regulation through NHE (Faff et al., 1996). This was confirmed by blockade of pHi
recovery by amiloride (Faff et al., 1996), though again non-specific effects of this
drug cannot be excluded. In conjunction, pHi recovery was blocked by bicarbonate
(ii)
(i)
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and sodium free solution (Faff et al., 1996). However the removal of bicarbonate
alone was insufficient to inhibit pHi recovery (Faff et al., 1996). This shows that
cortical glia express sodium dependent bicarbonate transporters, both Cl-/HCO3-
exchanger and NBC transports (Faff et al., 1996).
The resting pHi of glia in the medulla in the NTS and RTN is 7.3 (Erlichman
et al., 2003). The glia of both regions acidify upon removal of bicarbonate ions from
the milieu (Erlichman et al., 2003); however their mechanisms of pH regulation are
different. Glia of the RTN are alkalised by increased K+ in the perfusate (figure 6(iii)),
whereas this has no effect in the NTS (Erlichman et al., 2003). This increase in
intracellular pH was blocked by DIDS (Erlichman et al., 2003), however this is by no
means a specific inhibitor of NBC transporters. The removal of chloride ions from the
aCSF caused a decrease in the intracellular pH of glia in both nuclei, however the fall
in pHi in the RTN was greater than that of glia cells in the NTS (Erlichman et al.,
2003). Thus like cortical glia, medullary glia in both regions have Cl-/HCO3-
exchangers, NHE and NBC transporters (Erlichman et al., 2003, Chesler, 2003)
(Ritucci et al., 2005). However the activity of these transporters differs between nuclei
(Erlichman et al., 2003).
Figure 6: pH regulation of medullary astrocytes and interactions with neurons. Question mark
denotes an unexplained role of the mechanism.
(i)(ii)
(iii)
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1.9.3 pH regulation in the medulla
Hypercapnia initiates neuronal firing, due to alterations in pHi. The extrusion
of HCO3- from these neurons causes an extracellular alkalisation (figure 7(i)).
Neuronal activity increases extracellular K+ concentration, which cause glial cells to
depolarise (Chesler, 2003), as is seen in hypercapnic conditions (Ritucci et al., 2005).
This depolarization causes a 4mV shift in membrane potential (Ritucci et al., 2005),
which brings it to the reversal potential of NBC transporters (Dietmar and Rose, 1996,
Chesler, 2003). Once this membrane potential is reached, glial cells begin to take up
bicarbonate ions from the ECF (figure 7(ii)) (Dietmar and Rose, 1996), this acts to
reduce the alkalisation caused by neuronal pH regulation (Erlichman et al., 2003).
Thus during hypercapnia, glial cells show intracellular alkalisation (figure 7(iii))
(Erlichman et al., 2003, Chesler, 2003, Dietmar and Rose, 1996). This increase in
glial pHi can be blocked by DIDS, implying that it is due to the NBC (Erlichman et al.,
2003). Thus a biphasic response to neuronal firing should be seen, first an alkalisation
(neuronal pH regulation), followed by an acidic one (glia pH regulation). Interestingly
this biphasic response is commonly seen upon neuronal firing (Chesler, 2003,
Dietmar and Rose, 1996).
There are many other factors that will contribute to the pH of the ECF. The
increased neuronal firing will cause the release and re-uptake of neurotransmitters,
which require proton motive forces (figure 7(iv)). Such neurotransmitters include
glutamate (Chesler, 2003, Dietmar and Rose, 1996), ACh, aspartate and 5-HT
(Dietmar and Rose, 1996), many of which are released in the VLM during
hypercapnic stimulation. In conjunction with this, the activation of GABA (gamma
amino butyric acid) receptors allows passage of HCO3- out of cells, again causing an
alkaline shift (Chesler, 2003, Dietmar and Rose, 1996). Thus neuronal firing acts to
alkalise the ECF by two different mechanisms, which supersede the small effect of
glial HCO3- uptake. In fact neuronal firing causes alkaline shifts of the ECF by 0.1-0.2
pH units (Chesler, 2003). This appears to make perfect sense as an alkalisation of the
ECF increases synaptic activity in terms of excitatory transmitters such as glutamate
(figure 7(v)) and suppresses inhibitory transmitters such as GABA (Dietmar and Rose,
1996). Thus during hypercapnia synaptic transmission in the vicinity of
chemosensitive neurons is enhanced. Interestingly an alkaline pH in the ECF
surrounding chemosensitive neurons was proposed by Kalia and Ransom 25 years ago
(Ballanyi et al., 1999).
48
This poses several very interesting questions. Although a decrease in pHi and
increase in pHe would aid the chemosensitive response (by triggering neuronal firing
and enhancing synaptic transmission, respectively) in terms of neurons, how does this
environment effect glia (figure 7(vi))? If they are unable to counteract the effects of
chemosensitive neurons on pHe, why do they express NBC transporters and remove
bicarbonate from the extracellular space? The answer to this seemingly paradoxical
question is that it is the regulation of glia pHi, and not pHe that is important. If this is
the case then why is an increase in glial pHi so important? The answer to this question
remains unknown, but implies that glia have an unknown role in chemosensitivity that
surpasses their participation in pHe regulation (figure 7(vii)).
Figure 7: pH regulation in the ventral surface of the medulla. Though the mechanisms of pH
regulation are understood in terms of functions in chemosensitive neurons, many questions remain
unanswered about the effect of pH changes on glial cells, denoted by question marks.
(v)
(i)
(ii)
(iii)
(iv)
(vi)
(vii)
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1.9.4 Recapitulating the in vivo environment
The second important question then is what stimulus in vitro would more
appropriately replicate this environment? Hypercapnic acidosis would appear to be
unsuitable. The constant perfusion of aCSF (artificial cerebrospinal fluid) would act to
wash away any consequent compensatory pH changes in the ECF surrounding
neurons and glia in the tissue. In conjunction the tissue would be bathed in an acidic
solution, creating an extracellular environment opposite to that which has been
hypothesised in vivo. Though this would stimulate chemosensory neurons through
alterations of their pHi it would inhibit synaptic transmission through its actions on
pHe. Second to this, hypercapnic acidosis actually causes a profound and sustained
decrease in glial pHi (Ritucci et al., 2005), again contrary to in vivo conditions.
Isohydric hypercapnia on the other hand would not induce such profound acidification
of the internal pH of glia, but would still provide the initial fall in pH required to
stimulate chemosensitive neurons. However this stimulus also does not provide an
alkaline condition in the ECF, for the same reason as stated for hypercapnic acidosis.
So what would more accurately recapitulate the in vivo environment? Firstly we know
that an increase in CO2 is required to alter the pHi of chemosensitive neurons,
however it would need to be present in an alkaline solution. In this way increased CO2
would reduce the pHi of chemosensitive neurons, but would maintain the extracellular
alkalosis. In conjunction an aCSF with this composition would cause an increase in
both the pH surrounding glia as well as their cytosol.
The importance of the role of constant perfusion of in vitro preparations is best
shown with experiments using carbonic anhydrase inhibitors. In humans in vivo
experiments, injections of acetazolamide (AZ) increase the CO2 response (Vovk et al.,
2000). It is thought to do this by blunting the peripheral response (through blockade
of carbonic anhydrase), and enhancing central chemosensitivity (through lowered pHe)
(Vovk et al., 2000). In adult cats in vivo methazolamide (a blocker of carbonic
anhydrase) and acetazolamide injected into the pre-Bötzinger area increased both the
amplitude and frequency of phrenic nerve discharge (Solomon et al., 2000). However
bath applied AZ is without effect on the CO2 response of in vitro preparations
(Necakov et al., 2002). This was determined to be because the CO2 concentration of
the perfusate determines CO2 concentration in tissue, rendering the extracellular
carbonic anhydrase useless. In contrast in vivo the CO2 concentration is determined by
the action of carbonic anhydrase in the tissue and thus alterations are seen (Necakov
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et al., 2002). Of course it may be that the carbonic anhydrase is washed out of in vitro
preparations but is present in vivo. In either case, these results show that we must be
careful when designing in vitro models to make sure that in vivo conditions are met,
an alkaline extracellular pH with intracellular acidification.
In my opinion this is one of the biggest problems facing the study of
chemosensitivity at present. All the studies discussed to this present point have been
undertaken using different models of in vitro hypercapnia. This makes comparisons
between studies difficult and causes contradictions between studies of the same
chemosensitive nuclei. One of the first and most obvious steps that needs to be
undertaken is the measurement of extracellular and intracellular pH in vivo. Once this
has been done as it has for other brain regions then in vitro models can be designed
that replicate this environment. At present many studies, such as those of RTN
neurons, utilise a decrease of up to 0.5 pH units, a value that can never be obtained
under normal conditions in vivo. These studies have gone on to claim that under these
conditions the chemosensitivity index (CI: the amount by which a neuron increases
firing under hypercapnic conditions compared to controls) makes them prime
candidates for central chemosensitivity and that they could contribute almost the
entire chemosensitive response. If more modest shifts, closer to those that could be
seen in vivo are used then the CI of these neurons is nowhere near what it must be to
make these claims.
1.9.5 Implications of glia involvement in central CO2 chemosensitivity
Fluorocitrate is an inhibitor of the tricarboxylic acid cycle in glial cells. This
produces highly toxic effects and leads to glial dysfunction. It has been reported that
injection of fluorocitrate into the RTN of conscious adult rats caused an increase in
ventilation and heightens the response to CO2, due to increased extracellular
acidification (Holleran et al., 2001). This finding would seem to imply that glia play
no part in the response to chemosensitivity. However in this series of experiments
50% of the animals went into respiratory distress (Holleran et al., 2001), for obvious
reasons these experiments were discontinued. This does however provide an
intriguing question, why did fluorocitrate have such opposite effects on the response
to hypercapnia? There are a few possibilities as to why this occurred. One hypothesis
would be that the location of the injection sites were different between these two sets
of animals, and therefore the site of glia dysfunction is important. A second idea is
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that the animals which survived had a lower diffusional spread of the toxin and thus it
is the amount of glia that are affected which is important. In another series of
experiments, injections of fluorocitrate into the RTN of conscious rats again increased
breathing due to tissue acidification (Erlichman et al., 1998). However in this series of
experiments fluorocitrate caused a reduced maximal response to inspired CO2
(Erlichman et al., 1998). Since the location of the injections were identical between
these two experiments one would assume it is the volume of the area covered by the
fluorocitrate that is important, though this cannot be elucidate. However
intraperitoneal injections of methoxysulphate another glial toxin into neonatal rats,
which should affect a much larger proportion of glia than site directed injections,
resulted in reduced levels of basal ventilation and a reduction in their CO2 response
(Young et al., 2005). As stated previously these experiments do not provide definitive
proof of glial involvement, merely they imply the possible involvement of this cell
type.
1.10 Maturation of the chemosensory response
Medullary chemosensitivity is present throughout foetal development
(Eugenin et al., 2006). In early stage foetuses embryonic day 13-16 (E13-16) this is
due to an increase in burst amplitude of the phrenic nerve with no change in frequency
(Eugenin et al., 2006). However at E17-18, this changes to an increase in frequency
that is accompanied by a reduction in amplitude (Eugenin et al., 2006). Surprisingly
chemosensitivity exists before respiratory rhythm is seen, thus it can influence
ventilation as soon as the respiratory pacemaker begin firing (Eugenin et al., 2006).
In neonatal preparation hypercapnia stimulates ventilation in general, but does
not elicit metabolic response that may modify the demand for ventilation (Putnam et
al., 2005). Neonates like early foetuses increase ventilation by an increase in tidal
volume (Studen et al., 2001), though this changes to an increase in frequency after P3
(Wickström et al., 2002). Therefore like foetal preparations chemosensitivity varies
with age (Putnam et al., 2005). It is at its highest between P1-5, then wanes to reach a
nadir at P8 at which point it begins to rise until the adult response is reached by P21
(Putnam et al., 2005, Studen et al., 2001). Thus, like autonomic control of other
systems chemosensitivity appears to show a tri-phasic response (Putnam et al., 2005).
The decrease in respiratory response corresponds to a reduction in c-Fos staining
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which occurs after 6 days (Wickström et al., 1999). The increase in respiration from
the nadir is coincident with astrocytic maturation which occurs between P8-P12
(Putnam et al., 2005, Ritucci et al., 2005, Wickström et al., 2002, Davis et al., 2006),
again implicating some form of glia involvement in the hypercapnic ventilatory
response. Another series of c-Fos studies have shown that the RTN is more active in
early postnatal life than adulthood (though this true of chemosensation as a whole)
(Belegu et al., 1999). This may account for such high sensitivity in early post-natal
life. Some of these changes may be due to the fact that chemoreceptors are closer to
the surface in neonates than in adults (Forster et al., 1997). Thus during early
postnatal life CO2 sensitivity decreases as cell bodies of chemosensory nuclei move
further away from the surface where they were able to detect fluctuation in blood
chemistry more easily. Their ability to compensate for this after P8 may be due to the
migration of dendrites to the surface to re-establish their association with blood
vessels. Once adult chemosensitivity is established it appears to remain constant
throughout life, at least in humans (Browne et al., 2003).
1.11 ATP as a transmitter
The first evidence that adenosine and related compounds could affect excitable
cells came in 1929, where the perfusate from minced bull hearts caused a bradycardia
in dogs and heart block in guinea pigs when directly applied to the muscle (Drury and
Szent-Györgyi, 1929). The active compound was purified and shown to contain
adenine, a pentose sugar and phosphoric acid with an empirical formula of
C10H14O7N4P-H2O (Drury and Szent-Györgyi, 1929), thus indicating either adenosine
or adenosine mono-phosphate (AMP). Applications of these compounds replicated the
effects of the whole heart perfusate in guinea pigs and dogs and caused a bradycardia
in rabbits (Drury and Szent-Györgyi, 1929).
The first evidence for ATP as a peripheral transmitter did not come however
until 1970. Guinea pig intestines were stimulated electrically and the perfusates
applied to the intestine of other guinea pigs (Burnstock et al., 1970). Since only the
perfusates of stimulated guinea pig intestines induced any response, it implies that
something must be released upon stimulation. To investigate this further the
perfusates were dried and purified (Burnstock et al., 1970). The minced bull heart
perfusates contained a high quantity of purines (Burnstock et al., 1970). Applications
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of adenosine replicated the effects of the endogenously released ligand in frogs and
turkeys as well as rodents (Burnstock et al., 1970). However it could not be
determined whether the release of adenosine was from the nerve terminals or the
surrounding tissue. In order to study the release from the nerves alone, Auerbach’s
plexuses were removed from turkey gizzards, stimulated and the resultant perfusate
was dried and purified (Burnstock et al., 1970). This resulted in the identification of
ATP and ADP (adenosine diphosphate) as the active compounds. These were much
more potent inhibitors of gut motility than adenosine (Burnstock et al., 1970). When
the ATP was perfused through the vasculature of the stomach of toads, the ATP was
hydrolysed to adenosine (Burnstock et al., 1970). As ATP had differential effects on
segments of ileum, there was a proposal of two purinergic receptors for ATP
(Burnstock et al., 1970), thus creating the basis of the three aspects of ATP signalling
we know today, where ATP, its metabolite adenosine and ectonucleotidases (which
are responsible for the hydrolysis of ATP to adenosine) can all have influences over
the same reflex.
It was not until 1992 however that the first evidence for ATP as a central
neurotransmitter appeared (Edwards et al., 1992). It was noticed that fast ligand gated
synaptic currents in the medial habenula were not blocked by a cocktail of antagonists
to all neurotransmitters known at the time (Edwards et al., 1992). These currents were
however sensitive to suramin (a purinergic antagonist) and desensitised by α,β
methyl-ATP (a non-hydrolysable analogue) (Edwards et al., 1992). The currents
evoked by ATP were still present in excised patches showing the presence of a fast
ligand gated ion channel sensitive to ATP in the post-synaptic membranes of these
neurons (Edwards et al., 1992). The final and most important step in proving the
existence of purinergic signalling was the cloning of the purinergic receptors.
1.12 Purinergic receptors
In 1978 it was first established that there are two types of purinergic receptors,
P1 receptors modulate the response to adenosine, whilst P2 receptors are responsible
for conveying the effects of ATP (Burnstock and Kennedy, 1985). Subsequently P2
receptors have been subdivided into two distinct classes, ionotropic P2X and
metabotropic P2Y (Burnstock and Kennedy, 1985).
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1.12.1 P2X receptors
There are seven types of P2X receptors, which are non-selective cation
channels gated by ATP (Torres et al., 1999). ATP is a strong agonist whereas ADP is
a weak agonist for P2X but AMP (adenosine monophosphate) and adenosine have no
effect (Buell and Rassendren, 1998). Though there are many agonists and antagonists
for P2X receptors, the specificity of these agonists and antagonists are limited, leading
to problems with pharmacological identification (Lambrecht, 2000).
Though they do not discriminate between monovalent cations the permeability
of the channels reduces with increasing atomic number (Torres et al., 1999), though
permeability to low atomic number cations can be equal (Evans et al., 1996). In
addition they are permeable to divalent cations (Torres et al., 1999, Ma et al., 2006)
and modulated by others (Ma et al., 2006, Evans et al., 1996). Their increase in
permeability to these ions upon binding of ATP is not through dilatation of the pore1
(Ma et al., 2006), thus it must be due to the unplugging of the gate. The ion
conduction pathway is predominantly formed on the second transmembrane (TM2)
helix, though it cannot be ruled out that TM1 may play a role (Li et al., 2008). It is the
external half of the TM2 helix that contains the gate, which is thought to be
hydrophobic (Li et al., 2008). This domain may also convey the selectivity of the
channel to ionic permeability (Li et al., 2008). These channels have pore sizes and
permeabilities similar to those of 5-HT and nACh channels (Evans et al., 1996) and
share structural feature with ASIC (acid sensing ion channel) channels (Li et al.,
2008). These channels like ASIC channels are highly sensitive to pH, probably
conveyed by the areas that are structurally similar to ASIC. P2X 1, 3 and 4 currents
are attenuated by acidification, whereas alkalisation is without effect (Stoop et al.,
1997). In contrast P2X2 currents are potentiated with acidification (Stoop et al., 1997).
Though they are highly sensitive to large changes in pH, their responses to changes
within physiological range are small (Stoop et al., 1997). The effects of pH on these
channels are not exerted through changes in pore size, it changes the affinity of the
binding site for its agonist (Stoop et al., 1997).
1.12.2 Co-assembly of P2X channels
These receptors, with the exception of P2X6, have been shown to form homo-
ogliomeric assemblies in HEK (human embryonic kidney) cells (Torres et al., 1999).
1 Dilatation may occur with prolonged exposure to ATP or other ligands
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In conjunction they are also capable of forming hetero-oligomeric channels (figure 8).
P2X7 is structurally and functionally different to other P2X receptors and this is why
it only appears to form homomeric channels (Buell and Rassendren, 1998). It is the
longest P2X protein, possibly from a P2X gene fusing with a pore forming gene,
giving it an extra codon (Buell and Rassendren, 1998). Unlike other P2X channels
which are responsible for signal transduction, P2X7 channels are part of the apoptotic
pathway (Buell and Rassendren, 1998).
Heteromeric assembly of sub-types that share similar pharmacological
properties, such as P2X6 and P2X4 which are insensitive to pyridoxal-phosphate-6-
azophenyl-2',4'-disulfonate (PPADS) and suramin, will create a channel with the
same properties as the individual sub-types (Collo et al., 1996). This form of
heteromeric channel formation appears to be a common occurrence as P2X4 and P2X6
share a similar distribution (Collo et al., 1996). When subtypes with different
properties co-assemble, under different conditions one sub-type dominates the other.
This is can be shown by the pH sensitivity of these channels (Stoop et al., 1997).
P2X3 currents are attenuated by acidification but P2X2/3 currents are increased with
acidification, showing that the P2X2 receptor dominates the channel (Stoop et al.,
1997). In some cases however this can cause the formation of channels with new
properties. P2X1/2 channels show biphasic modulation to acidification, the first phase
resembles that of P2X1 and second P2X2 when expressed in Xenopus oocytes (Brown
et al., 2001). In conjunction alkaline solutions also increased agonist potency of this
hetero-oligomer, a property not seen for either of the homomeric channels (Brown et
al., 2001) and acidification potentiated the P2X1 like currents, where it usually
attenuates them (Brown et al., 2001). Purinergic receptors may also modulate the
actions of other ion channels, i.e. P2X5 can mediate ASIC currents in a calcium
independent manner (Spelta et al., 2004).
Figure 8: Summary of homomeric and heteromeric assembly of P2X receptors. Taken from Torres
et al J Biol Chem 274(10), 6653-6659 (1999).
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1.12.3 The P2Y1 receptor
P2Y1 receptors are activated by ADP and ATP but are insensitive to AMP and
adenosine (Ralevic and Burnstock, 1998). P2Y1 receptors are G-protein coupled
receptors (GPCR) and thus mediate slower responses than P2X receptors (Ralevic and
Burnstock, 1998). They are usually found coupled to Gq, G11 and Gi proteins (Ralevic
and Burnstock, 1998). There are two known pathways that these receptors modulate
(Ralevic and Burnstock, 1998). The first is the inositol triphosphate (IP3) pathway,
which it initiates by activation of phospholipase C, leading to increased calcium
mobilisation within cells (Ralevic and Burnstock, 1998). The second is the inhibition
of the adenylate cyclase pathway (Ralevic and Burnstock, 1998). In addition P2Y, like
P2X receptors, can also modulate other channels (Wirkner et al., 2003).
1.13 Purine receptors in VLM
ATP binding has been seen in the medulla (Fong et al., 2002), and many
purinergic receptors are expressed there. The medulla (of the marmoset and rat) has
widespread staining for all P2X ionotropic receptors, though the distribution of each
varies (Yao et al., 2000, Thomas et al., 2001). In the rat P2X 1, 2, 5, 6 were seen
throughout the VLM (Thomas et al., 2001), whereas P2X3 and P2X4 are located only
in more caudal and medial portions (Thomas et al., 2001). P2X6 is the most
commonly observed receptor in the VLM and immunoreactivity was very strong
throughout the entire rostro-caudal extent and was the most heavily expressed P2X
receptor on the VLM surface (Thomas et al., 2001). P2X 2, 3, 4, 6 are primarily located
on dendrites with dense staining in the fibre matrix (Yao et al., 2000). Interestingly
the P2X2 channel the only channel enhanced by acidification and P2X5 which can
modulate acid sensing channels were highly expressed and showed localised staining
(Kanjhan et al., 1999, Yao et al., 2000). Interestingly heavy staining of P2X
immunoreactivity was seen at the pial surface (Thomas et al., 2001). It must be noted
here that there are differential reports to the expression of P2X1 (Yao et al., 2000,
Thomas et al., 2001), this has been attributed to the use of different P2X1 antibodies,
some of which have been shown to react with tissue from P2X1 knockout mice
(Ashour et al., 2006). In conjunction many nuclei in the medulla have been shown to
contain P2Y1 receptors (Kanjhan et al., 1999). The expression of many purinergic
receptors and widespread ATP binding in the medulla lead to a series of experiments
to define its role there.
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1.13.1 ATP in the VLM
Ten years ago the first evidence for the role of ATP in chemosensation began
to arise. In peripherally denervated rats bilateral injections of suramin into the
retrofacial area raised the threshold level of CO2 required to initiate the hypercapnic
ventilatory response (Thomas et al., 1999). In conjunction it also diminished the
increased frequency and amplitude of ventilatory response seen with increased
inspired CO2 in adult rats (Thomas et al., 1999). Extracellular recordings showed that
suramin and PPADS primarily exert their effects on neurons that pace inspiratory
rhythm, such that they reduce or abolish the excitatory effect of CO2 on inspiratory
neurons in the Bötzinger or pre-Bötzinger complexes of the VRG (Thomas and Spyer,
2000) and pre-I neurons of the pFRG (Thomas and Spyer, 2000, Kawai et al., 2006).
In conjunction the direct application of ATP to inspiratory related areas excites
them (Thomas and Spyer, 2000). In contrast to its effect on inspiratory related areas of
the VRG, PPADS and suramin were without effect on expiratory related areas, post-
inspiratory and expiratory neurons of the VRG (Thomas and Spyer, 2000). However
ATP did excite them (Thomas and Spyer, 2000), causing a reduction in phrenic nerve
activity (Thomas et al., 2001), but only when they are in their active phase, (Gourine
et al., 2003). In addition α,β-methyl ATP replicated this response (Thomas et al.,
2001).
The location of purinergic receptors in numerous chemosensitive and
respiratory nuclei and the effects of ATP on respiratory neurons led to the hypothesis
that ATP may play a role in respiratory control and chemosensitivity. Evidence has
begun to imply that ATP is released tonically at the VLM surface (Spyer et al., 2003).
Therefore two hypotheses emerged: firstly that ATP may be released in response to
hypercapnia or secondly pH changes in the VLM associated with hypercapnia may
increase the efficacy of P2X2 thus leading to an increased influence of tonic ATP
release, though it may be a mixture of both. Importantly P2X2 receptor knock out
mice do not show perturbations in their response to inspired CO2 (Rong et al., 2003),
and ATP is released at the VLM surface (Gourine et al., 2005a), leading to the
conclusion that it is release of ATP from the ventral surface and not a change in
sensitivity of purinergic receptors for their ligand (Spyer et al., 2003).
Intriguingly ATP released from the ventral surface was confined to the most
superficial layer and overlies the classical chemosensitive areas first described in the
cat almost fifty years ago (Gourine et al., 2005a). ATP release was shown to be
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released immediately after end tidal CO2 begins to increase and precedes any adaptive
breathing (Gourine et al., 2005a). Applications of the purinergic receptor antagonists,
PPADS and TNP-ATP (2',3'-O-(2,4,6-Trinitrophenyl) adenosine 5'-triphosphate), not
only reduced the hypercapnic ventilatory response but also the threshold level of CO2
required to initiate the response in vivo (Gourine et al., 2005a). In conjunction
applications of ATP to the ventral surface replicated the ventilatory response to
hypercapnia (Gourine et al., 2005a). However P2X receptor blockade did not
completely ablate the response, indicating a role for P2Y receptors (Gourine et al.,
2005a). Interestingly P2Y receptor agonists also increase respiratory rate, showing
their involvement (Gourine et al., 2005a). Since residual increases in respiratory rate
remain after blockade of purinergic receptors, there must be other transmitters
involved (Spyer and Thomas, 2000). Since ATP causes excitation of breathing, only
neurons responsible for increasing inspiratory rate that have ATP receptors are
involved in mediating respiratiory changes induced by this transmitter (Spyer and
Thomas, 2000).
1.13.2 ATP and hypoxia
As well as its role in modulating the ventilatory response to hypercapnia ATP
release in the medulla is also involved in the response to hypoxia. During hypoxia
ATP is released from deeper structures than hypercapnia, approximately 400-800µm
from the ventral surface (Gourine et al., 2005b). There is also a delay in the release of
ATP upon hypoxic stimulation, it is not released until after hypoxia induced
augmentation of respiratory activity (Gourine et al., 2005b), thus it is not responsible
for initiating increased respiratory drive. Application of PPADS during hypoxia
augmented hypoxic ventilatory depression, thus ATP acts to oppose reductions in
breathing seen in the second phase of the hypoxic ventilatory response (Gourine et al.,
2005b). Peripherally denervated animals showed no increase in respiration seen
during the first phase of the hypoxic ventilatory response (Gourine et al., 2005b).
However they still exhibit hypoxic ventilatory depression and the associated ATP
release that counteracts it, though at much lower levels (Gourine et al., 2005b). Thus
ATP is vital to the central response to both hypoxia and hypercapnia.
1.13.3 P2X2 and chemosensation
Mice deficient in P2X2 and P2X2/3 receptors have normal responses to mild
hypoxia, but perverse responses to severe hypoxia (Rong et al., 2003). At 7.5% O2
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profound respiratory depression was observed in these mice but not in P2X3
knockouts or wild types (Rong et al., 2003). Carotid body afferents exhibit ongoing
activity under normal conditions, and are silenced when levels of O2 reach 50% (Rong
et al., 2003). Applications of PPADS to the carotid body of wild type mice blocks
background activity and hypoxia induced increases in sinus nerve activity (Rong et al.,
2003), whereas applications of ATP or other purinergic agonists increased firing, in
carotid body afferents (Rong et al., 2003). This basal level of firing is reduced in P2X2
double and P2X2/3 knockouts, but not when P2X3 is knocked out alone (Rong et al.,
2003). In conjunction ATP applications to the carotid body of P2X2 and P2X2/3
knockouts cause only modest rises or no increase in respiratory rate (Rong et al.,
2003). Thus the response to peripheral O2 chemoreception is mediated by P2X2
containing receptors, which are located on afferent terminals surrounding glomus cells
(Rong et al., 2003).
P2X2 and P2X3 messenger ribose nucleic acid (mRNA) is also found on
petrosal neurons (Prasad et al., 2001, He et al., 2006), where hypoxia causes a
reversible sub-threshold depolarisation in type 1 cells, which are the site of
chemosensory transduction (Prasad et al., 2001). Applications of ATP stimulates
calcium waves in these cells, which can be blocked by PPADS and suramin (He et al.,
2006). The reduction of calcium waves in the cells upon application of these
antagonists reduces firing in post-synaptic petrosal neurons (Prasad et al., 2001) and
removes the ventilatory response to chronic hypoxia (He et al., 2006). Thus ATP is a
common mediator of the peripheral and central chemosensitive responses (Spyer et al.,
2003). Though ATP is undoubtedly involved in these processes the cells types and
mechanisms involved have not yet been elucidated.
P2X2, 3, 2/3 knockout mice however show absolutely no alterations in their
response to hypercapnia compared to their wild type counterparts (Rong et al., 2003).
This was concluded to mean that these receptors do not play a role in the response to
hypercapnia. However ATP also acts as a co-transmitter during hypercapnia in carotid
bodies (Prasad et al., 2001). Since these cells express purinergic receptors and ATP is
released here it would be strange if this hypothesis were true. Although animals seem
unable to compensate for the loss of this receptor (Finger, 2005, Rong et al., 2003),
they are able to compensate for the loss of carotid inputs (Pan et al., 1998). Therefore
it may be that there is a re-organisation of the chemosensory pathway, to adjust for the
loss of this receptor’s contribution in the carotid body. A second note is that the
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involvement of P2X2 was selected on the basis that it is positively modulated by
decreasing pH, which is thought to occur at the VLM surface. However as discussed
earlier it may be that this region alkalises during hypercapnia, if this is the case then
the P2X2 receptor is the least likely P2X receptor to be involved in this response. The
lack of alterations to inspired CO2 in mice lacking this receptor may reflect this. In
conjunction if an alkalisation were to occur as predicted, it would actually serve to
increase the affinity of all P2X (excluding P2X2) to ATP. Thus it may be that release
of ATP works with an increased sensitivity of purinergic receptors at the VLM
surface during hypercapnia.
1.14 ATP and respiration in neonates
There are hotspots in acute medullary tissue slices from neonates that are
excited by ATP. These hotspots correspond closely to the region from which the
strongest respiratory field potentials are recorded and incorporates the pre-Bötzinger
complex (Lorier et al., 2007). The response to ATP is dose dependent in that 1mM
ATP increased respiratory frequency, but 10mM ceased activity (Lorier et al., 2004).
ATP’s actions on the pre-Bötzinger complex increases the frequency of bursting but is
without effect on burst amplitude in neonates (Lorier et al., 2004). It evokes currents
in inspiratory neurons of pre-Bötzinger complex (Lorier et al., 2008) by opening
cation channels and inhibiting a K+ current (Lorier et al., 2008). Applications of
ionotropic purinergic receptor antagonists into this area did not counter the effect of
exogenous ATP and pH was without effect, implying P2Y involvement (Lorier et al.,
2007). The response to exogenous ATP was biphasic, and the secondary slowing was
dependent on ATP hydrolysis (Lorier et al., 2007). Suramin reduced basal respiration,
and Cu2+ (an allosteric modulator) increased resting frequency (Lorier et al., 2007)
implying P2X2 involvement in this region (Lorier et al., 2004). That PPADS alone did
not affect bursting but does reduce the response to exogenous ATP (Lorier et al., 2004)
indicates that tonic release of ATP is not seen at this developmental stage.
Interestingly P2Y antagonists that do not affect P2X receptor induce larger current
changes than ATP itself (Lorier et al., 2008). As for adult rats ATP evokes currents in
expiratory neurons and non-respiratory neurons via P2X and P2Y receptors in the
neonate (Lorier et al., 2008). Intriguingly, PPADS did not affect the CO2 response in
neonates as it does in adults (Lorier et al., 2004), implying that ATP signalling during
hypercapnia occurs as chemosensitivity matures.
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1.14.1 ATP and respiration in adults
Bilateral injections of suramin into the pre-Bötzinger and Bötzinger
complexes reduced basal phrenic nerve activity and baseline firing of inspiratory
neurons that reside there (Thomas et al., 1999, Thomas and Spyer, 2000, Gourine et
al., 2003), implying tonic release of ATP in this region (Spyer et al., 2003), though
surprisingly no tone of ATP from the ventral surface of the medulla was seen upon
removal of ATP biosensors (Gourine et al., 2005a). Interestingly unilateral injections
of suramin had no effect on basal respiration, but did block the response to ATP
(Thomas et al., 2001). Intriguingly adenosine antagonists augmented the effect of
hypercapnia on these neurons (Thomas and Spyer, 2000), indicating that the effects of
ATP post-hypercapnia are self limiting.
As stated earlier inspiratory neurons in pre-Bötzinger complex express P2Y
receptors. Transfection of this receptor alone into astrocytoma cell lines is sufficient
to cause intracellular calcium mobilisation (Fam et al., 2000) and dorsal spinal cord
astrocytes raise intracellular Ca2+ upon P2Y receptor activation (Fam et al., 2000).
Thus P2Y receptors could potentiate the Ca2+-activated non-specific cation current
(Ican) through propagating calcium waves in inspiratory related neurons, in a similar
manner to metabotropic glutamate receptors (Funk et al., 2008). Thus during
hypercapnia an increase in ATP levels will cause greater activation of P2Y and
increased intracellular calcium, and thus greater activation of TRPM4 (Transient
receptor potential cation channel, subfamily M, member 4), leading to an influx of
sodium and an increase in the firing rate.
Figure 9: Possible participation of P2Y receptors in the modulation of putative pacemakers in the
pre-Bötzinger complex. P2Y activation leads to the induction of calcium waves, which activate
TRPM4 channel leading to sodium influx and depolarisation. Figure adapted from Del Negro and
Hayes J Physiol 586, 2245-2246 (2008).
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1.15 ATP and Chemosensory neurons of the VLM
The distribution of serotonergic neurons of the medullary raphé (Bradley et al.,
2002) closely resembles that of sites that release ATP under hypercapnic conditions
(Gourine et al., 2005a) (figure 10).
Figure 10: Association between serotonergic neurons of the VLM surface (green) with ATP
release sites at the VLM surface (white circles). Picture adapted from Bradley et al Nature
Neuroscience 5, 401 - 402 (2002) and Gourine et al Nature 436, 108-111 (2005a).
Injections of ATP into the RM caused a marked inhibition of respiration (Cao
and Song, 2007), similar to electrical stimulation of the same area (Cao et al., 2006).
In contrast, injections of ATP into the RP caused facilitation in a dose dependent
manner (Cao and Song, 2007), similar to electrical stimulation (Cao et al., 2006). The
response of ATP injected into the RM and RP could be blocked by ATP antagonists,
however it did not affect basal respiration (Cao and Song, 2007), implying that ATP
release needs to be stimulated before it affects these regions. This is not surprising, as
although these neurons contribute to the hypercapnic ventilatory response, they are
not known to tonically influence respiration. Interestingly the highest sensitivity of
raphé to ATP is located in the caudal VLM (Ribas-Salgueiro et al., 2003), in an area
that would incorporate the RO. This area in contrast to the other raphé nuclei does
have a tonic effect on the respiratory drive. Therefore if tonic release of ATP is seen
at the ventral surface, as it is in the vicinity of the pre-Bötzinger complex, then ATP
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may also affect basal respiration through its influence here. Interestingly the
chemosensitivity of raphé neurons has been shown to be age dependent, as is ATP
release from the ventral surface, leaving the intriguing possibility that ATP release
and chemosensitivity may develop together. This could mean either that serotonergic
neurons are responsible for ATP release, or that ATP may be responsible for the
chemosensitivity of serotonergic neurons.
The RTN also lies beneath the most rostral site of ATP release. Neurons that
reside here are directly excited by ATP through the activation of P2Y receptors
(Mulkey et al., 2006). ATP also inhibits these neurons indirectly from the activation
of P2X receptors on inhibitory neurons, though whether these are GABAergic or
glycinergic is unknown (Mulkey et al., 2006). Though PPADS was without effect on
the baseline firing of these neurons, these experiments were performed on neonatal
rats, at an age where ATP release is not seen. However since these neurons are
modulated by ATP and express purinergic receptors, one would expect them to
respond to ATP released in this vicinity.
1.16 Methods of ATP detection
In order to study the mechanisms by which ATP is released in depth, one must
use reduced preparations or transfection of proteins thought to act as conduits into
naïve cells. One must then show that the preparations are able to release ATP. There
are three main methods of ATP detection employed today.
The luciferase/luciferin reaction: - Luciferin is a pigment of the common fire
fly, which reacts with oxygen under the influence of luciferase in an ATP dependent
manner. Luciferin is converted to oxyluciferin and energy, which is released in the
form of light (figure 11). The ATP dependence of the reaction is due to the formation
of an intermediate protein luciferyl adenylate during the conversion pathway
(Dukhovich et al., 1996).
Figure 11: Conversion of Luciferin to oxyluciferin under the influence of a luciferase enzyme.
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By stimulating cells in the presence of luciferase and luciferin, light will be
emitted in the vicinity of ATP release. However this method is quite difficult to get to
work and generally it provides only qualitative data.
The second way of detecting ATP release is by the use of ATP sensor cells.
Here a cell line is transfected with the P2Y1 receptor, which when activated induces
calcium waves in these cells. The cells are placed over regions of interest and loaded
with a calcium sensitive dye. Thus when the cells responsible for ATP release are
activated calcium waves are detected in the reporter cell. This can provide a very
sensitive detection mechanism to very low concentrations of ATP and can map
discrete areas of ATP release. However again this method is only qualitative.
The final method of detection is the use of ATP microelectrode biosensors.
The sensors contain a platinum wire encapsulated by a porous glass coating. The glass
coating traps enzymes which convert glycerol to H2O2, an electroactive compound,
against the platinum wire. The H2O2 reacts with the platinum wire causing a change in
current which can be recorded. This method provides a more quantitative measure of
ATP release, as it an ATP dependent process. However these sensors are quite large
in diameter ~50 µm and thus cannot be used to detect ATP within a synapse. In
addition the platinum wire can be affected by small electroactive compounds. The use
of null sensors and a di-amino benzene (DAB) screening layer minimise these effects,
but they require some training in the interpretation of the results.
1.17 Mechanisms of ATP release
There are several forms of ATP release described in the literature that are of
both glial and neuronal origins. There is classical synaptic vesicular release from
terminal boutons of neurons in the medial habenula (Edwards et al., 1992). Here ATP
is stored in vesicles in post-synaptic neurons. During neuronal firing calcium entry
causes vesicle docking and priming readying them for release. Upon the next bout of
calcium entry, these vesicles fuse with the membrane and cause exocytosis of ATP
into the synaptic cleft. It then acts on purinergic receptors in the medial habenula
causing them to fire and eliciting a response.
Recently this form of vesicle docking and neurotransmitter release has been
shown to occur in the dorsal root ganglion (DRG) of the spinal cord. Here ATP is also
transported in vesicles ready for release in a similar fashion to that which is seen at
the synapse. However, in contrast to being released from the terminal bouton, ATP is
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released quantally from the somata of neurons in the DRG through the endo- and exo-
cytosis pathways (Zhang et al., 2007a). In contrast to stimulating neurons in this
region, ATP released here stimulates satellite glia, through stimulation of P2X7
receptors (Zhang et al., 2007a).
In contrast, glial derived ATP release takes many forms. In hippocampal slices,
glia release ATP via SNARE-dependent vesicular release in the same manner as
neurons of the medial habenula (Pascual et al., 2005). Here ATP is hydrolysed to
adenosine which affects synaptic plasticity leading to long term facilitation and
increasing basal transmission (Pascual et al., 2005). Further evidence supporting this
form of release from astrocytes came when astrocytes were shown to contain ATP
loaded vesicles which undergo spontaneous release (Striedinger et al., 2007). By
disrupting proteins that are responsible for the fusion of vesicles with astrocytic cell
membranes, ATP release from these astrocytes was abolished (Striedinger et al.,
2007). Spontaneous vesicular release of ATP in response to calcium waves is seen in
astrocyte progenitors and aids neural progenitor migration (Striedinger et al., 2007).
The final conclusive evidence was provided in the form of an inducible knockout of
SNARE protein in GFAP positive glia, which can be used to remove this form of
signalling.
Hippocampal astrocytes also store glutamate and ATP in secretory granules in
lysosomatal vesicles (Zhang et al., 2007b). The lysosomatal vesicles can undergo both
full and partial fusion with the glial cell membranes in this area (Zhang et al., 2007b).
Partial fusion occurs spontaneously through a ‘kiss and run’ mechanism resulting in
only a small amount of transmitter release (Zhang et al., 2007b). In contrast full
fusion is only seen under hypoxic conditions and occurs through a similar mechanism
to exocytotic release (Zhang et al., 2007b). In addition oxygen-glucose deprivation,
the in vitro model of ischeamia, induces ATP release through maxi-anion channels in
primary cortical cell cultures from neonatal mice (Liu et al., 2008). These mechanisms
are unlikely to be the primary source of ATP at the surface of the medulla during
hypercapnia, as ATP is not released there in response to hypoxic stimulation.
However this may provide the molecular mechanism for ATP release at depths of
400-800µm from the surface during hypoxia.
In cow aortas, hypotonic stress induces release of ATP through volume
regulated anion channels (VRAC’s) (Hisadome et al., 2002). In these cells, as in the
bladder, hypotonic solutions lead to cellular swelling causing the activation of the
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channel. Upon channel opening ATP release acts in a paracrine fashion to
neighbouring cells to induce a co-ordinated response.
Finally a common mechanism of ATP release in many systems is through gap-
junction hemichannels. Calcium waves in astrocytes were thought to be propagated by
electrical coupling through gap junctions. Calcium waves in cortical astrocytes
however were seen to pass over areas devoid of cells; thus there must be an alternative
pathway that can perform this function (Cotrina et al., 1998, Hassinger et al., 1996).
The inhibition of these waves by purinergic antagonists suggest the paracrine release
of ATP fulfilled this role (Cotrina et al., 1998, Pearson et al., 2005, Cotrina et al.,
2000). This was confirmed when glial cells in the RPE, C6 glioma cells and cultured
astrocytes were shown to release ATP (Pearson et al., 2005, Stoutt et al., 2002), which
acted to propagate the calcium wave (Pearson et al., 2005, Stoutt et al., 2002, Peuchen
et al., 1996), through activation of P2Y receptors (Peuchen et al., 1996, Cotrina et al.,
1998). Interestingly connexins and purinergic receptors form transcriptomes (Iacobas
et al., 2007), meaning these genes are co-ordinately expressed. This may be because
the expression of both of these proteins in a single glial cell is required for calcium
waves.
If one can identify the mechanism of ATP release induced by hypercapnia at
the ventral surface of the VLM, it will aid in the identification of the cell types
responsible for it. The first step in determining which mechanism is employed here is
to test the dependence of it on extracellular calcium, as this can distinguish between
SNARE and non-SNARE dependent mechanisms. This can also determine whether
ATP is released from primary chemosensory cells or is secondary to firing of neurons,
as can the use of TTX. Once the pool of possible targets has been reduced,
pharmacology can then be employed to distinguish which of the remaining
mechanisms is utilised.
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Chapter 2: ATP is released from the VLM in response
to changes in PCO2, and may influence the response
to both hypo- and hypercapnia in rats
2.1 Abstract
Despite the discovery of the ventral chemosensitive areas of the medulla
oblongata, the cell types and mechanisms involved in CO2 chemosensory transduction
have remained elusive. Recently, ATP release from these areas has been
demonstrated to be a vital component of the CO2 chemosensory reflex. By cutting
horizontal slices of the ventral medulla that contain the ventral chemosensitive nuclei,
I studied CO2-evoked ATP release by means of microelectrode biosensors. I have
developed a model that reliably recapitulates hypercapnia-induced ATP release in
vitro, by mimicking a key characteristic of the in vivo stimulus: an increase in PCO2
that is accompanied only by modest changes in extracellular pH. By systematically
altering pH, HCO3- and CO2 levels, I have excluded extracellular acidification as the
stimulus for ATP release. To test the possible involvement of intracellular pH, I
modified it both directly with propionate and ammonium chloride and indirectly by
blocking carbonic anhydrase. ATP release was not evoked or modified by these
treatments. I conclude that it is the change in PCO2 itself that is directly responsible
for eliciting ATP release from the surface of the VLM.
2.2 Introduction
Respiration is a ceaseless activity essential for life that begins in utero and
continues until death. Without this vital process it would be impossible for large
multicellular organisms to exist, and even relatively brief pauses can lead to profound
effects on major organs. To provide adequate ventilation dependent on activity and
environmental conditions, respiration is subject to a variety of mechano- and
chemosensory feedback mechanisms. The partial pressure of oxygen (PO2) in arterial
blood is sensed by the peripheral nervous system. In contrast the PCO2 of blood is
predominantly detected centrally (Feldman et al., 2003). Of the two blood gases,
carbon dioxide provides the most powerful drive to breathe (Haldane and Priestley,
1905), and is therefore more tightly controlled. Sites within the central nervous
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system responsible for detecting these changes are known as chemoreceptors, and are
positioned so that they are able to efficiently detect fluctuations in blood gases and
influence the central respiratory pattern generator to evoke adaptive changes in
breathing.
Breakthroughs in biosensor technology have led to new experimental
approaches that have enhanced the way we conduct scientific research. Their
invention has made conducting previously impossible investigations possible,
particularly in the field of chemosensitivity (Gourine et al., 2005a, Gourine, 2005,
Spyer et al., 2003). Since the effects of this homeostatic mechanism could be
measured only through changes in respiratory output, mechanisms of adult
chemosensitivity have until now been studied only in vivo or in a semi-intact working
heart brainstem preparation. The complexity of both the preparation and the system
responsible for chemoreception means that identification of the molecular
mechanisms of chemosensory transduction are extremely difficult without a reduced
preparation. Although rhythmic activity can be studied in vitro, it is limited to
neonatal preparations (Paton et al., 2002). Whilst these preparations have been
undeniably invaluable, chemosensory mechanisms of the neonate differ to the adult
(Putnam et al., 2005, Wickström et al., 2002, Davis et al., 2006). They are thus poor
models, ineffective for the study of the adult response. Using microelectrode
biosensors, I have created a new in vitro model for studying the classical
chemosensitive areas of the VLM surface of the adult rat, in isolation from the rest of
the system: by utilising ATP release as a measure of chemosensory output, I am no
longer reliant on respiratory activity. This has allowed for the first time, in depth
studies into these regions.
The surface of the medulla has multiple sites for chemoreception, the first of
these discovered was found on the ventrolateral medullary surface (here on in called
the classical chemosensitive areas) (Loeschcke et al., 1970, Mitchell et al., 1963,
Loeschcke, 1982). Not only do these areas respond to chemosensory stimuli, cooling
of them decreases the ventilatory response to hypercapnia (increased CO2) (Forster et
al., 1997, Ohtake et al., 1996). Though they were discovered almost fifty years ago,
the cell types and mechanisms involved have remained enigmatic, until recently. ATP
is released from sites that correspond to the classical chemosensitive areas (Gourine et
al., 2005a). Moreover, applications of exogenous ATP replicate the response to
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increased CO2 and applications of its antagonist PPADS to the site of ATP release
reduces the ventilatory response to hypercapnia (Gourine et al., 2005a).
To develop understanding of chemosensory transduction further, I thought it
pertinent to characterise the nature of the CO2 stimulus that evokes ATP release
(Wang et al., 2002, Mulkey et al., 2004). Changes in PCO2 could act directly or
indirectly either through extracellular or intracellular pH or through changes in HCO3-
. A common consensus is that CO2 dependent acidification acts on pH sensitive
channels. For example pH dependent closure of K+ channels has been proposed as the
primary focus of chemosensory transduction in chemosensitive neurons (Duprat et al
1997. In particular TASK1 channels (TWIK-related acid sensing potassium channel
1) were favoured in this role. However TASK-/- mice do not have perturbations in
their hypercapnic response (Mulkey et al., 2007b). Nevertheless other pH sensitive
channels remain, such as further TASK channels or acid sensing ion channels
(ASICs). By understanding the nature of the CO2-evoked ATP release I hope to gain
new insight into the transduction mechanisms themselves.
2.3 Methods
Once in the artificial cerebrospinal fluid (aCSF) carbon dioxide reacts with
water and is in equilibrium with bicarbonate and hydrogen ions under the influence of
carbonic anhydrase. Although this will occur spontaneously, this process is greatly
accelerated by this enzyme. Thus, the response to hypercapnia could be mediated by
any of these molecules excluding water (figure 1).
CO2 + H2O ↔ HCO3- + H+
CA
Figure 1: The conversion of CO2 to H+ and HCO3- is catalysed by carbonic anhydrase (CA).
I therefore systematically altered all three of the possible stimulatory
molecules (figure 2a). To recapitulate the in vivo environment more accurately, I kept
pH changes to a minimum. A solution containing 80mM HCO3- ions was bubbled
with 9, 12 or 15% CO2 creating a pH change of +0.15, 0.0 or -0.15 pH units
respectively. For a 50mM HCO3- solution, CO2 levels of 6, 9 and 12% gave the same
pH changes that were seen in the 80mM HCO3- solution (figure 2a). The PCO2 of all
isohydric and control solutions was measured on a Siemens RapidLab 248 blood gas
analyser (figure 2b).
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Figure 2: Constitution of solutions and the calculation of PCO2. a) The relationship between PCO2,
HCO3- and extracellular pH of solutions. b) The relationship between the percentage and partial
pressure of CO2 at pH 7.5.
2.3.1 Tissue preparation
Experiments were performed on adult Sprague-Dawley rats (4-6 weeks). The
medulla oblongata was removed in its entirety from the animal with no spinal cord
and a ventral tissue slice was sectioned at 400μm. The medulla was dissected out in
cold (approximately 4-6ºC) aCSF (NaCl 124mM, NaHCO3 26mM, NaH2PO4
1.25mM, KCl 3mM, MgSO4 11mM, CaCl2 1mM and D-glucose 10mM, equilibrated
with 95%O2, 5 % CO2). During the sectioning care was taken to ensure that no blood
found its way onto the medullary surface, for successful recording of ATP release. It
was also essential that the pia mater, the innermost membrane surrounding the brain,
remained intact throughout the preparation. Once removed the preparation was placed
into a perfusion chamber containing standard aCSF (NaCl 124mM, NaHCO3 26mM,
NaH2PO4 1.25mM, KCl 3mM, MgSO4 1mM, CaCl2 1mM and D-glucose 10mM
equilibrated with 95%O2, 5 % CO2) at 33ºC at a flow rate of approximately 5ml.min-1.
2.3.2 Sensor placement
Once in the perfusion chamber, two 0.5mm biosensors were placed on the
medullary slice in a variety of locations according to medullary landmarks (figure 3).
At all sensor positions the tissue was treated with a standard stimulus of 80mM HCO3-
solution bubbled with 91% O2, 9% CO2 (pH 7.65), as this elicited the largest amount
of ATP release (figure 10) and therefore would give me the greatest chance to observe
it and any changes that may occur.
Hypercapnia
Hypocapnia
Physiological
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Figure 3: Placement of ATP microelectrode biosensors on the ventral surface of the medulla.
Grey circles represent the classical chemosensitive areas. Red lines represent the placement of 0.5mm
biosensors.
2.3.3 ATP Biosensors
The biosensors require glycerol as a substrate, to produce the electro-active
molecule hydrogen peroxide. As this is an ATP dependent process, hydrogen
peroxide is formed in proportion to ATP. Being electro-active, hydrogen peroxide can
be oxidised at a platinum wire, polarized to 500 mV relative to Ag/AgCl (silver/silver
chloride). The reduction of the platinum generates an electrical recording (figure 4).
2mM glycerol was therefore present in all solutions to enable biosensor operation
(figure 4).
Null sensors are identical to ATP biosensors with a polymer layer devoid of
enzymes. They react to any non-specific electro-active compounds or electrical
disturbances in the perfusion chamber. This activity can then be subtracted from that
of the ATP biosensor, thus providing more accurate recordings (figure 5).
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ATP + glycerol
ADP + glycerol-3-phosphate
glycerone-phosphate + H2O2
Glycerol
kinase
Glycerol-3-
phosphate
oxidase
Figure 412: Enzymatic cascade of the ATP biosensor. Note that glycerol is essential for biosensor
operation. (Picture supplied by Sarissa biomedical).
Sensors were calibrated with 10µM ATP before and after each experiment. By
comparing the total current change evoked by a known concentration of ATP I can
calculate the amount of ATP released during each experiment (figure 5).
Figure 5: Calibration tracers of null and ATP biosensors. Top: Trace made from the subtraction of
the null signal from the ATP signalling. Middle: Raw trace from the ATP biosensor. Bottom: Raw trace
from the null biosensor during calibration with 10µM ATP.
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2.3.4 Hypercapnic acidosis
The tissue slice was left for 15 minutes to equilibrate (pH 7.5), before
undergoing a 3 minute treatment in the hypercapnic solution (pH 7.1 or 7.2). The
tissue underwent a further two 3 minute hypercapnic washes at 15 minute intervals.
After the final hypercapnic stimulus, the tissue was left for 10 minutes before the
biosensors were removed and calibrated. The hypercapnic acidotic solution is the
same composition as the control solution (26mM HCO3- and 124mM NaCl), bubbled
with 9% CO2, 91%O2 causing an approximate pH change of -0.4 pH units from pH
7.5 to 7.1.
2.3.5 Isohydric Hypercapnia
The tissue was left to equilibrate (pH 7.5) for 30 minutes, after which it
underwent a 5 minute treatment with an isohydric solution, either an isohydric
hypercapnic solution containing 80mM HCO3- and 70mM NaCl (altered to keep
sodium levels and osmolarity constant), or an isohydric solution containing 50mM
HCO3- and 100mM NaCl. The tissue was then washed in the standard aCSF for a
further 45 minutes (to allow for recovery), the sensors removed (to allow
measurement of the tone) and calibrated.
2.3.6 Isohydric Hypocapnia
Preparation of the tissue and placement of the sensors was identical to that for
isohydric hypercapnia in the caudal location (figure 3). Tissue was left to equilibrate
for 30 minutes, then went into a 5 minute treatment with isohydric hypocapnic
solution (10mM HCO3- and 140mM NaCl) and bubbled with 98% O2, 2% CO2 (pH
7.5), before a 45 minute wash in standard aCSF.
2.3.7 Intracellular pH changes.
After the initial recovery period, 80mM HCO3- aCSF saturated with 91% O2,
9% CO2 was applied for 5 minutes, followed by a 30 minute wash to assess
responsiveness of the tissue to CO2. The intracellular pH modifiers, propionic acid
(Fisher) 5mM or NH4Cl 20mM (Sigma), were then applied for a period of 5 minutes
in standard aCSF followed by a 30 minute wash in standard aCSF before the sensors
were removed and calibrated.
Alternatively, after an assessment of tissue responsiveness, acetazolamide 500
µM (Sigma), to test for the participation of carbonic anhydrase, was applied for a
period of 20 minutes in standard aCSF to allow it to take affect. Subsequently the
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tissue underwent a second application of a hypercapnic 80mM HCO3- aCSF
containing acetazolamide, followed by a 30 minute wash in standard aCSF containing
the drug. The tissue was then washed for a further 20 minutes in standard aCSF before
the sensors were removed and calibrated.
2.4 Results
2.4.1 Hypercapnic acidosis
I began my experiments by utilising the classical model of chemosensation,
hypercapnic acidosis (figure 6). Hypercapnic acidosis, an increase in PCO2 associated
with a fall in pH, is known to cause ATP release at the VLM surface (Gourine et al.,
2005). Although this stimulus provided me with ATP release (3.2 ± 0.2µM, n=12), it
was not reliable from preparation to preparation. Furthermore I was unable to evoke
multiple episodes of ATP release, essential for assessing its mechanisms. The reason
for the labile nature of ATP release was unknown. However I decided to seek better
models for studying hypercapnia in vitro.
Figure 6: Hypercapnic acidosis evokes ATP release from the ventral surface of the medulla. Note
that ATP is released almost immediately upon hypercapnic stimulation. Sensor signal is net ATP
release (null sensor subtracted from the ATP trace)
2.4.2 Physiological changes of PCO2/pH cause ATP release
To provide a more physiological stimulus I utilised a modified isohydric
hypercapnic solution containing 80mM HCO3-, 9% CO2, pH 7.65. This solution has a
PCO2 of 62 mmHg equivalent to a moderate episode of hypercapnia in vivo. This
model evoked multiple bouts of release (2.2 ± 0.3µM, n =13) over an extended period
of time from the caudal chemosensitive site (figure 7a and e). In conjunction the
second episode evoked sufficient ATP for further investigation (1.5 ± 0.2µM, n=13)
(figure 7a). At this site ATP release can diffuse at least 400µm into the medulla
(figure 7b) at a concentration high enough to activate purinergic receptors (2.3 ±
0.1µM, n =5) (figure 7e). However ATP release is not present in deeper structures
pH
ATP
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(0.0 ± 0.3 µM, n=4) with similar sensor placement (figure 7c and e). As seen in a
previous study (Gourine et al., 2005a) ATP release was also observed in the rostral
chemosensitive site (0.8 ± 0.1µM, n =4) (figure 7d and e). ATP release was not seen
outside of the classical chemosensitive areas (i.e. close to the lateral cut surface; data
not shown) therefore this mechanism is site specific. It is limited to the most
superficial layers of the VLM and overlies all chemosensitive regions that reside there.
Figure 7: CO2-evoked ATP release from the ventral surface of the medulla. a) Multiple episodes
from the caudal site. b) ATP release can be detected from the dorsal surface of the ventral most slice
(0-400µm) tissue. c) The second tissue slice is devoid of ATP release (400-800µm) (the fall below
baseline seen here is likely due to some residual pH sensitivity of the biosensors which does not effect
the sensors equally). d) ATP release from the rostral site, equivalent position to the RTN. e) Summary
of ATP release from different sites of the medulla.
A basal concentration of ATP, a tone, was measured by removing the sensors
from the ventral surface of the medulla and measuring the resulting fall in the sensor
signal (3.2 ± 0.9µM, n=13) (figure 8). This concentration of ATP is sufficient to cause
sustained excitation of purinergic receptors, in the vicinity of the ventral surface. This
tone was not present in the second slice (0.1 ± 0.3µM, n = 4). This, the first
description of tonic release of ATP at the ventral surface of the medulla implies that
ATP may provide a continuing source of drive to the chemosensory and respiratory
nuclei that reside there.
a
b c
d e
76
Figure 8: ATP tone on the ventral surface of the medulla. Shaded area designates where the sensors
were removed. The tone is measured as the difference between the current of the differential recording
after the sensor is removed from the slice compared to the current when the sensors are in contact with
the tissue dotted line.
2.4.3 Systematic variation of PCO2, pH and HCO3-
To determine the key features of the CO2 stimulus I systematically varied
PCO2, pH and HCO3-. The modified isohydric hypercapnic models elicited ATP
release in all combinations tested (figure 9 and 10a).
Figure 9: Effects of different models of hypercapnia on ATP release from the ventral surface of
the medulla. Note that peak ATP release decreases with extracellular acidification, and increases at the
same pH with increasing concentrations of CO2.
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ATP release is governed by interactions between PCO2 and pH, with PCO2
having an excitatory effect and pH having an inhibitory effect (figure 10); thus for any
given pH ATP release increases with increases in PCO2. In fact the positive effect of
PCO2 appears to be able to overcome the inhibitory effect of pH if the concentration is
high enough (figure 10). Therefore I have excluded extracellular pH as a possible
stimulus. The solutions bubbled with 9% CO2 provided similar PCO2 shifts (80mM,
9%: 34-62 mmHg and 50mM, 9% CO2 34-54.5 mmHg) that are seen during in vivo
experiments (40-60 mmHg). Therefore these models appear to provide a much better
replication of in vivo conditions and will enable the further study of this mechanism.
Figure 10: Effects of different models of hypercapnia on ATP release from the ventral surface of
the medulla. a) Systematic changes in HCO3-, pH and CO2. Note that increasing PCO2 can overcome
the inhibitory effect of extracellular acidification.
2.4.4 Isohydric hypocapnia
The discovery of the ATP tone led me to postulate that a decrease in PCO2
may act to reduce ATP release and thus any tonic influence it may have. Isohydric
hypocapnia (PCO2 19mmHg) had the opposite effect to isohydric hypercapnia, and
significantly reduced basal ATP levels at the surface of the medulla (-0.6 ± 0.1µM,
n=6; figure 11). Interestingly this is similar to that of tissue treated with a similar
increase in PCO2 (55mmHg) at the same pH (0.7 ± 0.1µM, n=4). Note also that the
duration of the response to hypo- and hyper- capnia shared the same relationship (low
PCO2: 1988 ± 327 secs, n = 6. High PCO2: 1779 ± 181 secs, n = 4).
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Figure 11: Reduction in ATP tone on the ventral surface of the medulla caused by isohydric
hypocapnia. Note the sustained fall in ATP tone caused by a fall in PCO2.
2.4.5 ATP release at the VLM highly correlates to PCO2 concentrations
The relationship between the percentage and partial pressure of CO2 was linear
(figure 2b), whereas the relationship between ATP release and PCO2 at pH 7.5
exhibited a trend towards saturation at high levels of PCO2 (figure 12), with the
steepest part of the curve within physiological range. Since pH is not a contributing
factor in this comparison, there must be a physiological reason for the plateau, for
example the rate at which the mechanism of ATP release can work within the cell.
Figure 12: The effect of increasing PCO2 at pH 7.5. Note th
between ATP release and PCO2 over a clinically relevant rang
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To test the possible involvement of carbonic anhydrase I used acetazolamide,
a blocker of this enzyme. Acetazolamide did not reduce the response to isohydric
hypercapnia compared to interleaved controls (figure 14a and c). It was also without
effect on the time taken for ATP release to reach its peak (figure 14b and c).
Therefore hypercapnia-triggered ATP release does not depend on carbonic anhydrase,
thus the mechanism is likely to be directly modulated by CO2.
2.5 Discussion
2.5.1 ATP release from the ventral surface
I began by replicating the in vitro experiments performed by Gourine et al
2005, and evoked ATP release. However the inability of this preparation to elicit
repeated episodes led me to search for alternative methods of hypercapnic stimulation.
My search for a more appropriate stimulus, led me to use quasi-isohydric solutions
similar to those used in previous investigations into chemosensitive stimuli (Filosa
and Putnam, 2003, Richerson, 2004, Wang et al., 2002, Ritucci et al., 2005, Otsuguro
et al., 2006). Use of thee stimuli led to reliable and repeatable ATP release on the
VLM surface (figure 7, 9 and 10).
2.5.2 ATP release in the ventral medulla
I examined the location of ATP release from the VLM (figure 7). My
objective was to test if this more physiological stimulus would evoke ATP release
from other classical chemosensitive regions. I found that it did but at lower levels
compared to the caudal region (figure 7e). I next clarified that ATP release was
confined to the ventral surface, as it was for Gourine et al 2005. Since ATP release
was not seen on the surface of the second slice, from cells directly adjacent to those of
the dorsal surface of the first tissue slice, I concluded that the ATP must be released at
the ventral surface, but is capable of penetrating at least 400µm dorsally.
Interestingly the pre-Bötzinger complex is located 150-400µm from the
ventral surface (Kuwana et al., 2006) and sends dendritic projections to it (Kawai et
al., 1996). The pre-Bötzinger complex is the kernel for respiratory rhythm generation
(Smith et al., 1991), and has not only been shown to contain purinergic receptors, but
to be modulated by ATP (Lorier et al., 2004, Lorier et al., 2007). Therefore at these
concentrations and this level of penetration, ATP would be placed to affect both the
somatatic and dendritic P2Y receptors and thus directly affect respiratory rate.
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Serotonergic neurons of the medullary raphé, whose cell bodies and dendrites
reside within 150µm of the VLM surface (Ribas-Salgueiro et al., 2005, Richerson,
2004) are also modulated by ATP and applications of ATP cause a similar response to
electrical stimulation of these nuclei (Cao et al., 2006, Cao and Song, 2007). Since
serotonergic neurons provide a tonic drive to the pre-Bötzinger complex, which
stabilise the membrane potential there (Pace et al., 2007), as well as sending
chemosensory information to the respiratory rhythm generator (Richerson, 2004,
Ribas-Salgueiro et al., 2005, Hodges et al., 2008, Bodineau et al., 2004, Li and Nattie,
2008b), ATP signalling is again poised to influence both respiratory rate and the
chemosensitive response.
The retrotrapezoid nucleus (RTN) is situated directly under the rostral
chemosensitive site, with its cell bodies and dendrites located at the ventral surface of
the medulla (Mulkey et al., 2004). The RTN provides tonic excitatory drive to the pre-
Bötzinger complex and appears to contain intrinsically chemosensitive neurons
(Mulkey et al., 2004, Li et al., 2006, Weston et al., 2004, Nattie, 2000). The RTN is of
major importance to chemosensory drive; moreover it has been shown to contain both
P2Y and P2X receptors. The chemosensitive neurons are directly excited by
exogenous ATP acting through P2Y1R (Mulkey et al., 2006). At this site too, ATP can
again alter both the respiratory and chemosensory drive.
2.5.3 Characterisation of the stimulus
Under hypercapnic conditions in vivo the blood pH changes by approximately
0.15 units (Gozal et al., 1995), a value I have also observed (see chapter 3). It is
however unknown if the same pH change occurs in the extracellular fluid; it has been
hypothesised that pH may actually become alkaline (Ballanyi et al., 1999) as proton
transporters on chemosensitive neurons remove them from the extracellular space. It
is also probable that the actions of such proton transporters in conjunction with
bicarbonate ion transporters means that no pH change would be seen.
Interestingly ATP release varied as a consequence of PCO2, and not
extracellular pH (which had an inhibitory effect) or HCO3- levels (figure 9). The
primary stimulus for the response to hypercapnia must therefore be dependent on
PCO2. However this data does not discriminate whether it is a direct action of CO2 or
consequent changes in intracellular pH. It does however remove the possibility of the
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involvement of acid sensing ion channels, as they are activated by extracellular pH
and are not affected by PCO2.
To test the possible involvement of intracellular pH (pHi) changes, I used
pharmacological agents that can change pHi, without affecting extracellular pH. These
agents were not sufficient to elicit ATP release (figure 13). To further investigate the
effects of pHi on ATP release, I antagonised the effects of carbonic anhydrase to alter
the effect of CO2 on changes in pHi. Attenuating the actions of this enzyme slows the
conversion of CO2 to HCO3- and H+; thus changes in pHi are protracted and should
lead to either alterations in the amount of ATP released or increase the time taken for
ATP release to reach its peak. I saw no significant change in either the peak of ATP
release or the time taken for ATP release to reach its peak (figure 14). Thus I excluded
changes in pHi and HCO3- as possible stimuli for evoking the release of ATP, leaving
only changes in PCO2. Isohydric hypercapnia causes much smaller changes to pHi
when compared to hypercapnic acidosis (Ritucci et al, 2005), which indicates it is of
lesser importance in this preparation.
2.5.4 Implications for chemoreception
This is the first time that chemosensitivity has been shown to derive directly
from changes in PCO2. This provides an interesting insight into chemosensation as a
whole, and it would appear that different chemosensitive sites respond to different
signalling molecules. RTN neurons can be excited by changes in extracellular pH
(pHe) (Mulkey et al., 2004), while serotonergic neurons respond to pHi (Wang et al.,
2002), by contrast ATP releasing cells respond to PCO2 (this study). This may be a
contributing reason as to why there are so many chemosensitive sites, each senses
different aspects of the same signal. These signals may then converge, if all sites are
stimulated then a large response is seen, but if only a few are stimulated a smaller
response is seen. It may also provide a mechanism by which adaptation to chronic
disease may be seen. For instance in terms of metabolic acidosis, pHe remains
constantly low and above the threshold for activation of breathing. Under these
conditions this pathway may effectively desensitise leaving other remaining aspects of
the stimulus (PCO2, pHi etc) as being important.
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2.5.5 Reductions in ATP release at the VLM during hypocapnia may modulate
breathing
Another exciting finding of this current study is that there appears to be tonic
release of ATP from the chemosensory sites (figure 8). Thus during eucapnia ATP
may provide a tonic drive to breathe. More interestingly, it would also allow
purinergic signalling to underlie the response to hypocapnia. Indeed when I reduced
PCO2, I found this caused a reduction in ATP tone at the ventral surface in the caudal
chemosensitive area (figure 10 and 11). During hypocapnia the respiratory rate
decreases, thus slowing the excretion of CO2 from the lungs and bringing it back into
normal parameters. This reduction in tone could remove the tonic excitatory influence
of ATP from the respiratory and chemosensory systems and thus leads to a slowing in
breathing. Physiologically hypocapnia is more commonly observed than hypercapnia
e.g. during excursions to high altitude, thus this form of respiratory control, by
reductions in ATP release at the VLM surface, is likely too play a more prominent
role.
2.6 Summary
To conclude, I have discovered a new physiological stimulus for eliciting ATP
release from the classical chemosensitive areas. ATP is released from the classical
chemosensitive areas in response to changes in PCO2, and is confined to the ventral
surface of the medulla. It can however reach nuclei important in chemosensitivity and
respiration and may influence the response to both hypo- and hypercapnia.
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Chapter 3: ATP is released through connexin 26
hemichannels on the leptomeningeal cells and on sub-
pial astrocytes at the VLM surface in response to
hypercapnia
3.1 Abstract
ATP release from the ventro-lateral medullary (VLM) surface is a key
component in the hypercapnic response in vivo and can be seen in vitro (Gourine et al
2005). In the previous chapter I demonstrated that ATP is released as a consequence
of changes in PCO2 rather than pH and may have a role in the response to hypocapnia
as well as hypercapnia (chapter 2). Using our new, more physiological stimulus I have
now studied the mechanisms and cell types involved in this process. I have
demonstrated that ATP release is independent of extracellular Ca2+ and have evidence
that gating of connexin hemichannels mediates ATP release. Quantitative PCR and
immunofluorescence show that connexin 26 is highly expressed at the VLM surface.
Application of gap-junction antagonists, with selectivity towards connexin 26, greatly
reduced ATP release in response to elevated CO2 in vitro and in vivo and reduced the
tone of ATP at the VLM surface. Dye loading studies have shown that that the cells
responsible for releasing ATP are of glial origin and reside within the first 150µm of
the VLM surface and a second group of cells in the leptomeninges. Therefore I
propose that ATP is released from sub-pial astrocytes and leptomeningeal cells
through connexin 26 hemichannels in response to alterations in PCO2.
3.2 Introduction
ATP is known to be released from specific sites on the surface of the ventral
medulla (Gourine et al., 2005a). Though the chemosensitivity of these sites was
discovered nearly fifty years ago (Loeschcke et al., 1970, Mitchell et al., 1963,
Loeschcke, 1982), the cell types and mechanisms involved in this process remain
unknown. The previous chapter shows that changes in PCO2 directly, and not through
its actions on either extracellular or intracellular pH, was the determining factor
(chapter 2). Importantly, although extracellular pH was removed as a possible
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stimulus, it was found to be a contributing factor to the amount of ATP seen in
response to hypercapnia. A fall in pHe reduced the amount of ATP seen at the ventral
surface, for equivalent levels of PCO2 (chapter 2). These discoveries have provided
some insight as to what may be occurring in this process, although a mechanism that
is PCO2 sensitive and reduced by decreases in pHe has not yet been described.
There are known mechanisms of ATP release elsewhere in the brain and body.
ATP can be released through synaptic vesicular neuronal exocytosis, such as in
adapting pulmonary stretch receptor afferents seen in the NTS (Gourine et al., 2008).
In addition neuronal vesicular release can be seen extra-synaptically, such as in the
dorsal root ganglia (Zhang et al., 2007a). Cultured astrocytes are also capable of
exocytotic release of neurotransmitters via lysosomatal fusion (Zhang et al., 2007b).
All of these processes have been shown to be exquisitely sensitive to extracellular
calcium for many of their processes, therefore its removal should inhibit these
mechanisms.
There are also non-exocytotic mechanisms of release such as gap junction
hemichannels. ATP release has been shown by connexins (Kang et al., 2008) in the
cochlear (Zhao et al., 2005) and retina (Pearson et al., 2005) and pannexins in
Xenopus oocytes (Bao et al., 2004) and an implied role in the taste buds (Romanov et
al., 2007, Huang et al., 2007). Hemichannels have been shown to open in response to
lowered extracellular calcium; thus, if mediated by hemichannels, ATP release should
be independent of this stimulus. Finally, volume regulated anion channels (VRACs):
these maxi-anion channels are the route for ATP release in aortic endothelial cells
(Hisadome et al., 2002). VRACs are highly dependent on intracellular calcium
(Takano et al., 2005, Lang et al., 1998), yet the dependence on extracellular calcium
for the activation of this ion channel family is largely unknown. Since these
mechanisms show differential response to altering calcium ions, alterations in
extracellular calcium could provide insights into the release mechanism.
One implication from the previous chapter is the inhibitory effect of
decreasing pHe. Importantly this discovery removes the involvement of acid sensing
channels. TASK channels (TWIK-related acid sensing potassium channels) and ASIC
(acid sensing ion channels) are activated by decreasing extracellular pH (Duprat et al.,
1997, Waldermann et al., 1997). In contrast, gap junctions and hemichannels close
with decreasing extracellular pH, which suggests that it may be either connexin or
pannexin mediated.
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It is also unknown whether ATP release is of glial or neuronal origin. Since it
is confined to the most superficial structures of the ventral medulla (Gourine et al.,
2005a), one must look at the cell types that reside there. The VLM surface has a
thickened marginal glial layer, which is to say that the first 150µm of the ventral
medulla is enriched in glia with very few neuronal cell bodies seen (Sato et al., 1992,
Okada et al., 2001). An important discovery in terms of this hypothesis was that silent
cells within the MGL depolarise in response to hypercapnia, indicating a yet unknown
role for glia in the hypercapnic response (Fukuda et al., 1978, Ritucci et al., 2005).
Okada et al (2001) speculated that glia may be the primary chemoreceptors, and that
neurons involved in chemosensitivity may be acting in response to transmitters
released from this cell type.
The MGL of the medullary surface differs from the MGL throughout the rest
of the brain, in that, whilst they are few, it does contain neuronal cell bodies.
Although many neurons send dendritic projections to the ventral surface, there are
few studies that report axonal projections there. However since the concentration of
ATP release seen in the dorsal surface of a cut tissue slice is not different to that seen
on the ventral surface, it may be released from deeper structures at levels between
150-400µm. The neurons at this level and those that reside in the MGL do receive
afferent inputs and it is possible that the neurotransmitter released by these afferent
inputs is ATP. Possible neuronal sources of ATP are the medullary raphé (Richerson,
2004) and the RTN (Mulkey et al., 2004) which reside in the VLM or commissural
NTS which sends projections to every aspect of the VLM surface (Takakura et al.,
2006, Moreira et al., 2007, Bodineau et al., 2000). The ventral slice preparation
removes the possibility of release from more dorsal structures such as the NTS. It
may also be plausible that it released from a yet undiscovered set of interneurons
residing in this region.
In this study I aim to identify the mechanism of ATP release at the ventral
surface of the medulla, and in doing so try to elucidate molecular markers for the cell
types involved. Using these molecular markers I hope to identify the location and
types of cells that are involved in this response.
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3.3 Methods
3.3.1 In vitro tissue preparation
Tissue was extracted from 4-6 week old Sprague Dawley rats as described in
Chapter 2. Biosensors were placed and calibrated in a similar manner to that described
in the previous chapter. The composition of solutions used also remained unaltered.
3.3.2 Application of pharmacological agents
All chemicals and compounds are from Sigma, unless otherwise indicated. 2
mM glycerol was added to all solutions to enable operation of the ATP biosensor.
After the initial recovery period, 80mM HCO3- aCSF (NaCl 70mM, NaHCO3 80mM,
NaH2PO4 1.25mM, KCl 3mM, MgSO4 11mM, CaCl2 1mM and D-glucose 10mM)
saturated with 91%O2, 9% CO2 was applied for five minutes followed by a 30 minute
wash period in standard aCSF (to test for tissue responsiveness). The pharmacological
agent (carbenoxolone 10 µM, carbenoxolone 100 µM, Co2+ 500 µM, 5-nitro-2-(3-
phenylpropylamino)benzoic acid (NPPB) 200 µM, proadifen 200 µM or probenecid 1
mM) was then applied for a period of 20 minutes in standard aCSF to allow it to take
affect. A second application of a hypercapnic 80mM HCO3- aCSF containing the
appropriate drug was applied followed by a thirty-minute wash in standard aCSF
containing the drug. The tissue was then washed for a further twenty minutes in
standard aCSF before the sensors were removed (to allow measurement of the tone;
see chapter 2) and the sensors calibrated.
3.3.3 Effects of extracellular Ca2+
After the initial recovery period, 80 mM HCO3- aCSF saturated with 9% CO2
was applied for five minutes (to assess tissue responsiveness) followed by a 30 minute
wash period. The Ca2+-free aCSF (standard aCSF in which CaCl2 was substituted by
MgCl2 with the addition of 1 mM EGTA: ethylene glycol tetraacetic acid) was then
applied for 20 minutes before a second application of a Ca2+-free 80 mM HCO3- aCSF
saturated with 91%O2, 9% CO2 (80 mM HCO3- aCSF in which CaCl2 was substituted
by MgCl2 with addition of 1 mM EGTA). This was followed by a 30 minute wash in
Ca2+-free aCSF. The tissue was then washed for a further twenty minutes in standard
aCSF before the sensors were removed (to allow measurement of the tone) and then
calibrated.
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3.3.4 Effects of Cx26 blockers on the response to zero calcium
After the initial recovery period of 15 minutes, Ca2+-free aCSF was applied for
10 minutes. The solution was switched to Ca2+-free aCSF containing a Cx26 blocker
(carbenoxolone 100 µM, Co2+ 500 µM, NPPB 200 µM or Proadifen 200 µM) was
applied for five minutes, followed by a 30 minute wash in Ca2+-free aCSF. The tissue
was then washed for a further twenty minutes in standard aCSF before the sensors
were removed (to allow measurement of the tone) and calibrated.
The effects of the all drug applications were compared to the second episode
of ATP release in time-matched controls.
3.3.5 In vivo recordings
Experiments were performed on 16 adult (age 10-12 weeks) male
anaesthetised and artificially ventilated Sprague-Dawley rats and carried out in
accordance with the UK Animals (Scientific Procedures) Act, 1986. The ventral
surface of the medulla was exposed as described previously (Gourine et al., 2005a).
Activity of the phrenic nerve was recorded as an indicator of respiratory activity. End-
tidal levels of CO2 were monitored on-line and kept at designated level by altering
respiratory volume and frequency. ATP and null sensors (Sarissa Biomedical Ltd)
were placed in a direct contact with the designated areas of the ventral surface of the
medulla oblongata. Hypercapnia was then induced by titrating CO2 into the
respiratory mixture for a period of 3-5 min.
The rats were anaesthetised with urethane (1.6 g/kg, I.P.). Adequate
anaesthesia was ensured by maintaining stable levels of arterial blood pressure, heart
and central respiratory rate. The femoral artery and vein were cannulated for
measurement of arterial blood pressure and administration of anaesthetic, respectively.
The trachea was cannulated and the animal was ventilated with a mixture of 50%
oxygen and 50% nitrogen (unless otherwise required by the protocol) using a positive
pressure ventilator (Harvard rodent ventilator, model 683) with a tidal volume of ~2
ml and a ventilator frequency similar to spontaneous frequency (~60 strokes/min).
The animal was then injected with gallamine triethiodide (Flaxedil™, 10 mg/kg, I.V.;
then 1-2 mg/kg/h, I.V.) and was placed in a stereotaxic frame. The ventral surface of
the medulla oblongata (VLM) was exposed as described previously (Gourine et al
2005).
Activity of the phrenic nerve was recorded as an indicator of central
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respiratory drive. The signal was amplified (x 20,000), filtered (500-1500 Hz) and
rectified and smoothed ( = 50 ms). Partial pressures of O2 and CO2 as well as pH of
the arterial blood were measured every 1-2 h. End-tidal levels of CO2 were monitored
on-line using a fast-response CO2 analyser (model Capstar-100, CI Inc., Ardmore, PA,
USA) and kept at a designated level by altering tidal volume and respiratory
frequency. In all the experiments the partial pressure of oxygen (PO2) in the arterial
blood was kept at >100 mmHg to ensure minimal drive from the peripheral
chemoreceptors. The body temperature was maintained with a servo-controlled
heating pad at 37.0 ± 0.2°C.
ATP and null sensors were connected to a MicroC potentiostat (WPI, Sarasota,
Florida, USA) or Duostat Me200+ (Sycopel international Ltd) and held on a
stereotaxic micromanipulator. The sensors were aligned with the pyramidal tracts and
major blood vessels running on the VLM and then were placed in a direct contact with
the VLM 0.1-0.5 mm lateral from the pyramidal tracts. The sensitive part of the
sensor was ~0.5 mm in length placed over a significant portion of the VLM
chemosensitive areas just rostral from the XII nerve roots. The identical placement of
the ATP sensors and null sensors was achieved by aligning them to the pyramidal
tracts, landmark blood vessels and by means of the vernier scale of the manipulator.
Once the sensors were placed, the exposed area of the brain and both sensors were
covered with an excessive volume of modified Bulmer’s buffer (100 mM NaCl, 10
mM phosphate buffer, 1 mM MgCl2 and 2 mM glycerol) and a period of 20-30 min
was allowed until a steady baseline was obtained.
3.3.6 Quantitative PCR
300µm slices were cut along the ventral-dorsal axis of the rat medulla and
RNA extracted using the RNeasy kit (Qiagen). Reverse transcription (by standard
methods) was performed and the resultant complementary DNA (cDNA) was used in
subsequent QPCR analysis using an Applied Biosystems Real Time 7000. Rat β-actin,
Connexin 26, 32, 36, 43 and Pannexin 2 primers were designed using the primer
design package (Primer Express) supplied with the Applied Biosystems Real Time
7000 and were synthesised by Invitrogen. Each QPCR reaction was performed in
triplicate and the experiment was performed 3 independent times (3 rats).
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Primer sequences were: β -actin forward (F) aggccaaccgtgaaaagatg and reverse (R)
gcctggatggctacgtacatg; Cx26 (F) gggagaggatgaggcaacct and (R) aatgtttgcccgggagatg;
Cx32 (F) ccaacacggtggactgctt and (R) aggcggcgagcataaaga; Cx36 (F)
cctacggagaagacggtctttc and (R) aggcggcgagcataaaga; Cx43 (F) tttccccgacgacaacca
and (R) tggctaatggctggagttcat; and pannexin 2 (F) gctggtcaccctggtcttca and (R)
cagtagccacgggcgtaca.
3.3.7 Immunocytochemistry
400 µm thick slices containing the ventral surface of medulla oblongata were
fixed in 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer pH 7.4 for 45 mins at
room temperature. They were then placed in 30% sucrose in 0.1 M phosphate buffer
solution (PBS), pH 7.4 and left overnight at 4oC. The fixed tissue was then embedded
in Cryo-M-Bed (Bright Instruments) and re-sectioned into 20 µm transverse sections.  
All primary and secondary antibodies were made up in immunosolution (0.1M
phosphate buffer, 0.1% BSA (bovine serum albumin), 0.1% sodium azide, 0.4%
Triton X-100, pH 7.4). Slices were blocked overnight at 4oC in 10% horse serum.
Chick anti-GFAP (Chemicon) and mouse anti-Connexin 26 (Invitrogen) were applied
at 1:500 and 1:200 respectively and incubated overnight at 4oC. The slices were then
washed in 0.1 M phosphate buffer and were incubated with appropriate secondary
antibodies for 2 hrs (Alexafluor 488 goat anti-mouse for Connexin 26 and β-
galactosidase and Alexafluor 594 goat anti-chick for GFAP, both obtained from
Invitrogen. After further washing the slices were dried and mounted in Vectashield
(Vector Labs) and visualised under an SP2 Leica confocal microsope. Some sections
(in this case 60 µm thick) were processed as free-floating sections. In these instances
sections were also stained for MAP2 (1:500, Sigma). Slices were finally mounted in
Vectashield DAPI (Vector Labs).
3.3.8 Immunohistochemistry of LacZ reporter
I received whole medullas from heterozygote Cx26+/LacZ transgenic mice (a
gift from Klaus Willecke), where a LacZ reporter gene had been inserted in place of
one copy of the Cx26 gene. The medullas were sectioned on a cryostat at 60µm
intervals as described in the previous section. Free floating tissue sections were
incubated in 500µl of 15% X-Gal buffer (0.075g X-Gal, Melford Labs, in 500µl
DMF), 50µl X-Gal buffer solution (0.165g potassium ferricyanide and 0.211g
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potassium ferrocyanide in 50ml PBS) and 1µM magnesium sulphate. The tissue was
left overnight at 37ºC to develop and washed with PBS. Sections were then dried and
mounted in Vectashield (Vector Labs) and visualised under an Olympus light
microscope. All reagents are from Sigma unless otherwise stated.
3.3.9 Dye loading of medullary slice
After preparing the slice as above and an initial recovery period, 80mM HCO3-
aCSF saturated with 9% CO2 containing either carboxyfluorescein (CBF, 100µM) or
its fixable form fluorescein isothiocyanate (FITC, 100µM) was applied for 5 minutes,
followed by a wash of 30 minutes in standard aCSF. Controls underwent a five-
minute application of the fluorescent compound in standard aCSF followed by a
fifteen-minute wash. To wash out the dye previously loaded into the tissue, a five
minute application of 80mM HCO3- aCSF the saturated with 9% CO2 was given in the
absence of the dye, followed by a 10 minute wash in standard aCSF. These
experiments were performed on the ventral medullary slice from 3 rats – each
replicate gave the same result. Carboxyfluorescein was chosen as it has a similar size
and charge as dyes that connexin 26 is permeable to (Zhao 2005, Webber et al 2004).
3.3.10 Data analysis
All measurements of ATP release are expressed as mean ± sem. Statistical
comparisons were made with a one-way ANOVA, the Kruskal-Wallis test or unpaired
sample t-tests where appropriate. All comparisons are two-sided. Analysis of cell
labelling to create pixel intensity histograms was performed with Image J software.
3.4 Results
3.4.1 ATP is released through hemichannels
Different mechanisms of ATP release are either sensitive or insensitive to the
concentration of extracellular calcium. Therefore to reduce the pool of possible
mechanisms I examined whether CO2-evoked ATP release requires extracellular Ca2+.
The application of the calcium free aCSF by itself induced a profound release of ATP
(4.0 ± 0.6 µM, n=4, figure 1a). Interestingly, an increase in PCO2 was still able to
evoke release of ATP on top of this elevated baseline (2.0 ± 0.5 µM, n=4) not
significantly different control conditions (2.2 ± 0.9 µM, n = 13, unpaired t-test, P =
0.18, figure 1a). CO2-evoked ATP release is therefore independent of extracellular
Ca2+, removing neuronal or glial exocytosis as possible mechanisms.
9a
That lowered extracellular Ca2+ could evoke ATP release, suggested gap
junction hemichannels as conduits for ATP release, as these will gate open in the
absence of extracellular Ca2+ (Müller et al., 2002, Peracchia and Peracchia, 2004). In
conjunction with this it has also been widely reported that gap junction hemichannels
are inhibited by large decreases in pH (Trexlar et al., 1999, Peracchia and Peracchia,
2004), as is ATP release in response to increased PCO2 (chapter 2). Carbenoxolone,
the broad-spectrum gap junction hemichannel blocker, inhibited ATP release
triggered by a calcium free solution (Fig 1b) as well as that evoked by CO2 (Fig 1c
and d), supporting the involvement of hemichannels. Carbenoxolone also reduced
tonic levels of ATP present at the ventral surface, suggesting that this tone arises from
spontaneous gating of gap junction hemichannels (1.4 ± 0.5 µM, n=9; Kruskal-Wallis
H=5836, p<0.001, compared to control; figure 1).
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confirmed these data by examining immunocytochemical localization of Cx26 protein.
Cx26 immunoreactivity was confined to the very ventral margin of the parenchyma at
the medullary surface and the pia mater (Fig 4) as reported by others (Solomon et al
2001). Thus Cx26 is localised to the VLM, the area that ATP release is confined to,
making it the most likely candidate for involvement in this mechanism.
Figure 2: Connexin 26 is localised to the ventral surface of the medulla. Upper panels: Expression
levels of Connexin and pannexin mRNA through the dorso-ventral axis of the medulla. Lower panels:
Location of Cx26 protein at the VLM surface and its correlation with GFAP. Note that Cx26 appears to
be expressed at the end feet of glial cells. Scale bar represents 40µm
3.4.3 Connexin 26 hemichannels are expressed the leptomeninges and capillaries
The cellular expression of the Cx26 protein is controversial. The creation of a
LacZ reporter mouse has been at the centre of this debate, since inconsistencies have
been reported between the expression of Cx26 in these mice as compared to
immunocytochemical data. In order to try and resolve some these discrepancies and to
provide unbiased documentation, I thought it appropriate to also investigate the
expression of Cx26 in these mice. β-galactosidase positive nuclei were densest in the
leptomeninges, particularly in the region that relates to the highest levels of ATP
release, both in vitro and in vivo (figure 3). LacZ staining was also observed in the
cells adjacent to penetrating vessels of the medulla and was particularly prevalent in
areas suspected to respond to hypercapnia evoked ATP release (see chapter 1), such
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as the medullary raphé complex (figure 3). This indicates that ATP may be released
directly from the leptomeninges and cells lining blood vessels.
Figure 3: β-galatosidase immunoreactivity in Cx26+/LacZ reporter mice. a) low magnification view
of the ventral medulla showing Cx26 expression in the leptomeninges (scale bar 300µm). B and c)
Higher power magnification of a) (white arrows indicate biosensor placement). d, e and f) Localisation
of Cx26 on penetrating vessels of the medulla. Scale bars represent 100µm unless otherwise stated.
3.4.4 Connexin 26 positive nuclei are enveloped by a GFAP cytoskeleton
Under the light microscope the expression of Cx26 in the LacZ reporter mice
was localised in the pia. However, extensive co-localisation of Cx26, GFAP and FITC
in the glial limitans was observed on the confocal microscope I therefore wanted to
identify if any β-galactosidase immunoreactivity from Cx26+/LacZ mice co-localised
with GFAP in the glial limitans. As under the light microscope β-galactosidase
immunoreactivity was seen throughout the leptomeninges and the surface and
penetrating vessels (figure 4). However at the surface of the ventral medulla there was
co-localisation of β-galactosidase and GFAP, showing that the most superficial
astrocytes of the medulla express Cx26, thus confirming the immuncytochemistry
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data in the previous section. At higher magnification it was apparent that β-
galactosidase positive nuclei were enveloped by GFAP (figure 4). Interestingly no co-
localisation was observed in the blood vessels or the pia indicating that more than one
cell type may be involved in the release of ATP, namely sub-pial astrocytes and
pericytes.
Figure 4: β-galactosidase (a marker of Cx26) positive nuclei are enveloped by GFAP. a, and d) β-
galactosidase staining of the medullary surface, g) at higher magnification. b, and e) GFAP staining, h)
at higher magnification. c and f) overlay i) at higher magnification. Scale bar for a, b and c represents
30µm; d, e and f represents 40µm; g, h and I represents 10µm. Note that β-galactosidase is located at
the surface of the medulla and is associated with the vasculature. Co-localisation of GFAP and β-
galactosidase appears as yellow in pictures c and f, in addition i shows that GFAP cytoskeleton encases
β-galactosidase stained nuclei.
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3.4.5 Blocking Connexin 26 hemichannels reduces ATP release in vitro
The localized expression of Cx26, an anion-selective hemichannel capable of
conducting ATP (Zhao, 2005), in structures located within the ventral medullary
chemosensitive regions, suggests the involvement of this particular channel in the
release of ATP in response to CO2. I tested this hypothesis by applying inhibitors
more selective for Cx26 hemichannels (Co2+, proadifen and NPPB) (Zhao, 2005,
Ripps et al., 2004). All three compounds greatly reduced the amount of ATP released
from the ventral surface of the medulla in response to a CO2 challenge (one way
anova, P=0.004, t-tests P<0.05 in all cases, Fig 5a-d).
Figure 5: Inhibition of ATP release by connexin 26 selective hemichannel blockers. A) Cobalt
500µM B) NPPB 200µM C) Proadifen 200µM D) Graph of peak ATP release for all hemichannel
blockers and controls calculated as the difference between the red dotted line and the peak of the black
line. Negative shifts are due to subtraction artefacts.
3.4.6 Blocking Connexin 26 Hemichannels reduces ATP release in response to EGTA
and reduces tonic levels of ATP at the VLM surface
To confirm the results obtained with carbenoxolone, I assessed the Cx26
selective blockers against all forms of ATP release seen at the VLM surface. Co2+,
proadifen and NPPB also reduced the ATP tone present at the ventral surface,
suggesting that it is the Cx26 hemichannel that is spontaneously gating to give rise to
tonic levels of ATP seen in this region (respectively to 0.6 ± 0.3 µM, n=6; 2.0 ± 0.6
µM, n=8; and 1.6 ± 0.4 µM, n=6; Kruskal-Wallis H=5836, p<0.001, compared to
control; Fig 6).
c
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Figure 6: Inhibition of tonic and reduced calcium evoked ATP release by connexin 26 selective
hemichannel blockers A) Reduction of tonic ATP levels by Connexin 26 selective hemichannel
blockers, grey box shows where sensors were removed B) Graph of peak ATP release in response to
removal of extracellular calcium for all hemichannel blockers and controls.
3.4.7 Blocking Pannexin 1 hemichannels does not affect ATP release in response to
hypercapnia
As pannexin 1 hemichannels have been reported as conduits for ATP release
(Romanov et al., 2007, Huang et al., 2007, Bao et al., 2004), I tested two agents at
concentrations selective for these channels, (Silverman et al., 2008): carbenoxolone
(10 µM); and probenecid (1mM). However these manipulations had no effect on CO2-
evoked ATP release ruling out a significant role for pannexin 1 hemichannels in CO2
chemosensory transduction at the ventral medullary surface (Figure 7)
Figure 7: Effect of pannexin 1 blockade on ATP release. A) probenecid 1mM B) Carbenoxolone
10µM C) Control D) Bar graph for comparisons between controls and blockers calculated as the
difference between the red dotted line and the peak of ATP release.
a) b)
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3.4.8 Blocking Connexin 26 Hemichannels reduces ATP release in vivo
To test whether ATP release through Cx26 hemichannels contributes to the
increases in breathing seen in response to elevated CO2 in vivo, I made recordings
from the ventral medullary surface of anaesthetized and artificially ventilated adult
rats. Application of either NPPB or proadifen to the surface of the medulla greatly
reduced CO2-evoked ATP release and significantly reduced the adaptive increases in
respiratory activity (Fig 8e-g). This reduction of the CO2-induced respiratory response
following inhibition of Cx26 at the ventral surface of the medulla was similar to that
caused by ATP receptor antagonists (Gourine et al., 2005a) and is similar to the
contribution of the ventral surface chemosensors to the total adaptive ventilatory
response to CO2 (Nattie, 2001). Interestingly carbenoxolone perfusion into the RTN, a
chemosensitive site that may be a possible target for ATP, reduces the hypercapnic
ventilatory response by a similar value (17%) in adult rats (Hewitt et al., 2004). These
in vivo data strongly suggest that ATP released via Cx26 hemichannels mediates the
adaptive increase in ventilation following an increase in inspired CO2.
Figure 8: Effect of connexin 26 blockade on ATP release and respiration in vivo. a) 200µM
proadifen b) 200µM NPPB c) Bar graph for comparisons between controls and proadifen e) Bar graph
for comparisons between controls and NPPB e) effect of hemichannel blockade on the total ventilatory
response
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3.4.9 Identifying CO2 sensitive cells
When Cx26 hemichannels open it should be possible to load cells that express
it with a low molecular weight fluorescent anionic dye. Since this hemichannel opens
in response to CO2, the dye should pass down a concentration gradient and fill the
CO2-sensitive cells of the medulla if it is present in the milieu during the stimulus.
Brief exposure of the isolated ventral medullary slice to carboxyfluorescein caused
modest dye loading over the entire ventral surface of the medulla including the
parenchyma and vasculature (Fig 9a). This again suggests the spontaneous gating of
hemichannels under control conditions (95% O2, 5% CO2), and is consistent with our
observations of a Cx26-dependent ATP tone.
However, elevated levels of PCO2 (5 minutes of 9% CO2, 80 mM HCO3-)
induced a significant increase in carboxyfluorescein loading throughout the ventral
medullary surface (including the pia and surface vessels: Fig 9a). I was able to
subsequently reduce dye loading to below control levels by exposing the slice to a
PCO2 of 62mmHg (5 minutes of 9% CO2, 80mM HCO3-) in a standard aCSF (Fig 9a).
Re-opening of the channel with an increase in PCO2 in the absence of the dye allows
evacuation of the carboxyfluorescein, as it passes down the concentration gradient in
the opposite direction.
To identify the sensor cells, I used immunocytochemical labelling of
transverse sections of medullary slices. Isolated tissue slices were first loaded with
FITC and then, to confirm that cell loading was a consequence of the opening of Cx26
hemichannels, were counterstained for this protein. To identify the cellular origin of
ATP release, I also counterstained for GFAP (Fig 9b and c) and microtubule
associated protein 2 (figure 9e). To show that FITC loading was through Cx26, I also
counter stained for this protein (figure 9d). This revealed that the CO2-dependent
FITC loading was colocalized with Cx26 and GFAP immunoreactivity. Conversely,
there was virtually no colocalization with MAP2 – a specific neuronal marker, even
though MAP2 positive neuronal processes were closely juxtaposed to the FITC
labelled cells. Thus CO2 is sensed by astrocytes and leptomeninges at the ventral
surface of the medulla oblongata
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Figure 9: Alterations in PCO2 allow low molecular weight dyes diffuse into sub-pial astrocytes
through C26 hemichannels. a) Carboxyfluorescein in tissue slice. b and c) FITC localised with GFAP
d and e) FITC and Cx26 Note the dye loading associated with the vasculature and leptomeninges of the
medulla in a). Scale bars represent - top: 5mm for a) and bottom: 40µm for b) - e).
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3.5 Discussion
3.5.1 ATP release is hemichannel mediated
The profile of ATP release seen upon the removal of extracellular calcium has
been observed in the retina, where ATP is released through connexin 43 (Pearson et
al., 2005). The relationship between extracellular calcium ion concentration and ATP
release may explain why the removal of calcium from the VLM surface potentiates
the response to hypercapnia, whereas addition attenuates it, in adult cats (Berkenbosch
and Adan, 1974, Berkenbosch et al., 1976). In conjunction a fall in pHe will close
hemichannels, which explains the inhibitory effect of decreases in pHe on ATP release.
The increase in pore opening caused by alkaline pH in addition to that caused by
increasing PCO2 reveals why our 80mM HCO3- hypercapnic solutions provides us
with the greatest amount of ATP. In support of these implications, applications of the
broad spectrum hemichannel blocker carbenoxolone significantly reduced ATP
released in response to changes in PCO2.
Carbenoxolone also significantly reduced the ATP released initiated by the
removal of extracellular calcium. The additive effect of removing extracellular
calcium and increasing PCO2 on ATP release indicates their modes of action are
through different binding sites. A third final discovery from this series of experiments
was the reduction of ATP tone seen at the surface of the ventral medulla caused by
carbenoxolone. This implies that the tonic levels of ATP at the VLM surface are
created by the spontaneous gating of gap junction hemichannels. As there is a basal
level of carbon dioxide in the blood (PCO2 ~40mmHg) and this leads to a basal PCO2
at the VLM surface, this causes the gating of the hemichannel and thus ATP release.
When PCO2 increases its effect on hemichannel gating increases and thus greater
levels of ATP are seen; when PCO2 decreases its effects lessen and reduces ATP
levels at the ventral surface, thus ATP could have affects during both hypo- and
hypercapnia as seen in chapter 2. This provides a new role for gap junction proteins in
the ventilatory system, as previously their role was thought to be confined to
modulating rhythm generation and synchronising inspiratory motor output (Solomon
et al., 2003).
3.5.2 Connexin 26 is enriched at the VLM surface
Although many connexin and pannexin sub-types are found at the ventral
surface, only connexin 26 mRNA was enriched in the ventral slice compared to more
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dorsal tissue (300-1800µm from the surface), with the others showing a more linear
and ubiquitous expression. Since ATP release is confined to VLM surface and most
hemichannel proteins are not I would expect to see ATP elsewhere if it were due to
any connexin except connexin 26.
The localisation of connexin 26 has come under scrutiny. Immunological
studies show connexin 26 is exclusively expressed in sub-pial astrocytes and sub-
ependymal layers (Mercier and Hatton, 2001). However, studies using genetic
coupling of β-galactosidase to the connexin 26 promoter to create a reporter allele
show that it is limited to the meninges only (Filippov et al., 2003). The discrepancy
between these two investigations has called the specificity of the Cx26 antibody into
question. However staining was confined to the very superficial cells, and were cross
reactivity occurring, one would expect a more ubiquitous staining profile in keeping
with the expression of other connexin sub-types. The major source of cross reactivity
is thought to be Cx30; importantly we did not find this protein present with cold PCR.
This connexin has been described only in one study, which reported it to be highly
expressed in the facial nucleus and superior olive (Condorelli et al 2002). Staining of
these regions was never seen with the Cx26 antibody I used; therefore I assume that
no cross reactivity has occurred. In addition the Cx26+/LacZ reporter mice still contain
the neomycin selection gene; importantly this is a powerful promoter and may affect
not only the expression of the reporter but may also affect the control of genes that
surround it. However the reporter mice used in this study had the selection gene
removed, so that this is not a factor. As only one of the Cx26 alleles has been replaced
by the reporter allele, some Cx26 positive cells will not express β-galactosidase. Thus
there are draw backs to either technique. In addition the reporter mice show only
nuclear staining and not where the protein is expressed, in contrast the antibody stain
shows the location of the protein, but not which cells are expressing it. Therefore I
employed both techniques in conjunction with real-time PCR to try and overcome
these problems.
The co-locations of Cx26 and glial fibrillary acidic protein (GFAP) suggest
that Cx26 is expressed in the end feet of sub pial astrocytes in direct contact with the
pia mater. This would place these hemichannels in direct contact with our biosensors.
In addition the Cx26+/LacZ mice also showed Cx26 positive nuclei at the surface of the
medulla, though not all of it was encased by GFAP. Thus there appears to be a second
cell type that expresses this protein, which is not of glial origin. There was also dense
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β-galactosidase staining of the pia mater and cells surrounding blood vessels, which
may be of the same cellular origin. This also provides an insight into the delicacy of
the dissection that leads to our preparation. If Cx26 is in direct contact with the pia
mater and is highly expressed in the pia mater itself, then any disruption to this
meningeal layer removes a vast amount of and causes damage to this protein and thus
no ATP release is seen.
3.5.3 Connexin 26 is the conduit for ATP release in vitro
Pharmacological identification of gap junction hemichannels is not yet
achievable, due to a lack of specific blockers. Though all hemichannel blockers
universally affect all subtypes, they do so differentially. Therefore I identified several
compounds that are more selective for connexin 26 over other hemichannels (Ripps et
al., 2004). I found that Co2+, NPPB and proadifen all significantly reduced the amount
of ATP released in response to changes in PCO2 and EGTA and also reduced tonic
levels of ATP. The actions of pharmacological blockade combined with the
anatomical location of connexin 26, demonstrates that all three mechanisms are not
just mediated through hemichannels but specifically connexin 26 in vitro.
Pannexin 1 is one of the only hemichannels that can be distinguished
pharmacologically. Pannexins, particularly pannexin 1, can act as pathway for ATP
release. Therefore to remove this as a possible source of ATP release under
hypercapnic conditions I applied carbenoxolone at concentrations effective enough to
inhibit pannexin 1 but not connexin hemichannels, and probenecid a selective blocker
of Pan 1. I found that applications of either pannexin 1 hemichannel blocker reduced
ATP release at the VLM surface, leaving connexin hemichannels as the only possible
source.
3.5.4 Connexin 26 is the conduit for ATP release in vivo
Now I had identified a conduit by which ATP may pass from the intracellular
to extracellular space in vitro, I wanted to confirm this observation in vivo. This
would not only verify the mechanism of ATP release but also that our model of ATP
release at the VLV surface was indeed valid. Significant reductions in ATP release at
the VLM surface by applications of NPPB and Proadifen were accompanied by
significant reductions in the hypercapnic ventilatory response. This result show that
ATP release at the VLM surface of intact anaesthetised animals is also mediated
through Cx26, and also confirmed the importance of purinergic signalling in the
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hypercapnic ventilatory response. Moreover the reduction in the increase in
ventilation was identical to the contribution of; the VLM surface, purinergic receptors
and gap junctions to the total response. The combination of these results shows that
ATP release through gap junction hemichannels at the VLM surface is the sole
contributor to participation of this region in the total response.
3.3.5 CO2 responsive cells can be dye loaded
Connexin hemichannels have been shown to be selective for the charge and
size of a molecule. Connexin 26 for instance is anion selective and allows the uptake
of Alexa 350 (MW 350) and Alexa 488 (MW: 570) but not Alexa 594 (MW: 760)
(Weber et al., 2004). Importantly, ATP is a negatively charged molecule with a
molecular weight of 507.2 (Stenesh, 1998). Dye loading studies are heavily utilised
for the study of gap junctions and hemichannels: for instance hemichannel expression
can be identified in cells of the cochlear, based upon dye selectivity (Zhao, 2005).
I hypothesised that it would be possible to dye load cells involved in the
release of ATP in the VLM, and that opening the channel by increasing PCO2 should
allow passage of the dye down the diffusion gradient into the cell. Since connexin 26
hemichannels have shown a preference for dyes such as Alexafluor 350 (Zhao, 2005,
Weber et al., 2004), I chose a dye of similar charge and weight, carboxyfluorescein
(CBF; MW 376). I found that applications of CBF in control aCSF caused modest dye
loading in accordance with the ATP tone seen; this shows that Cx26 hemichannels are
either in a sub-conductance state or exhibit spontaneous gating under control
conditions. A second application of CBF in the presence of elevated CO2 caused a
significant increase in dye loading at the medulla surface, indicating an increase pore
opening of the hemichannel in response to changes in PCO2 allows more dye in and
therefore ATP out. I found that it was possible to evacuate CBF from the cell by again
opening the channel with increased PCO2 in the absence of the dye, this time the
direction of the diffusion gradient would be the same as for ATP allowing it to escape.
This discovery not only provided me with further evidence of my working hypothesis
but also gave me proof of principle in terms of my ability to dye load the cells
involved in this response.
3.5.6 ATP is released from Cx26 positive sub-pial astrocytes
The counterstaining of dye loaded medullas with cellular identifiers enabled
me to determine the origin of ATP release at the cellular level and their relationship
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with connexin 26 hemichannels. I found that FITC labelling was confined to the first
150µm of the VLM, an area that extends from the surface to the boundary of the
MGL. In concordance with this I found a high correlation between dye loading and
GFAP, the densest levels of FITC matched the densest levels of GFAP, after the
initial 150µm the tissue was devoid of both FITC and GFAP staining. Where FITC
penetrates deeper into the medulla it appears to do so down glia projections,
especially around blood vessels. Using both methods of Cx26 detection, there was
shown to be an association between GFAP and Cx26 expression. Conversely, the
correlation between MAP2 and FITC staining was almost mutually exclusive,
whereas FITC staining ceased at 150µm, MAP2 staining began. There was evidence
of some MAP2 staining within the MGL in agreement with reports of neurons
residing here. However, the MAP 2 staining seemed to exist between FITC staining
with no overlap seen. Thus I can exclude neuronal involvement in this process.
3.6 Summary
ATP is released from sub-pial astrocytes through connexin 26 hemichannels.
Blockade of this release mechanism causes reduction in breathing that is equal to
blocking the effects of this signalling molecule at its receptors or to the destruction of
the cells responsible for releasing it.
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Chapter 4: Connexin 26 is the molecular transducer
for CO2 chemosensitivity
4. 1 Abstract
In previous chapters I have shown that connexin hemichannels are responsible
for the release of ATP at the surface of the medulla in response to hypercapnia. These
channels are constitutively active and are responsible for tonic ATP release at the
surface of the ventral medulla. The dorso-ventral distribution of Cx26 along with the
profile of pharmacological blockers makes this hemichannel the most likely candidate.
Its expression in the pia and sub-pial astrocytes stained with carboxyfluorescein in a
hypercapnic solution also supports this hypothesis. However the molecular transducer
for detecting fluctuations in PCO2 has yet to be elucidated. In this chapter I show that
blockade of CO2 or HCO3- sensitive second messenger systems is ineffective at
reducing ATP release. In addition I tested the CO2 sensitivity of five different
connexins, and show that they exhibit different responses. Of the connexins tested
only hemichannels consisting of β-connexins opened in response to elevated CO2.
Moreover, I show that the expression of Cx26 protein alone in HeLa cells is sufficient
to confer CO2 sensitivity and ATP release. By loading these transfected cells with
ATP I was able to recapitulate the entire in vivo response with a single protein. Thus I
propose a dual role for Cx26, as both the chemosensory transducer and the conduit for
ATP release, in the hypercapnic ventilatory response.
4.2 Introduction
The discovery of ATP release from the classical chemosensitive areas of the
ventral surface of the medulla, has led to a series of investigations to characterise the
stimulus and elucidate the mechanisms and cell types involved. It is dependent on
changes of PCO2, which may lead to its involvement in the response to hypocapnia as
well as hypercapnia (chapter 2). Blockade of Cx26 hemichannels decreased the tonic
levels of ATP and reduced hypercapnia-induced ATP release both in vitro and in vivo.
Moreover, this reduction in ATP release weakens the hypercapnic ventilatory
response (HVC). The decrease in the HVC is equivalent to the contribution of the
VLM surface to the overall response (Nattie, 2001), the blockade of purinergic
receptors and is similar to the participation of all gap junction hemichannels in this
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region (Hewitt et al., 2004). The discovery that Cx26 mediated ATP release led to the
identification of the cellular source of ATP as sub-pial astrocytes (Mercier and Hatton,
2001) and more likely the leptomeninges (Filippov et al., 2003). This identified for
the first time a primary role for astrocytes and leptomeninges in the hypercapnic
response. Although, the conduit for ATP release from glial cells is known to be Cx26
(chapter 3), the CO2 transducer has yet to be identified.
Previous work has suggested that CO2 is not detected directly but instead via
consequent in pH, either intracellularly (pHi) (Wang et al., 2002, Filosa et al., 2002)
or extracellularly (pHe) (Mulkey et al., 2004). The general consensus is that changes
in either pHi or pHe act on acid sensing cation ion channels on these neurons. Acid
sensing ion channels (ASIC) are proton sensitive cation channels (Shimokawa et al.,
2005). They are activated by rapid extracellular acidification (Shimokawa et al., 2005),
which acts on the extracellular face of the protein (Waldermann et al., 1997). Upon
activation they allow an influx of cations (Shimokawa et al., 2005), usually sodium
(Waldermann et al., 1997). However they usually require large alterations in pH not
within physiological range. TASK (tandem-pore acid sensing potassium channels) 1
and 3 channels confer intrinsic pH sensitivity to many medullary neurons (Mulkey et
al., 2007b). Nevertheless TASK knockout mice show no deficiency in their
ventilatory response to CO2 (Mulkey et al., 2007b). Thus they are not now thought to
be the transducer of CO2 chemoreception. Inward rectifying potassium channels are
sensitive to alterations in pH within the physiological range (Pineda and Aghajanian,
1997), and have been shown to convey chemosensitivity to neurons in the locus
coeruleus (Pineda and Aghajanian, 1997). In conjunction cells in this region have
reduced responses to hypercapnia acidosis, when an array of potassium channels or L-
type calcium channels are inhibited by tetraethylammonium (TEA) or nifedipine
respectively (Filosa and Putnam, 2003). However the blockade of other channels in
these studies may have affected the excitability of these neurons and thus provided a
false positive or an exaggerated response. In this chapter I demonstrate that Cx26 is
sufficient for CO2 sensing. Expression of this protein alone in HeLa cells conveys
chemosensitivity to them. Its high sensitivity to alterations in PCO2 in excised patches
shows that it is an intrinsic chemosensor. Moreover expression of this protein to HeLa
calls can completely recapitulate ATP release at the VLM surface in response to
hypercapnia. Thus Cx26 appears to be a new chemosensor.
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The involvement of Cx26 in this response has provided the first insight into
the mechanism which may underlie ATP release at the VLM surface. Exploiting this
as an initial starting point, I began to unravel the mystery that surrounds the
mechanism underlying this phenomenon. I have already shown that one carbon
dioxide and bicarbonate sensitive second messenger, carbonic anhydrase, is not
involved in this process (chapter 2) and here I eliminate the other, adenylate cyclase.
More importantly the expression of a single protein, Cx26, is all that is necessary to
transfer CO2 sensitivity to a non-chemosensitive cell line. In this chapter I show that
the CO2 binding domain resides on the extracellular face of the protein. In conjunction
I also provide evidence for the first time that this protein is indeed capable of allowing
passage of ATP through it. Therefore I propose that Cx26 is not only the conduit by
which ATP is released from sub-pial astrocytes but is also a transducing molecule for
identifying changes in extracellular PCO2.
4.3 Methods
4.3.1 In vitro recordings
4-6 week old Sprague-Dawley rats were sacrificed by an overdose of
isofluorane, the brain stem was rapidly dissected free under chilled aCSF, mounted on
a block and a 400 µm thick slice comprising the ventral surface of the medulla was
cut. This slice was then placed in the recording chamber maintained at 33ºC. ATP and
null biosensors were obtained from Sarissa Biomedical Ltd. They were placed on the
ventral surface of the medullary slice in equivalent positions either side of the midline.
I report the difference between the ATP and null biosensor recordings to give an
accurate measure of ATP release.
After the initial recovery period, 80mM HCO3- aCSF saturated with 9% CO2
was applied for five minutes followed by a 30 minute wash period in standard aCSF.
This enabled me to test the viability of the preparation. The pharmacological agent
SQ22536 (Tocris; 100 µM) was then applied for a period of 20 minutes in standard
aCSF to allow it to take effect. A second application of a hypercapnic 80mM HCO3-
aCSF containing the drug was applied followed by a thirty-minute wash in standard
aCSF containing the drug. The tissue was then washed for a further twenty minutes in
standard aCSF before the sensors were removed (to allow measurement of the tone)
and the sensors calibrated. Since there is a decrease in ATP release between
applications of hypercapnic solutions to the same tissue slice, ATP release in the
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presence of the inhibitor was compared to interleaved controls.
After the recovery period control tissue slices were exposed to 5 minute
application of 80mM HCO3- aCSF saturated with 9% CO2. The tissue was then
washed with control solution for fifty minutes before a second 5 minute application of
the hypercapnic solution. The tissue was then washed for a second time before the
sensors were removed and calibrated.
4.3.2 Cell culture
I maintained WT and Cx26 expressing HeLa cells in Dulbecco’s Modified
Eagle’s Medium (DMEM) with the following supplements: 1mM glutamine (Melford
Labs), 10% foetal calf serum (Invitrogen) and penicillin/streptomycin (Sigma) at
10U/ml and 10µg respectively. In addition, the Cx26 cells were under selective
pressure with puromycin (Sigma) at 1µg/ml. All cells were grown at 37oC in a
humidified 95% O2/5% CO2 incubator. For patch clamp recordings the cells were
plated out in 6 well plates at 2 x 106 cells per well for the Cx26 and 1 x 106 cells per
well for the WT HeLa cells.
4.3.3 Dye loading Cells
Sub-confluent Wild type (WT), Cx26, Cx30, Cx32, Cx36 and Cx43
expressing cells (on coverslips) were loaded with CBF (200µM), and experiments
were repeated at least 3 times. After an initial recovery period, 80mM HCO3- aCSF
saturated with 9% or 12% CO2 containing carboxyfluorescein (CBF, 200µM) was
applied for 5 minutes, followed by a wash of 10 minutes in standard aCSF containing
CBF, then a 20 minute wash in standard aCSF. Controls underwent a 15 minute
application of the fluorescent compound in standard aCSF followed by a 20 minute
wash. Each replicate gave the same result. Carboxyfluorescein was chosen as it has a
similar size (MW 376) and charge (anionic) as dyes that Cx26 is permeable to (Zhao
2005, Webber et al 2004). 40 cells were selected at random for each cell line,
condition and pixel intensity measured using an image analysis programme (image J);
on each fluorescent picture a region of interest was drawn around a single cell and
analysed. The median pixel intensities were taken and ranked in a cumulative
probability distribution; the distributions were then analysed using a Mann-Whitney U
test.
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4.3.4 Patch clamp recordings
Coverslips containing non-confluent cells were placed into a perfusion
chamber at 28°C in sterile filtered standard aCSF. Standard patch clamp techniques
were used to pull outside out or inside out isolated membrane patches or for whole
cell recordings. Although intracellular acidification has been shown to close
hemichannels, a recent report has shown that this is dependent on the type of buffer
used e.g. HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid). Therefore I
employed an intracellular solution that contained what has been termed “a good
buffer”. Whole cell patch pipettes contained an intracellular solution (K-Gluconate
120 mM, CsCl2 10 mM, TEACl 10 mM, EGTA 10 mM, ATP 3 mM, MgCl2 1 mM,
CaCl2 1 mM, sterile filtered, pH adjusted to 7.2 with KOH); Outside out patch
pipettes contained an intracellular solution (K-Aspartate 120 mM, CsCl2 10 mM,
TEACl 10 mM, EGTA 10 mM, ATP 6 mM, MgCl2 4 mM, CaCl2 1 mM, sterile
filtered, pH adjusted to 7.2 with KOH) inside out patch pipettes contained standard
aCSF. Isolated patches of the outside out configuration were held at -40mV and inside
out patches were hold at +40mV. After a reasonable baseline had been recorded,
patches were exposed to isohydric aCSF solutions saturated with variable amounts of
CO2 for 1 minute, followed by a wash period. Integrals of isolated patch recordings
were taken and compared by the Friedman test.
4.3.5 ATP release through Cx26 transfected cell lines
The cells (both Cx26-expressing and wild type) were exposed to 10 mM ATP
in the presence of 80 mM HCO3- aCSF saturated with 9% CO2 (to open the Cx26
channels and load them with exogenous ATP). They were then washed for 30 minutes
in standard aCSF before being exposed to the hypercapnic stimulus to test for release.
Preloading with ATP was essential to see CO2-evoked ATP release from Cx26-
expressing HeLa cells.
4.4 Results
4.4.1 SQ22536
The gating of connexin hemichannels in response to increases in PCO2 could
be due to the activation of a CO2 sensitive second messenger and subsequent
phosphorylation of the channel by protein kinases. A soluble adenylate cyclase (sAC)
is a conserved CO2/HCO3- sensor that is expressed in the brain (Zippin et al., 2001,
Wuttke et al., 2001, Chen et al., 2000). To test for the involvement of this enzyme, I
used a general adenylate cyclase inhibitor SQ22536.
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expression of Cx26 is sufficient to impart CO2 sensitivity, I expressed Cx26 in HeLa
cells. Dye loading was apparent in transfected HeLa cells, but absent in wild type
controls. The fluorescence profile of the wild type cells contains staining in one cell
(figure 2). Membrane disruption caused by cell death is presumed to have allowed the
passage of dye into the cell body. On the other hand, all Cx26 positive cells loaded
with dye, as can be seen by comparison with bright field illumination. This implies
that expression of Cx26 protein alone confers chemosensitivity to cells.
Figure 2: Cx26 transfected HeLa cells can be loaded with low molecular weight dyes at 9% CO2.
a) Cell loading with Carboxyfluorescein in 9% CO2/ 80mM HCO3- aCSF: Upper panels bright field
illumination; Lower panels 488 fluorescence. b) Histogram of pixel intensity obtained over the entire
field of epifluorescence. Note that the wild type curve shows a lot of pixels at low intensity (~5) and
that the Cx26 curve shows pixels at high, albeit different, intensities (~10-60), thus the greater range.
Scale bar represents 20µm.
Although expression of Cx26 confers CO2 sensitivity in this cell line, whether
the dye loading is a direct effect of Cx26 or an up regulation of another protein is not
certain. Thus to show that it is a direct consequence of Cx26 expression, I repeated the
protocol in the presence of a hemichannel blocker proadifen. Dye loading of Cx26
positive cells was blocked by proadifen (figure 3). This demonstrates that it is the
presence of Cx26 hemichannels themselves and not some contingent change in the
HeLa cells that is responsible for the CO2-dependent loading. Cell intensity for
carboxyfluorescein dye loading was significantly reduced, though not completely
removed. However proadifen at this dose does not completely block CO2-induced
ATP release.
ba
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Figure 3: Fluorescent loading of transfect HeLa cells can be blocked by a Cx26 hemichannel
blocker. a) Upper panels 488 fluorescence of Cx26 transfected HeLa cells in the presence of
carboxyfluorescein and 9% CO2/80mM HCO3- note that loading is blocked by proadifen. b) Histogram
of pixel intensity obtained over the entire field of epifluorescence. Note that the wild type curve shows
a lot of pixels at low intensities, albeit different, (~10-25) and that the Cx26 curve shows pixels at high,
albeit different, intensities (~10-140), thus the greater range. Scale bar represents 20µm.
4.4.3 PCO2 has differential effects on various members of the hemichannel protein
family
Although I have shown that expression of Cx26 confers CO2 sensitivity in
HeLa cells (figure 2 and 3), it may be that expression of any connexin hemichannel
could perform this function. To test this hypothesis I obtained HeLa cells that
expressed all the relevant medullary connexins and tested their response to CO2 with
dye loading. Connexin hemichannels have several open and closed states; typically
connexin hemichannels can exhibit spontaneous gating. Therefore cells exposed to
standard aCSF containing CBF showed background staining (figure 4 and 6).
Comparisons between median differences in cell loading between control
solutions and experimental solutions showed differential effects of hypercapnia on
connexin hemichannels. Cx26 and Cx32 showed increased staining, whereas Cx30
and Cx36 showed no change and Cx43 showed a decrease in staining. This shows that
CO2 sensitivity is conveyed only by specific connexin hemichannels. Wild type cells
exposed to hypercapnic solutions in the presence of CBF did not show any fluorescent
loading (data not shown).
a
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Figure 4: Dye loading of connexin expressing HeLa cells shows that CO2 has varying effects on
different connexin hemichannels. Column 1 is the carboxyfluorescein loading in standard aCSF, due
to constituent open states of gap junction hemichannels. Column 2 shows carboxyfluorescein staining
in the presence of 12%CO2/80mM HCO3- aCSF. Column 3 shows the cumulative probability of control
loading (pink line) and loading with the stimulus (blue line). Each row represents a different connexin
expressed in HeLa cells. Scale bar represents 20µm.
P = 0.01
P = 0.04
P = 0.03
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4.4.4 Increasing CO2 alters the conductance of connexin expressing HeLa cells
I made whole cell patch clamp recordings from the HeLa cell lines expressing
various connexins to examine the gating and sensitivity of hemichannels in response
to CO2 challenges. I found that conductance of HeLa cells containing Cx26, 30 and 32
hemichannels increased with increasing PCO2. In contrast those which possess Cx43
hemichannels exhibited reduced conductance when exposed to hypercapnic solutions.
Cx36 transfected HeLa cells on the other hand were unaffected by alterations in PCO2.
Figure 5: CO2 (12% in 80mM HCO3- aCSF) alters the conductance of hemichannels expressed in
HeLa cells. Whole cell patch clamp recordings taken from HeLa cells expressing a) Cx26. b) Cx30. c)
Cx32. d) Cx36. e) Cx43. Conductance is measured as the change in current caused by a 10mV step,
divided by the change in voltage.
Interestingly the pattern of conductance change of each hemichannel was very
similar to the change in fluorescence (figure 5 and 6). However at 95% confidence,
only Cx26, Cx30 and Cx32 were significantly different to zero (figure 5 and 6). The
lack of significance seen with Cx43 is due to the large standard deviation (figure 5
and 6).
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Figure 6: Alteration in dye loading of HeLa cells are caused by a change in hemichannel
conductance induced by 12% CO2 80mM HCO3- alters hemichannel conductance and in a similar
way. a) Mean conductance change from whole cell patch clamp data. b) Median fluorescence change in
dye loaded HeLa cells.
4.4.5 The connexin 26 hemichannel exhibit graded sensitivity to PCO2
To test whether Cx26 is sensitive to changes in PCO2 over the likely
physiological range, I examined whole cell conductance changes to graded levels of
PCO2. I found that Cx26 hemichannels are exquisitely sensitive to changes in PCO2.
Compared to a resting PCO2 34mmHg hypercapnic solutions (PCO2 55 and 71mmHg)
dramatically increased the whole cell conductance. Thus CO2 acts to unblock the gate
of the hemichannel and it spends more time in an open state, which would allow the
passage of more ATP into the ECF. Interestingly decreasing PCO2 to 19mmHg
caused a decrease in whole cell conductance (figure 7) compared to control levels
(PCO2 34mmHg).
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Figure 7: Effect of changes in CO2 on Cx26 hemichannel conductance. Insert 1) Graph to show the
effect of CO2 on ATP release from the VLM surface. Insert 2) Whole cell patch clamp recording Cx26
expressing cell line during application of 12% CO2/80mM HCO3- aCSF. Insert 3) Whole cell patch
clamp recording Cx26 expressing cell line during application of 2% CO2/10mM HCO3- aCSF.
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Thus this causes the channel gate to close and would restrict the flow of ATP
out of the cell. This relationship between Cx26 channel and gating and PCO2 is
almost identical to that for PCO2 and ATP release. Therefore it is highly probable that
this mechanism is working at the surface of the VLM during hypercapnia and
hypocapnia.
4.4.6 The connexin 32 hemichannel exhibit graded sensitivity to PCO2
To test whether Cx32 is also sensitive to changes in PCO2 over the likely
physiological range I examined whole cell conductance changes to graded levels of
PCO2. I found that Cx32 hemichannels are also sensitive to increases in PCO2.
Compared to a resting PCO2 (34mmHg) hypercapnic solutions (PCO2 55 and
71mmHg) increased the whole cell conductance. However in contrast to Cx26,
decreasing PCO2 to 19mmHg did not affect whole cell conductance (figure 8)
compared to control levels (PCO2 34mmHg). As the relationship between Cx32
channel gating and PCO2 differs to that for PCO2 and ATP release it is highly unlikely
that Cx32 is the conduit by which ATP is released at the surface of the medulla.
During hypercapnia there seems to be a rightward shift in the sensitivity of this
channel to PCO2 compared to Cx26. Therefore it is highly probable that this
mechanism is not working at the surface of the VLM (Mulkey et al., 2007b).
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Figure 8: Effect of changes in CO2 on Cx32 hemichannel conductance. Insert 1) Graph to show the
effect of CO2 on ATP release from the VLM surface. Insert 2) Whole cell patch clamp recording Cx26
expressing cell line during application of 12% CO2/80mM HCO3- aCSF. Insert 3) Whole cell patch
clamp recording Cx26 expressing cell line during application of 2% CO2/10mM HCO3- aCSF.
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4.4.7 Excised patches from HeLa cells transfected with Cx26 respond to alterations of
PCO2
My data shows that expression of Cx26 is sufficient to endow HeLa cells with
“physiological” sensitivity to PCO2. This strongly suggests that Cx26 is directly CO2
sensitive. However this sensitivity could involve interactions with unknown proteins.
Therefore I made patch clamp recordings from isolated membrane patches. As
this removes the protein from the intracellular components of the cell, any change
seen will be a direct interaction between CO2 and the channel. Moreover if the timing
of the response of either inside out or outside out configuration may give me a starting
point to try and distinguish where CO2 may be binding. Analysis of patch clamp
studies showed that outside out patches of Cx26 positive HeLa cells showed a large
conductance of 130pS (the gradient of the current-voltage relationship; figure 11). At
negative holding potentials, outside out patches showed a large inward current and a
significant increase (~6 fold) in the time the channel spent in the open state (increase
of 846000 pA.s, n = 8; figure 9 and 10) during the application of hypercapnic
solutions compared to wash periods. In addition applications of hypocapnic solutions
channels spent a decreased (~8 fold) amount of time in the open state (reduction of
328000 pA.s, n = 7; Friedman test, P>0.05; figure 9 and 10). Wild type controls did
not show any significant change between control and hypercapnic states (Friedman
test, P<0.05), as no channel gating was seen in these isolate patches no control for
hypocapnic solutions could be taken. Preliminary data from isolated inside out
patches showed a similar trend in current change with ~10 fold increase in the open
state during hypercapnia compared to control periods (n = 2; figure 10 and 11) and
~3fold decrease during hypocapnia (n=1). The time taken for the increased or
decreased gating to occur was shorter in inside out patches than in outside patches,
implying that the CO2 binding domain lies closer to the intracellular portion of the
channel and may reside in the C-terminus.
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Figure 9: Isolated patches containing Cx26 are responsive to changes in PCO2. Red line represent
applications of hypercapnic solution (71mmHg), blue lines indicate application of hypocapnic solution
(19mmHg).
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Figure 10: Enlarged channel activity from excised patches containing Cx26. a) Excised patch that
exhibited low spontaneous gating. b) excised patch that exhibited a lot of spontaneous gating.
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Figure 11: The current voltage relationship of the Cx26 hemichannel reveals a conductance of
130pS. Conductance of the channel was calculated from the gradient of the line.
4.4.8 Cx26 hemichannels are capable of allowing passage of ATP into the
extracellular space
I have shown that CO2 directly gates Cx26 hemichannels and causes ATP
release from the VLM surface where Cx26 is heavily expressed. However whether
Cx26 is capable of releasing ATP and whether it is able to do so in response to CO2 is
still unknown. To test this I placed ATP biosensors over sub-confluent Cx26
expressing HeLa cells and applied a hypercapnic solution. In pre-loaded Cx26-
expressing HeLa cells ATP release was detected with biosensors (0.3 ± 0.04 µM, n=5:
figure 10). ATP release was not evident from wild type cells (0.03 ± 0.2 µM, n=6,
p=0.005) that had undergone the same treatment (figure 12).
Figure 12: Cx26 transfected cell lines are capable of releasing ATP. Cells were preloaded by
opening hemichannels with a quasi-isohydric stimulus (91% O2, 9% CO2 and 80mM HCO3-) in the
presence of 10mM ATP.
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4.4.9 CO2 sensitivity may be more common than first thought
Excised patches of the outside out configuration (using the gluconate based
whole cell intracellular patch solution) revealed a low conductance channel (~11pS)
in both Cx26 transfected and wild type HeLa cells. This channel exhibit spontaneous
gating at 34mmHg CO2 and increased in frequency with the application of a solution
equilibrated to 71mmHg CO2 and decreased in frequency with the application of
19mmHg CO2 containing solution (figure 12). This channel had a reversal potential of
-50mV, which led to the choice of a -40mV holding potential for the outside out
excised patches and the use of a different intracellular solution for the testing of
isolated patches containing Cx26.
Figure 13: HeLa cells contain an endogenous CO2-senisitive channel. Isolated patches were held at
+10mV.
4.5 Discussion
4.5.1 CO2/HCO3- sensitive second messengers do not contribute to ATP release
In previous investigations I had shown that ATP at the VLM surface is
mediated by Cx26 hemichannels in response to changes in PCO2. I have removed
conversion of CO2 to HCO3- and H+ by blockade of carbonic anhydrase previously
(chapter 1). I therefore investigated possible HCO3- sensitive second messengers
(Chen et al., 2000) that may be responsible for converting increases in PCO2 to
increased gating of Cx26 hemichannels indirectly. Adenylate cyclase activates many
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intracellular pathways and some connexin hemichannels are modulated by the
adenylate cyclase/cAMP pathway (Duncan and Fletcher, 2002, Saez et al., 1990). In
conjunction adenylate cyclase is sensitive to CO2/HCO3- (Zippin et al., 2001, Wuttke
et al., 2001, Chen et al., 2000); thus CO2 activation of this enzyme may lead to an
intracellular cascade that causes the release of ATP. I found that SQ22536 inhibition
was without effect on any of the parameters recorded. This removed the only known
second messenger system that I know of that could be involved in this mechanism,
leaving the most plausible explanation that Cx26 is directly regulated by CO2.
4.5.2 Cx26 is sufficient for CO2 sensitivity
I obtained HeLa cells transfected with Cx26 protein (a gift from Klaus
Wilecke). Knowing from previous investigations that carboxyfluorescein was able to
penetrate cells via Cx26, I employed it in the present study. To test the direct CO2-
dependent modulation of Cx26 (Chapter 3) I applied carboxyfluorescein in the
presence of my CO2 stimulus (5 minutes 9% CO2 80mM HCO3-, fig 5a). Cx26
positive cells readily loaded with the dye, compared to their wild type counterparts.
Changes of PCO2 also caused comparable changes in the conductance of these Cx26
expressing HeLa cells. In fact this increase in whole cell conductance closely
resembles changes in ATP caused by altered CO2 levels in chapter 2. The
combination of these data sets shows that as PCO2 increases the channel conductance,
and therefore the Cx26 hemichannel spends more time in its open state, leading to an
increase in ATP release at the VLM surface; when PCO2 decreases the opposite is
true. As dye loading was not seen in wild types which lack Cx26, carboxyfluorescein
must have entered the Cx26 expressing cells through this hemichannel. To confirm
that this loading was in fact as a direct consequence of transfection with Cx26, I
repeated the experiments in the presence of the Cx26 selective inhibitor proadifen.
Proadifen, profoundly reduced dye loading in response to alterations of PCO2,
confirming that Cx26 is responsible for dye loading and gating of the Cx26
hemichannels is directly sensitive to the levels of CO2.
4.5.3 Expression of Connexin hemichannels leads to differential responses in CO2
sensitivity and dye loading.
Although I have obtained blockers more selective to Cx26 than other gap
junction hemichannels proteins, these compounds are not without effect on other
members of this protein family. Therefore I used a dye loading and patch clamp
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screen to test the CO2 sensitivities of all the prime candidates for ATP release at the
ventral surface of the medulla. I had predicted that these proteins would either be
positively gated by CO2 or be insensitive to it. The results of this experiment show
that in fact some hemichannels are closed by this stimulus. Cx43 is known to be the
least selective hemichannel in terms of both size and charge of molecules it allows to
either enter or leave a cell (Weber et al., 2004). Upon increasing CO2, the channel
gate closes (figure 4), the increased time the channel spends in its closed state restricts
the flow of low molecular weight dyes into the cell and thus reduces loading (figure 4
and 6). A reduction of dye loading implies that fewer molecules would be able to
move in the opposite direction, thus under hypercapnic conditions less ATP would be
seen; since ATP release increases I can exclude any involvement of this hemichannel
in this process. Likewise Cx36 is seemingly insensitive to CO2, it cannot therefore
participate in the hypercapnia induced release of ATP (figure 4 and 6). This leaves
only three possible hemichannels, Cx26, Cx30 and Cx32; interestingly these proteins
are the most closely related according to phylogenetic studies, whereas Cx36 and
Cx43 are found at greater distance on the phylogenetic tree (Manthey et al., 1999:
figure 14). This relationship between phylogenetics and CO2 sensitivity implicates
that CO2 sensitivity evolved to serve a specific function and has been selected for ever
since. Though Cx30 is positively modulated by CO2, from the cold PCR experiments
(data not shown), we know that Cx30 is not present in the whole medulla, and
therefore can also be ruled out as the molecular transducer.
This leaves us with only two principal candidates, Cx26 and Cx32. The patch
clamp and fluorescence data shows that Cx26 undergoes larger conductance changes
at 12% CO2 than its cousin. More importantly, Cx32 expressing HeLa cells did not
show a reduction in conductance when PCO2 was lowered to 19mmHg, thus it cannot
be responsible for the tonic levels of ATP seen at the VLM surface. Nevertheless
during extremely pathological hypercapnia it may contribute to ATP release. The
rightward shift in CO2-sensitivity means that once Cx26 is saturated with CO2 and
thus releasing ATP at full capacity, Cx32 may then begin to open and thus allowing
higher levels of ATP release to be achieved. Interestingly Cx32 may also be heavily
expressed in the pre-Bötzinger complex (Solomon et al 2001), which is present in my
second slice. Therefore it is possible that during hypercapnia, CO2 may act upon Cx32
to increase electrical coupling and therefore increase respiratory rate. Since Cx26 and
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Cx32 are both expressed at the VLM surface and are able to co-assemble, they could
be both involved in this response as homo- and hetero- meric channels.
Figure 14: Phylogeny tree of connexin hemichannels. Red box denotes positively modulated CO2
sensitive connexin hemichannels. Green box denotes negatively modulated CO2 sensitive channel. Blue
box denotes CO2 insensitive channels. Picture adapted from Manthey et al J. Biol. Chem., Vol. 274,
Issue 21, 14716-14723.
4.5.4 The CO2 binding domain lies on the intracellular face of the Cx26 protein
Once I had determined the CO2 dependent gating of Cx26, I began to study
this using patch clamp techniques. This enabled me to study the protein in isolation
from any intracellular components of chemosensitive cells that may be specialised to
this response. Interestingly, my hypercapnic stimulus initiated large transient inward
currents at negative membrane potentials in Cx26 positive patches excised in an
outside out orientation. Importantly, this type of response was not seen in equivalent
patches from wild type HeLa cells. Thus CO2-dependent gating occurs when the
protein is removed from any intracellular influence and is studied in isolation. In
conjunction, current changes evoked by increases in CO2 in patches of an inside out
configuration showed similar, albeit faster responses. This may indicate that the effect
of carbon dioxide is mediated by a binding domain accessible from either face of the
Cx26 hemichannel protein, but appears to be located on the intracellular side of the
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channel. Interestingly, carbon dioxide binding domains have never been described
before in connexin hemichannels.
Surprisingly, many investigations have looked into the relationship between
hemichannel gating and carbon dioxide. The chemical gate of gap junction
hemichannels is commonly referred to as the CO2 gate, though it also interacts with
calcium ions and protons. However these studies employ unusually high levels of CO2,
between 30 and 100% (Trexlar et al., 1999, Peracchia et al., 1999, Peracchia et al.,
2003, Peracchia, 2004, Peracchia and Peracchia, 2004). At these levels carbon dioxide
causes massive extracellular and intracellular acidification. It is the interaction
between this acidification and the closure of hemichannels that is being studied.
Importantly many of these studies use “bad buffers” for studying hemichannels, i.e.
HEPES (Bevans and Harris, 1999, Tao and Harris, 2004). These buffers contain
taurine analogues (sulphonated amines), which when protonated block hemichannel
pores. Therefore the closure of the hemichannel is due to interactions between the
protonated buffer and the channel, and not protonation of the channel itself. The levels
employed in this study are much closer to physiological levels, and have uncovered a
unique relationship.
4.4.5 ATP can be released from cells transfected with Cx26 protein
Once I had determined that Cx26 is sensitive to CO2 and that this sensitivity
showed a close relationship to that of CO2-triggered ATP release I wanted to confirm
that this channel was able to act as a conduit for ATP release. I began by testing this
hypothesis on untreated HeLa cells transfected with Cx26 protein, using ATP
microelectrode biosensors. Surprisingly I found that no ATP release could be detected.
I hypothesised that this may be due to the cellular concentration of ATP of HeLa cells.
Therefore I loaded the HeLa cells with ATP using my stimulus as a method of gating
the channel to allow influx of this molecule down the concentration gradient. I found
that pre-loaded cells released significant levels of ATP (figure 11). It has been hard to
reconcile the fact that Cx26 is expressed over the entire surface of the ventral medulla,
yet ATP release is localised to discrete areas. This disparity can be resolved by this
finding; in conjunction with Cx26 expression the concentration of ATP content of the
cells involved may be elevated. This means that either pial cells or sub-pial astrocytes
must either have an extraordinary high rate of ATP production or a specific sub-
cellular organisation; such that mitochondria are situated close to the hemichannel or
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they are compartmentalised so that the ATP can be stored beneath the hemichannel at
high concentrations. Alternatively it may be that either the level of ectonucleotidases,
enzymes responsible for the degradation of ATP, may be lower in chemosensitive
areas. Thus ATP levels will be higher in the ECF of chemosensitive areas.
4.5.6 Implications for chemosensitivity
Intrinsic chemosensitivity is currently defined as the maintenance of a
chemosensitive response in the absence of synaptic transmission, methods to achieve
this include the removal of extracellular calcium or the use of a cocktail of antagonists
for most neurotransmitters. Using this definition many neurons of the respiratory
network and medulla oblongata as a whole have a small degree of intrinsic
chemosensitivity (Kawai et al., 1996, Mulkey et al., 2004, Richerson, 2004, Nattie,
2000, Nattie and Li, 2002a). Importantly removing extracellular calcium will not
inhibit hemichannel mediated ATP release. In conjunction the synaptic blocker
cocktails used do not block gap junctions or contain purinergic antagonists. In light of
the evidence presented here I believe that intrinsic chemosensitivity should be defined
as the maintenance of a chemosensitive response in the absence of synaptic
transmission (including purinergic antagonists) and gap junction hemichannel
blockade. I also believe that in order to truly identify a chemosensitive cell one must
demonstrate that it possesses the relevant molecular transducer.
Until recently the search for a chemosensory transducing molecule has
focused on tandem pore potassium channels such as TASK channels (TWIK-related
acid sensing potassium channel), particularly TASK 1. TASK 1 channels exhibit pH
sensitivity over the physiological range, making it an apparently attractive
chemosensory target. Although this molecule does convey intrinsic pH sensitivity to
many neurons, TASK 1 knock out mice show no perturbations in the hypercapnic
ventilatory response (Mulkey et al., 2007b). Thus the search for an acid sensing cation
permeable channel continues. With many chemosensitive nuclei located close to the
surface of the brain, containing purinergic receptors and sensitive to ATP, may be
Cx26 is what we have all been looking for Cx26 acts as the chemosensor and
purinergic receptors confers chemosensitivity to the neuron.
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Chapter 5 Discussion
5.1 Implications for chemoreception
I have uncovered what appears to be the first incidence of a chemosensory
mechanism that directly detects alterations in PCO2 instead of the proxy of pH, as its
primary source of detection. Generally it is fluctuations in pH that are primarily
responsible for stimulation of chemosensory neurons. The RTN is directly stimulated
by extracellular pH (pHe) (Mulkey et al., 2004) in both bicarbonate and HEPES
buffered saline. The raphé neurons are stimulated by an alteration in intracellular pH
associated with all models of respiratory and metabolic acidosis (Wang et al., 2002).
Interestingly fluctuations in bicarbonate ions acting at adenylate cyclase have also
been implicated in both the RTN (Ritucci et al., 2005) and glomus cells of the carotid
body (Summers et al., 2002). Thus with the inclusion of CO2 acting directly on ATP
releasing cells in the superficial medulla, all possible forms of chemosensory
transduction are utilised in the response to hypercapnia as has been predicted from
previous investigations (Harada et al., 1985). Thus Gray’s multiple factor theory
seems to apply, though with a slight modification. Gray stated that pH, CO2 and O2 all
exert individual effects that contribute additively to give the full chemosensory
response (Putnam et al., 2004, Loeschcke, 1982). I shall reiterate a modified form of
Gray’s proposition that pH, CO2 and HCO3- all exert independent effects on separate
chemosensitive nuclei and the net ventilation under any given condition is the sum of
the partial effects of each of the separate agents through their actions on separate
chemosensitive nuclei, whether this be a diction of increased CO2 (or pH) or a
decrease in PCO2 (or pH).
5.1.1 Importance of the detection of multiple factors
In terms of complexity of the system as a whole this appears logical. The
recognition of different molecules in different areas would allow the brain to compute
the exact condition of the entire system. During metabolic acidosis areas that respond
to changes in either pHi or pHe would be stimulated, but areas responsible for
detecting HCO3- and CO2 fluctuations would not. During respiratory acidosis all areas
would be excited. During exercise there is an increase in H+ due to an increase in
anaerobic respiration, however bicarbonate levels reduce as it buffers lactate, thus
only H+-sensitive sites stimulate respiration, with bicarbonate dampening it slightly.
Thus it allows not only great flexibility of the system, but the implementation of the
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appropriate response to a given physiological environment as was discussed earlier
(Nattie, 2000, Su et al., 2007). It will also allow great adaptation of the system, during
chronic disease there may be prolonged periods when one of these chemosensory
triggers remains constitutively high, such as H+ concentration during metabolic
acidosis. During such chronic disease there is often a resetting of the acceptable level
of CO2 in the blood. By providing a system that monitors multiple facets of the same
chemical reaction (i.e. conversion of CO2), the respiratory system can still adapt to
changes in inspired or metabolic CO2 even when one of the signaling molecules of
this reflex is already saturated.
The fact that I saw tonic ATP at the surface of the VLM, in conjunction with
this multiple factor and multiple site theory would also seem to show the robust nature
of the response to CO2 does indeed depend on additive or greater, interactions of
inputs from multiple locations (Nattie, 2000) and some tonic baseline input is required
from all chemoreceptors to allow full expression of the systemic response (Nattie,
2000).
5.2 ATP release is hemichannel mediated
There are several possible mechanisms of ATP release defined in the
introduction. The removal of extracellular calcium was without effect on ATP release,
eliminating synaptic release from neurons as a plausible mechanism. The removal of
extracellular Ca2+ also caused ATP release in the absence of CO2 alterations. ATP
release on removal of extracellular Ca2+ has been observed for gap junction
hemichannels in the retinal pigment epithelia, where ATP is released through
connexin 43 (Cx43) hemichannels (Pearson et al 2005). The additive affect of
removing extracellular calcium and increasing PCO2 on ATP release indicates their
modes of action are through different binding sites or mechanisms. It also removes
most sources of neuronal mechanisms of transmitter release, which was the first
suggestion that the primary source of ATP release is of glial origin.
Though the effects of low calcium suggest the involvement of gap junction
hemichannels, it is by no means conclusive proof. Thus I next employed the use of
carbenoxolone. Carbenoxolone is a known uncoupler of gap junctions and an inhibitor
of hemichannel conductance. The first noticeable and expected result is that
carbenoxolone blocked the release of ATP in response to lowered Ca2+, showing that
it is able to block hemichannel mediated release of ATP at the ventral medullary
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surface. Carbenoxolone significantly inhibited hypercapnia activated ATP release at
the VLM surface, supporting its involvement here. Interestingly it also significantly
reduced tonic levels of ATP seen at the VLM surface. It appears that hemichannels
spontaneously gate at the ventral medulla in response to basal levels of CO2, upon
hypercapnic stimulation there is an increase in the gating of connexin hemichannels
leading to an increase in ATP concentration at the VLM surface.
5.3 Connexin 26 (Cx26) mRNA is enriched at the VLM surface
Although my evidence suggests that ATP release from the VLM surface is
mediated by connexin hemichannels, there is a vast array of connexin hemichannels
capable of releasing ATP. I had to then determine which connexin hemichannel was
acting as the conduit in the superficial medulla. Reports had shown that connexins 26,
30, 32, 36 and 43 are the most abundantly expressed in mammalian brains (Solomon
and Dean, 2002). Therefore I ran a cold PCR screen for these proteins and confirmed
that, with the exception of connexin 30 (Cx30), all were present in the medulla.
Interestingly the VLM expresses the highest levels of 26, as compared to the rest of
the brainstem (Solomon and Dean, 2002) a result confirmed here. I also found high
levels of both pannexin 1 and 2 in this brain region. To narrow down the possible
candidates I ran real time PCR to look for the enrichment of message at the VLM
surface, as I was trying to match regional specificity of ATP release with the
expression levels of a specific connexin. Of the many connexin and pannexin sub-
types expressed in the medulla, only Cx26 showed site specificity to the ventral
surface. The other connexins and both pannexins showed a more or less uniform
distribution throughout the ventro-dorsal extent of the medulla. Therefore one would
expect to see ATP release elsewhere in the medulla, if other connexins were
responsible for the passage of ATP into the extracellular space. It is therefore more
than reasonable to conclude that Cx26 is the most probable conduit for ATP release
and this conclusion warranted further investigation.
5.3.1 Cx26 protein is confined to the most superficial layer of the VLM
The detection of mRNA using real time PCR only allowed localisation of
Cx26 to within 400µm of the ventral surface. To identify if there was a further
localisation within this limited boundary, I employed the use of a Cx26 antibody and
a transgenic mouse with a lacZ reporter allele, where a β-galactosidase sequence is
inserted into the open reading frame of one copy of the gene. The reason for this dual
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approach was the discrepancy in the expression of Cx26 by these two methods. LacZ
reporter mice show that Cx26 is expressed only in the meninges surrounding the brain
(Fillipov et al 2003), whereas immunofluorescent studies had shown it to be in the
underlying glia and the cells lining the ventricles, the sub-ependymal layer (Mercier
and Hatton 2001). I found exactly the same differences in this study; however
confocal microscopy showed GFAP staining enveloping Cx26 positive nuclei in
Cx26+/LacZ mice. With the Cx26 antibody, staining the superficial cells of the medulla
and the lacZ mice showing staining in the pia and blood vessels. The staining of all
penetrating vessels supplying chemosensory nuclei especially those supplying the
serotonergic raphé neurons is a very intriguing finding (the importance of the raphé
complex will be discussed later). The highly localised expression of Cx26 to the pia
means that absolute levels are extremely low, thus a 5 fold decrease as is seen in the
real time PCR experiments would only represent very low amounts of Cx26
throughout the rest of the dorso-ventral axis. Thus the presence of Cx26 on the
penetrating vessels could account for all of the Cx26 expression seen in the
subsequent slice in the real time PCR. If this is the case then Cx26 is expressed only
where cells exposed to the highest fluctuations of PCO2 are seen and thus the
detecting mechanism will be most sensitive.
One possible reason for the discrepancy between these two results is the cross
reactivity of the Cx26 antibody. Since antibody staining was confined only to the
most superficial of cells this is unlikely, coupled to the fact that the connexin reported
as being responsible for cross reactions of this antibody is not present in the medulla.
A much more likely explanation is that these two forms of staining detect Cx26 in
different cellular locations. The β-galactosidase transcript is switched on whenever
the promoter of the Cx26 allele that it is attached to is activated. The transcript is only
expressed in the nuclei of these cells, whereas the Cx26 antibody binds to the protein
when expressed in the cell membrane. Were a glial cell anchored to the pia
responsible for the production of Cx26, it would not be distinguishable under light
microscopy from the pia itself. If glia cells were anchored strongly to the pia and only
a single layer of glia cells produced Cx26, then it is conceivable that they are removed
with the pia creating a false negative in the PCR results of Filippov et al 2003. A
second though highly unlikely possibility is that Cx26 mRNA is made in pial cells
then transported to sub-pial astrocytes where it is translated and expressed. Though
highly unlikely this would not be without its merits, this would allow the expression
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of Cx26 in homomeric channels only, as sub-pial astrocytes manufacture many
different connexin sub-types. Thus in either case the lacZ mouse would show staining
that is either of, or appears to be of, pial origin, whilst the antibody will show
astrocytic staining. Whatever the case it would suggest that the removal of the pia
removes Cx26 hemichannels. Therefore in any adult in vitro or in situ preparation
experimenters must make sure not to disturb the meningeal layer, as is required in this
preparation. Otherwise this arm of the chemosensitive response will not be present
and will lead to results unrepresentative of the in vivo response.
5.4 All Cx26 positive cells dye load
The application of our stimulus must unblock the gate of the connexin
hemichannels to a degree that would allow a molecule of at least 509Da to pass
through it, in order to allow the passage of ATP into the extracellular space. Connexin
hemichannels are non-directional channels: thus if the channel will allow the diffusion
of molecules down the diffusion gradient into the extracellular space, it will allow the
passage of dyes down the diffusion gradient into the intracellular space. Dye loading
studies of this type are heavily utilised for the study of gap junctions and hemi-
channels, for instance hemichannel expression can be identified in cells of the
cochlear, based upon dye selectivity (Zhao 2005). As Cx26 is most permeable to
anionic low molecular weight dyes such as Alexa 350 (Weber et al., 2004, Zhao, 2005)
I used a fluorescent dye of similar molecular weight (CBF; MW 376) and charge.
I firstly exposed the medulla to CBF in the absence of any hypercapnic
stimulus. The tonic release of ATP suggests that the channel is spontaneously gating
and thus some background staining was inevitable. Alternatively many hemichannels
of some species including human Cx26 are found in a partially open sub-conductance
state and this could have led to background staining and tonic ATP release (González
et al., 2006, Ripps et al., 2004). Any further increase in staining from this baseline
level was therefore representative of dye uptake due to hypercapnia triggered opening
of hemichannels. This is also important as many cells express hemichannels, which
are also constitutively open or spontaneously gate, thus there will be background
activity due to non-Cx26 containing hemichannels. There was an increase in dye
loading over the entire surface of the medulla upon activation of the hemichannels
that reside there, with increased CO2. Interestingly coronal sections of the medullas
loaded in this manner, showing this to be confined only to the most superficial cells
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and cells around blood vessels. This loading was confined only to areas that expresses
Cx26 and was absent from tissue that does not express Cx26. This was only true for
Cx26 and no other connexin.
5.4.1 Dye loading is confined to sub-pial astrocytes, the pia mater and blood vessels
Using this method I aimed to answer the question of whether sub-pial
astrocytes are involved in this process and whether they express Cx26. Using this
method I loaded cells with FITC and then counterstained them with markers of
cellular identity and Cx26 antibodies. GFAP was used as a marker of glial cells and
microtubule associated protein 2 (MAP2) was used as a specific neuronal marker.
FITC labelling was confined to the MGL, the first 150µm, of the ventral
medulla and was extensively co-localised with GFAP. The densest staining of FITC
overlaps with the densest staining observed for GFAP. In addition FITC staining
penetrated into the medulla in cells that surround blood vessels, which would allow
for the excitation of deeper structures. Conversely dye loading and MAP2 staining
was mutually exclusive, though a correlation was seen. MAP2 staining was seen in
close apposition to dye loading, implying a close association between neurons and
ATP releasing cells with in the MGL. Therefore when CO2 levels increase it is
detected by Cx26 positive glia, which release ATP possibley directly onto neuronal
processes within the MGL.
5.4.2 Cx26 is expressed in sub-pial astrocytes and possibly pericytes
The co-localisations of Cx26 and GFAP at the light microscopy level suggest
that Cx26 is expressed in the end feet of sub pial astrocytes in direct contact with the
pia mater and therefore the blood vessels that reside there. In conjunction β-
galactosidase stained nuclei that were not enveloped in GFAP appear in a similar
distribution to pericytes, though no co-localisation was seen with NG2 (a marker of
pericytes). Thus these cells, whatever they may be, which are associated with blood
vessels and the pia (which contains blood vessels) may contribute to hypercapnia-
triggered ATP release. Surprisingly using both antibody staining and lacZ reporter
mice I saw Cx26 staining throughout the rostro-caudal and medio-lateral extent of
medulla. The lateral staining where ATP release sites are not observed indicates that
Cx26 alone is not sufficient for ATP release. This may mean that an intracellular
intermediary is needed or specific internal environments are required. However the
expression of Cx26 over the entire surface of the medulla including all ATP release
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sites and its restriction to the ventral surface like ATP means that ATP is released
only in areas where Cx26 is expressed and not from areas that are devoid of it.
Therefore this shows that there is a high correlation with Cx26, though not all Cx26
positive cells release ATP. This cannot be said of other connexins, such as connexin
32 (Cx32) which is heavily expressed in the pre-Bötzinger complex (Solomon et al.,
2001), an area devoid of ATP release.
5.4.3 The expression of connexin sub-types is cell specific
Connexin expression is cell type specific and this may also lead to some clues
to the hemichannel involved in releasing ATP. More than 90% of astrocytes in the
central nervous system express Cx43 (Rash et al., 2001, Dermietzel et al., 1991). As
relatively only a handful of astrocytes release ATP in response to alterations of PCO2
and in a site specific manner, this would seem to imply that Cx43 is not involved in
this process, though it does not directly exclude it. Cx30 is astrocyte specific and is
never seen in neurons or oligodendrocytes (Rash et al., 2001); however its lack of
expression in the medulla excludes it as a possibility. Connexin 36 (Cx36) is purely a
neuronal connexin (Rash et al., 2001) and thus can be excluded. Cx32 in a mature
brain is found only in neurons (Solomon et al., 2001) and oligodendrocytes (Rash et
al., 2001), which do not exhibit GFAP staining (Kashima et al., 1993). In fact Cx32 is
never found in association with GFAP in the dentate gyrus (Melanson-Drapeau et al.,
2003) or in Schwann cells (the oligodendrocytes of the peripheral nervous system)
(Nicholson et al., 2001) or the medulla (Solomon et al., 2001).
In the peripheral nervous system there is an inverse regulation of GFAP and
Cx32, such that GFAP is up regulated in the absence of Cx32 and almost undetectable
when it is expressed in Schwann cells (Nicholson et al., 2001). Thus it is highly
unlikely that the cells dye loaded in these experiments were due to the opening of
Cx32 gap junction positive hemichannels, due to the co-localisation of dye loading
with GFAP. Cx26 on the other hand is located only in astrocytes (Rash et al., 2001,
Mercier and Hatton, 2001) or pial cells (Filippov et al., 2003, Rash et al., 2001)
though they are expressed in neural progenitors (Rash et al., 2001), its localisation
with neurons in animals of this age is extremely limited (Solomon et al., 2001). In
contrast it is up regulated in glial cells with age. Thus no Cx26 is found in animals
younger than P7, an age where no ATP is seen in vitro (Huckstepp, id Bihi and Dale;
unpublished observation). However is it present in adults in large quantities (Solomon
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et al., 2001), at an age where ATP release occurs (this study). Interestingly the
development of Cx26 expression is coincident with the chemosensitivity of ATP
sensitive raphé neurons. Neurons of the raphé complex are not chemosensitive until
P12 (Wang and Richerson, 1999) and Cx26 expression in astrocytes of the ventral
medulla begins around P11 (Solomon et al., 2001).
5.4.4 ATP release requires additional environmental conditions
Since dye loading was not limited to ATP releasing sites, it is not due to the
localisation of an intracellular intermediatory that gates Cx26 hemichannels. If it were,
I would have expected localised increases in CBF and FITC loading that would
correlate only with ATP releasing areas of the VLM, which there were not. Instead
this implies that all Cx26 hemichannels open under hypercapnic environments. That is
not to say that an intermediate isn’t involved in the gating of Cx26 hemichannels just
that if there is it is expressed in all Cx26 positive cells. Thus it must be an internal
environment unrelated to Cx26 expression that governs whether ATP is released. That
dye loading and evacuation were observed during hypercapnia suggests that if a
diffusion gradient exists, molecules can exit superficial cells through Cx26
hemichannels. This poses an interesting question, is it then in fact that ATP release
sites are governed by whether a diffusion gradient for ATP exists or not? If this were
true then only areas where a diffusion gradient exists would release ATP, and this
would explain the discrepancy between global dye loading and localised ATP release.
Initial experiments to test whether Cx26 positive HeLa cells are capable of
releasing ATP were unsuccessful. If as hypothesized it is the diffusion gradient of
ATP between the cell and the ECF, increasing the cellular content of ATP should
enable transfected HeLa cells to release ATP. I chose to load the cells, by applying
our stimulus with ATP present in the milieu. I selected this method for three main
reasons. Firstly it would take a very long time to individually inject each cell, and this
provides a method for loading all HeLa cells simultaneously in a rapid fashion.
Secondly it would provide proof of the principle of my proposed mechanism twice in
one experiment, for the ATP to get in and out of the cell it would require CO2-
activation of the hemichannel. Finally, this is a non-invasive method, and thus I
thought it could not be said that the ATP released was an artifact caused by the
method with which I loaded them.
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This method provided very reproducible results, and ATP was seen in all
experiments where pre-loading took place. This suggests that in order to see CO2-
activated ATP release two things must be present, firstly a hemichannel comprised of
a connexin (or connexins) that is positively modulated by CO2 and secondly a
gradient for ATP to diffuse down. I have already proposed three methods by which
the second may be attained in Cx26 positive cells they are: Cx26 positive cells must
either have an extraordinary high rate of ATP production or a specific cellular
organisation, such that mitochondria are situated close to the hemichannel or they are
compartmentalised so that the ATP can be stored beneath the hemichannel at high
concentrations. Further investigations may provide evidence for which of these occurs.
5.5 Cx26 is sufficient for CO2 sensitivity
To further study the intrinsic properties of this membrane channel, and other
proteins of this family which are expressed in the medulla I obtained HeLa cells
transfected with Cx26, 30, 32, 36 and 43. HeLa cells are almost completely devoid of
any endogenous connexins, thus making them ideal for studies such as this. Since I
had already shown that permeation of these channels in response to CO2 occurs, I
employed the use of dye loading in this study. I began by confirming that what I had
seen in vitro tissue slices was in fact due to movement of the dye through connexin
hemichannels. As there was mounting evidence for the participation of Cx26, I began
with HeLa cells expressing this protein. Cx26 transfected cells loaded readily with
carboxyfluorescein in the presence of 9% CO2 in an elevated bicarbonate solution. In
contrast staining was never seen in wild type HeLa cells. Thus it appears that Cx26
expression alone is sufficient to convey CO2-sensitivity to a cell. To confirm this and
to make sure that the insertion of the gene had not caused the upregulation of another
unrelated membrane pore, I repeated the experiments in the presence of a gap junction
hemichannel inhibitor, proadifen. The presence of proadifen in the perfusate
significantly reduced the amount of dye that entered these cells, confirming that it was
not due to a non-specific side effect. To further confirm this I used whole cell patch
clamp to study any conductance changes of this channel in response to this stimulus.
In accordance with the dye loading studies I found an increase in the membrane
conductance in these cells indicating the opening of a large channel. As this
membrane change was not observed in wild types, which have all of the same
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membrane channels as the transfected cells with the exception of Cx26, I concluded
that it must be this channel which is opening.
HeLa cells are an immortal cancerous cell line of ovarian origin. One would
expect that these cells are not usually programmed to be chemosensitive, and that
their expression of intracellular proteins and enzymes would be different to that of
superficial medullary glia cells. It would not therefore be unfair to assume that
connexin hemichannels in these cells would not be regulated in the same way as in the
medulla. However it may be that another chemosensory transducer in these cells may
be interacting with the Cx26 hemichannel causing it to gate in response to CO2 where
usually it would not. Thus I repeated the experiments in cell lines expressing other
connexin hemichannels. This served two purposes: firstly it could rule out any non-
specific of hemichannel transfection unless of course all of these hemichannels react
in the same way; secondly it would allow us to determine if all hemichannels are
sensitive to CO2 and if so in what manner. For this series of experiments however I
used the higher concentration of CO2 (12%), as my whole cell data had indicated it
provided greater conductance changes.
5.5.1 Connexin hemichannels are regulated differentially by CO2
Connexin hemichannels are usually flickering between sub-conductance states
and are not usually fully closed (or open) (Bukauskas and Peracchia, 1997, Ripps et
al., 2004). Thus I had predicted to see non-specific background loading as I did for
my in vitro tissue slice preparation previously. Therefore to control for this I used the
same protocol in the presence and absence of changes in PCO2. This also would allow
me to detect reductions in conductance in response to hypercapnia as well as increases.
The first striking observation was that the background staining for Cx43 is
actually as high and in some cases higher than loading of cells stimulated by CO2.
This may be due to many reasons: Cx43 transfected channels may express more
hemichannels than other transfect cell lines; Cx43 may spend more time in open states
than other connexin hemichannels or it is more permeable to the dye than other
transfected cell lines. My patch clamp data shows it has the second largest resting
conductance after Cx26, in addition Cx43 is one of the most permeable hemichannels
(Weber et al., 2004). Thus it appears to be a combination of the two. Interestingly
Cx43 hemichannels close in response to increased PCO2, with large decreases in
conductance and dye loading intensity. Physiologically this is a vital function. Cx43 is
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the gap junction responsible for electrical coupling of excitable cells in the heart
(Duncan and Fletcher, 2002). During arrhythmia gap junctions uncouple in order to
stop the spread of damage in cardiac tissue (Cascio et al., 2005). During
pathophysiological conditions in myocardial tissue (i.e. myocardial infarction), PCO2
increases, this would cause Cx43 hemichannels to close and thus would act to
preserve non-affected tissue from damage and/or over excitation. Cx43 channel
closure in response to elevated PCO2 is inconsistent with their involvement in ATP
release at the ventral medullary surface, and thus we can conclude that they are not
involved.
Cx36 the only existing gamma connexin was insensitive to alteration in PCO2
by either method used. Interestingly this connexin is derived from the original gene
duplication of the common precursor. Therefore it may be the ‘purest’ connexin in
terms of structure and function and may imply that CO2 sensitivity has involved from
an ‘inert’ precursor. Importantly a lack of CO2 sensitivity implies that it is not a non-
specific reaction between an intracellular component of HeLa cells and hemichannels
in general. Thus with the exception of Cx26 we have excluded all other connexins for
one reason or another. Thus it is most likely that Cx26 is the conduit of ATP release,
to quote Sir Arthur Conan-Doyle, “Once you eliminate the impossible, whatever
remains, no matter how improbable, must be the truth”2.
All three β-connexins however were sensitive to hypercapnia - this is not
surprising as Cx30 arose from the gene duplication of Cx26 (Dahl et al., 1996) - and
all three are highly related. The lack of Cx30 in the medulla means this will no longer
be discussed here. Both Cx26 and Cx32 were shown to be significantly different in
both experiments. Of the two connexins Cx32 was seen to be the least sensitive to
CO2, by approximately 30% in both series of experiments. In addition the
conductance of Cx32 did not decrease with lowered PCO2 levels; thus there is no
correlation between ATP release at the VLM surface and Cx32 hemichannel
conductance at the same level of PCO2. One would expect that the release mechanism
would be through the most sensitive hemichannel to the stimulus, in this case Cx26.
Though it may be possible that ATP is released through both hemichannels or a
heteromeric channel comprised of both connexins. For all of the reasons stated earlier
(particularly the lack of Cx32 in GFAP positive cells) and in light of this new finding,
2 From Sherlock Holmes a Scandal in Bohemia (a form of modus tollendo ponens/disjunctive
syllogism)
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Occam’s razor/lex parsimoniae3, would suggest that it is through Cx26. There was
also an interesting correlation between ATP release and Cx26 hemichannel
conductance. A reduction of PCO2 by 60% causes a reduction in ATP release by 32%
and Cx26 conductance by 28%, whereas increasing PCO2 by 62% causes a 41%
increase in ATP and a 44% increase in Cx26 conductance.
5.6 Properties of Cx26
The hemichannels mediating ATP release have been shown to contain all of
the properties to designate them as Cx26. In conjunction to the location and cell type
specificity, they share many other properties. Cx26 hemichannels are found to be
constitutively open (Ripps et al., 2004), in line with tonic ATP release; it has been
shown to be blocked by all the inhibitors used here (Ripps et al., 2004, Zhao, 2005).
They are closed by extracellular calcium (Ripps et al., 2004). I have excluded all other
medullary connexins with the exception of Cx26, and have shown that at every stage
Cx26 appears to be the most likely candidate.
5.7 Structure of hemichannels
Gap junctions comprise of two hexameric connexons or pannexons each made
of 6 sub-units individually called connexins or pannexins. Homomeric hexamers
comprise a single type of connexin protein (Evans and Martin, 2002). Alternatively
they may be heteromeric, where they comprise two different connexin proteins (figure
1) (Evans and Martin, 2002). In terms of gap junction they may be homotypic where
both connexons are identical (whether they are homo- or heteromeric: figure 1).
Otherwise they are heterotypic where each hemichannel is different, again regardless
of whether the individual hexamers are homo- or heteromeric (figure 1).
3 entia non sunt multiplicanda praeter necessitatem: all things being equal the simplist explanation is
the best
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Figure 1: Arrangement of connexin proteins in gap junctions. Figure taken from Evans and Martin,
Molecular membrane biology 19; 121-136 (2002)
Each connexin is named after its molecular weight (i.e. Cx26 is 26kDa). They
consist of four transmembrane regions, two extracellular loops and one intracellular
loop. The carboxy- and amino- terminals are located intracellularly (Spray et al.,
2006). There are 20 connexins that have been identified, separated into three
subfamilies. Type 1 connexins are known as α-connexins and contain connexins
above 32kDa in size (connexins 33, 37, 40, 43, 45, 46, 50, 57) (Rozental et al., 2000).
Type 2 connexins are known as β-connexins and are comprised of connexins lower
than 33 kDa (26, 30, 30.3 31 31.1 32) (Rozental et al., 2000). There is only one
known type 3 or γ-connexin that is Cx36 (Rozental et al., 2000). The major difference
between connexin proteins is found in the carboxy tail, and this forms the major
contribution to the difference in their molecular weight (Evans and Martin, 2002).
There are also three pannexins, named pannexin 1, 2 and 3, whose structure, though
very similar to connexins, contain significant differences (figure 2).
Figure 2: Two dimensional structure of connexin and pannexin proteins in cell membranes.
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Hemichannels were once thought to only be an intermediatory, found in the
membrane whilst they laterally diffuse into gap junction plaques (Spray et al., 2006).
Now they are known to connect the cytoplasm of cells to the extracellular space
(Spray et al., 2006). Connexins are known to contain at least two gates (Peracchia et
al., 2003, Peracchia et al., 1999, González et al., 2006), a voltage gate that opens or
closes with alterations in membrane potential thus increasing or decreasing contact
between excitable cells during times of activation. The second gate known as the
chemical gate is sensitive to pHi and will be discussed later. Interestingly both gates
can influence each other (Peracchia et al., 2003, Peracchia et al., 1999, González et al.,
2006).
5.7.1 Structure of Cx26
Cx26 has a positive cytoplasmic face, which creates an environment that
concentrates negatively charged molecules such as ATP at the entrance to the pore
(Maeda et al., 2009). Conversely the pore of the channel is negatively charged, this
will accelerate the movement of the negatively charged molecules through the channel
through electrostatic repulsion (Maeda et al., 2009). Hence the amino acid side chains
that line the pore and its entrance create an anion selective channel, perfect for
conducting molecules such as ATP (Maeda et al., 2009). The channel itself is
funneled having a pore diameter of 40Ǻ at the cytoplasmic entrance and 25Å at the
extracellular side (Maeda et al., 2009). However just before the extracellular cavity
the channel narrows to 14Å (Maeda et al., 2009) creating the size selectivity for
molecules with a molecular weight of <750.
5.7.2 Gating mechanisms of gap junctions
There are currently three gating mechanisms proposed for gating of connexin
hemichannels; a rotational gate that assumes that a conformational change in the
connexin causes the rotation of all six subunits which forms a pore (Peracchia, 2004);
a ball and chain gating mechanisms, which assumes that the amino acid terminal of
the connexin forms a hinge containing a ball like structure on the end, a
conformational change in the hinge causes the ball to be situated either inside or
outside of the pore (Evans and Martin, 2002, Peracchia, 2004); and a cork and bottle
mechanism, this requires the binding of an intracellular molecule to the intracellular
face of the connexin to form a plug, the binding sites are altered to determine whether
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binding can or cannot take place (Peracchia, 2004). It is now universally accepted that
the rotational gate model is not used by connexins.
Thus connexins either use a ball and chain or bottle or cork gating mechanism
in response to decreased pHi, the form of gating used appears to differ between
connexins. Cx43 has an extremely long carboxy- tail; upon acidification this tail binds
to the second half of its intracellular loop thus blocking the entrance to the channel
pore and this is known as the chemical gate (Duffy et al., 2002). The massively
reduced length of the β-connexins means that they are unable to form these complexes
with their intracellular loop. Thus many low molecular weight connexins have
calmodulin binding sites on their C-termini, Cx26 for instance has a single calmodulin
binding site whereas Cx30 has two (Blödow et al., 2003). Surprisingly Cx50 which
has the second longest carboxyl tail of all connexins also uses this form of gating
mechanism (Peracchia and Peracchia, 2004). Thus it appears that either connexins use
a ball and chain or a cork and bottle where calmodulin provides the plug.
5.8 The CO2 binding domain may lie in the carboxy-terminus of the Cx26 protein
So far all of the experimental evidence from this study and that in the literature
point to the regulation of ATP through the direct gating of Cx26 hemichannels.
However it may still be that an intracellular component participates in this response.
Therefore I used excised membrane patch clamp techniques to study the intrinsic
properties of the channel. An excised patch contains a small piece of membrane
containing the channel and almost no cytosol. In patches of an outside out orientation,
increases in PCO2 induced large transient outward currents at negative membrane
potentials. These currents were absent from patches of the same configuration from
wild type cells. The lack of cytosolic content and absence of any response in patches
lacking the channel shows that Cx26 is indeed intrinsically sensitive to CO2. In
contrast patches of an inside out orientation showed large outward currents at positive
holding potentials. The faster response of the channel to CO2 in the inside out
configuration indicates that the binding domain may lie closer to the intracellular face.
As Cx26 is situated close to blood vessels and is readily accessible to CO2 in
either orientation, this would place the CO2 sensor directly on contact with the CO2
passing through a blood vessel into the ECF of the superficial medulla. This would
enable it to detect changes in PCO2 almost immediately. In terms of a chemosensory
mechanism this is almost as perfect as it can be. Almost instantly upon CO2 diffusing
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through the blood vessel wall it will reach Cx26 hemichannels, these will activate
releasing ATP without having to wait for any intracellular cascade. That this is one of
the simplest mechanisms ever described, the transducer and effector are one and the
same molecule and it all occurs rapidily, is what makes this such an interesting
proposition.
5.8.1 Gating of Cx26 hemichannels
Cx26 is thought to be comprised of two uncorrelated structures separated by a
hinge (Purnick et al., 2000), where the N-terminus of the protein is flexible (Purnick
et al., 2000). The first ten amino acids are integral to maintaining a central pore
density (Oshima et al., 2008) and thus they constitute a plug (Oshima et al., 2008,
Purnick et al., 2000, Young and Peracchia, 2004). Thus it is predicted that this
channel operates via a ball and chain mechanism, with the first ten residues lining the
pore of the channel.
Figure 3: Gating mechanism of Cx26. The channels is gated from the intracellular compartment via a
ball made up of at least the first ten residues of the N-terminus.
5.9 Possible CO2 binding domains on connexin proteins
Cx26 has the same structure as all other connexins with the shortest carboxy
tail in the mammalian connexin family. It has 4 transmembrane domains, 2
extracellular loops and an intracellular loop and is similar to Cx32 (Zhang and
Nicholson, 1994).
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Carbon dioxide (CO2) is a small molecule and thus it is unlikely that a
complex binding domain will exist on the connexin protein, for this molecule to
interact with. CO2 is known to interact with at least one protein, haemoglobin (Hb),
thus it is likely that CO2 will interact in a similar manner with Cx26 as with Hb. In red
blood cells, CO2 binds to the uncharged terminal amino groups to form carbamino
compounds (-NH-CO2H) on the α and β chains (Kilmartin and Rossi-Bernardi, 1971).
Alternatively, a second formation of carbamino compounds occurs in rubisco
(Ribulose-1,5-bisphosphate carboxylase oxygenase). Here carbamino compounds are
formed between the free amine of a Lysine and the carboxy side chains of Glutamate
and Aspartate, this compound is stabilised by free magnesium ions acting as a
coordination ion (Taylor and Andersson, 1997). That increased magnesium in the
intracellular patch solution was required for Cx26 gating in the presence of CO2
seems to imply that this form of coordinate compound is formed in Cx26 and is
responsible for the gating of this protein. Therefore I have looked for basic residues
on the proposed ball of the Cx26 protein and acid residues that they might bind to. My
hypothesis is that once CO2 reaches the gate it will bind to the amino groups forming
carbamino compounds. Once bound to the free amine it will be able to form co-
ordinate compounds with amino acids lining the pore (figure 4).
Figure 4: Possible CO2 gating mechanism of Cx26. CO2 binds to uncharged amines on the plug of
the Cx26 N-terminus forming carbamino compounds and neutralising basic resides. Neutralisation
causing a loss of attraction between acidic and basic side chains, hence causing the plug to move out of
the pore.
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Using sequence alignment (ClustalW) of all five connexins (figure 5) for
which I have classified the CO2 sensitivity of, I have identified possible sites of action
for CO2. I have done this by looking for basic residues in the sequence. Once aligned
and coloured for acidity I have looked for regions that have a conserved basic
sequence between CO2 activated connexins, which are not seen in hemichannels that
do not gate in response to CO2. In doing so I found two regions of interest,
fascinatingly in these regions on Cx36 and Cx43, contain no basic residues. Thus I
believe that it is these regions which are responsible for reacting with CO2 in all CO2
sensitive connexins.
It can be seen from the sequence alignments of the N-terminus of the protein
that Cx26, 30 and 32 contain a KH…..K or RH…..R motif not seen in Cx36 or Cx43
thus providing regions that could be responsible for intracellular gating. A second
region CO2 may bind to is the intracellular loop which shows an acidic motif in Cx26,
30 and 32 (EE.D..E, E….ED and D….EE, respectively) a motif not seen in the other
connexins. Unfortunately the 3.5Å structure does not resolve this region. The
difference between the basic and acidic side chains of these connexins may cause
differential binding of the plug and thus explain the differences in CO2 sensitivity.
As we can see from the sequence alignment the highly basic region found in
all three CO2-positively gated connexins, but not Cx43 or Cx36 lies on the proposed
ball. The acidity of the amino acids of this region falls in line with the patch clamp
and dye loading data. Interestingly based upon the model of amino acid structure
related to Cx26 we can see that there does not appear to be any acidic in this region.
The most likely binding domain for the ball is found on the intracellular loop, which
is unexpected. If however the intracellular loop more closely resembled that of Cx32,
which it may do as no antibody reactivity was seen in this area, then what would
appear to be the intracellular loop now becomes the beginning of the transmembrane
domain 3. This would allow the binding of the hypothesised ball to the internal face of
the pore (see figure 6). We can see that the intra-pore binding domain is highly acidic
and thus would easily bond to the highly basic n-terminus. Both of these regions are
highly variable on Cx43 and thus it may act oppositely.
It must also be noted that there are amphoteric amino acids, which may act as
acids or bases at different pH’s. They may not directly interact with carbon dioxide,
but they are closely associated with acidic and basic amino acids. This close
proximity means that they may influence the interactions between CO2 and the amino
146
acids that surround them. Therefore I have highlighted them in these regions specified
below.
Figure 5: Sequence alignments for 5 connexins showing differences in acidic (coloured red), basic
(coloured green) and amphoteric (blue) side chains. Areas of interest are highlighted with asterisks.
The ease of access to the intracellular loop in inside out patches to CO2 may
explain why gating occurs faster in this configuration compared to outside patches,
where CO2 has to diffuse across the membrane before it can form a carbamino
compound. Alternatively CO2 may diffuse into the cell neutralising the basic amino
acids leaving them unable to bind to acidic residues and thus the ball is repelled from
the pore. In contrast it has already been shown that acidic conditions cause the binding
of the carboxy terminal to an unspecified domain on the intracellular face of the Cx43
protein (Duffy et al., 2002). May be this is one of the two regions I have specified
here or may be an interaction between all three. Thus there are a few possibilities as to
how this mechanism may occur, but it is likely to contain the regions I have described
here.
*
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Figure 6: Location of possible CO2 reactive domains on connexin hemichannels. Left Cx26. Right
Cx32. Red/green boxes show differences between CO2-activated and deactivated connexins, blue boxes
show conserved regions. Picture adapted from Zhang and Nicholoson J Membrane Biol 139 15-29
(1994).
5.10 Cx26 is the conduit for ATP release in vitro
So far all the indications point towards the involvement of Cx26 in the release
of ATP in response to hypercapnia with evidence against the involvement of other
connexins. It is located in the right place, its expression levels coincide with the
development of ATP signaling, its association with surface and penetrating blood
vessels, its co-localization with dye loaded cells and its co-localization with GFAP
and ATP release is not seen outside of the areas that express this channel. I next
sought to see if I could provide evidence of its participation pharmacologically. This
however provides problems. Pharmacological identification of gap junction
hemichannels is not yet achievable, due to a lack of specific blockers. Though all
hemichannel blockers universally affect all subtypes, they do so differentially. I
therefore identified compounds that are more selective for Cx26 than other
hemichannels cobalt, NPPB and proadifen (Ripps et al 2004), though cobalt and
NPPB have been shown to affect other hemichannels (Kang et al., 2008, Cotrina et al.,
1998). Cobalt is generally used at much higher levels (2mM) (Huettner et al., 2006)
than this study (500µm) and does not affect all hemichannels (Huettner et al., 2006).
Proadifen on the other hand has been shown only to affect Cx26 (Zhao, 2005).
Nevertheless the removal of all of the relevant connexins means that even without
specificity the effect of these blockers is highly likely their effects are on ATP are
through their actions on Cx26.
All three gap junction blockers significantly reduced all forms of ATP release.
The blockade of ATP release in response to removal of extracellular calcium shows
148
that they block hemichannels. The reduction in CO2-activated ATP release by these
selective blockers shows that it is highly likely that Cx26 acts as the conduit for
release in vitro. In conjunction the loss in tonic release of ATP also implies that this
release is through the same mechanism as that in response to hypercapnia and not
parallel pathways.
In contrast to the lack of specificity of connexin hemichannel blockers,
pannexin 1 can be pharmacologically distinguished. Since it has been shown to
release ATP I thought it pertinent to test its involvement here. Both low
concentrations of carbenoxolone and probenecid were without effect on ATP release
in response to changes in PCO2 and tonic levels of ATP release. Thus I have excluded
this as the mechanism underlying ATP release in the superficial medulla.
5.10.1 Cx26 is the conduit for ATP release in vivo
Although I had characterised the release sites of ATP in vitro and matched
them to those seen in vivo and tried to create an environment that more accurately
recapitulates in vivo conditions. I could not be certain that what I had seen was not an
artefact of the extraction method or stimulus that I provided. In conjunction although
in vitro methods are phenomenal for building models and gathering data, I believe
they must be validated by replication in vivo. Therefore I applied proadifen and NPPB
to an in vivo preparation of the adult rat. I had selected these blockers for two reasons,
firstly the effects of carbenoxolone applied to the VLM surface had been previously
described, and cobalt at this concentration has a significant effect on calcium channels.
Secondly proadifen has a tendency to precipitate out of the solution if it is not
dissolved in and kept in specific conditions. ATP release during hypercapnia was
significantly reduced by these blockers and in conjunction so was adaptive breathing.
The reduction in the hypercapnic ventilatory response caused by these
blockers was similar to that caused by: ATP receptor antagonists (Gourine et al 2005),
all gap junction hemichannels in the superficial medulla (Hewitt et al 2004) and the
contribution of the ventral surface chemosensors to the total adaptive ventilatory
response to CO2 (Nattie 2001). Thus confirming not only that Cx26 mediates the
release of ATP, but also that it is the primary gap junction protein involved in
chemosensory transduction. In addition it implies that Cx26 contributes the major
chemosensory drive in the superficial medulla.
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5.10.2 Divalent ion concentrations effect respiration and the response to hypercapnia
In adult cats in vivo intracisternal perfusion of aCSF containing a dye causes
staining only in the most superficial layer of the entire medullary surface
(Berkenbosch and Adan, 1974, Berkenbosch et al., 1976). Thus aCSF perfused in this
way causes drug delivery or a change in environment of the MGL presumably without
effect on any other medullary nuclei. Artificial CSF containing varying concentrations
of Ca2+ was perfused in this manner and caused changes not only in the hypercapnic
response but also resting ventilation. Increasing calcium concentrations, reduced
resting ventilation whilst decreasing them increased ventilation (Berkenbosch and
Adan, 1974, Berkenbosch et al., 1976). Although these authors had no mechanistic
explanation of their findings, I can however reinterpret them in light of my data. The
alterations of calcium used in this investigation are sufficient to cause an increase or
decrease in gap junction hemichannel gating. The closure of hemichannels at the
VLM surface would result in a loss of tonic ATP; thus its continual facilitatory drive
is removed and a reduction in ventilation is seen. Therefore addition of calcium which
closes hemichannels at the VLM surface has a similar effect on respiration as
application of purinergic antagonists in a similar area. In conjunction a decrease in
calcium, which would open hemichannels, causes an increase in resting ventilation,
due to an increase in facilitatory drive. In addition the removal of calcium caused a
potentiation of the hypercapnic ventilatory response, whereas increases in calcium
ions attenuated it (Berkenbosch and Adan, 1974, Berkenbosch et al., 1976). It appears
that potentiation or attenuation of hemichannel conductance in the superficial layers
of the medulla results in similar effects in the ventilation in response to increased CO2.
Importantly the response to hypoxia, which is not controlled by, or does not cause
release of, ATP at the ventral surface of the medulla (Gourine et al., 2005b), is
unaffected by alterations of Ca2+ in this region (Berkenbosch and Adan, 1974).
Using the same technique, the effect of magnesium ion concentrations was
assessed in the same manner (Berkenbosch et al., 1976). Alterations of magnesium
concentrations caused identical effects on respiration and chemosensitivity as those of
calcium, however to a lesser extent (Berkenbosch et al., 1976). Interestingly the effect
of magnesium on hemichannel conductance are the same as that of calcium ions;
however calcium has a much higher binding affinity and so is a more potent
inactivator (Ebihara et al., 2003). Thus the effects of divalent ion concentration on
respiration can possibly be explained through hemichannel mediated ATP release in
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the adult response. To further support this I could investigate how calcium
concentrations influence the CO2-sensitivity of Cx26 hemichannels.
Similar responses to these divalent cations were also reported in the neonate,
which is surprising as ATP release is not seen in rats of this age. This can be
reconciled as it appears that the mechanisms responsible for these alterations are
much more complex. The effect of low calcium in the neonate has been attributed to
membrane stabilisation and the augmentation of calcium-dependent potassium
channels (Kuwana et al., 1998), which can contribute to neuronal chemosensitivity
from before birth (Wellner-Kienitz et al., 1998). Unfortunately the effect of divalent
cation concentration cannot be directly compared as calcium concentrations were
altered throughout the entire medulla of the neonatal preparation; hence it will affect
many processes and not just hemichannels.
5.10.3 Cx26 has an alternative pathway for membrane trafficking
Cells use a different trafficking mechanism for Cx26 to every other connexin.
Connexins as a family are manufactured and formed into hemichannels in the golgi
apparatus and transported to the membrane via the endoplasmic reticulum. If a cell
produces only one connexin isoform in a given period of time it will form homomeric
hemichannels, if it produces more than one they will be constructed into heteromeric
channels in the ER. The treatment of cells expressing Cx26, 32 and 43 with brefeldin
A, a golgi toxin, leads to the loss of Cx43 and 32 but does not affect Cx26 (Evans and
Martin, 2002, Gemel et al., 2004, Martin et al., 2001). In contrast treatment of cells
with nocodazole, a cytoskeleton inhibitor of microtubule polymerisation, reduced
Cx26 without effect on Cx32 or 43 (Martin et al., 2001). Thus it appears important for
cells to ensure that Cx26 is expressed as a homomeric unit. Importantly the pathway
for the manufacture and trafficking of Cx26 homomeric channels is a much faster
route than that for Cx32 and Cx43 (Evans and Martin, 2002).
Since Cx26 and 32 can form heteromeric channels it would also appear that
Cx26 can if necessary use both routes. Thus there are two conclusions that can be
drawn from these results; Cx26 must be inserted into the membrane rapidly and as a
homomeric channel. This begs the question, why is this hemichannel so important?
Firstly I believe that it must be to some extent its sensitivity to CO2. Though this is a
vital role in the response to hypercapnia, there are also indications that this may be
useful in other physiological situations (these will be discussed later). Interestingly
151
Cx26 has only been shown to localise with other β-connexins, in one study with an
array of connexins it co-localised only with Cx32 (Elfgang et al., 1995). In addition it
only co-assembles with one other connexin, Cx30 (Locke et al,. 2006). Thus Cx26
only seems to co-assemble with other CO2-activated connexins when forming gap
junctions and possibly therefore hemichannels. Therefore even when using the normal
connexin trafficking route there appears to be a need to conserve CO2-activated
hemichannels even if only in the heteromeric form.
5.11 Implications for chemosensitivity
Intrinsic chemosensitivity is currently defined as the maintenance of a
chemosensitive response in the absence of synaptic transmission, these methods
include the removal of extracellular calcium or the use of a cocktail of antagonists for
most neurotransmitters. Using this definition many neurons of the respiratory network
and medulla oblongata as a whole have a small degree of intrinsic chemosensitivity
(Kawai et al., 1996, Mulkey et al., 2004, Richerson, 2004, Nattie, 2000, Nattie and Li,
2002a). However removing extracellular calcium will not inhibit hemichannel
mediated ATP release. Furthermore the synaptic blocker cocktails used do not block
gap junctions (Putnam et al., 2004) or contain purinergic antagonists. In light of the
evidence presented here I believe that intrinsic chemosensitivity should be defined as
the maintenance of a chemosensitive response in the absence of synaptic transmission
(including purinergic antagonists) and gap junction hemichannel blockade. This
however does not account for the unknown and thus contains the same flaws as the
previous definition. Therefore I believe that in order to truly identify a chemosensitive
cell, one must identify a molecular transducer present in the cell that remains
chemosensitive in isolated patches, such as in this study; once identified, blockade or
removal of this channel in vivo must result in a reduced ventilatory response to
hypercapnia.
Until recently the search for a chemosensory transducing molecule has
focused on tandem pore acid sensing potassium such as TASK channels (TWIK-
related acid sensing potassium channel), particularly TASK 1. Although this molecule
does convey intrinsic pH chemosensitivity to many neurons, TASK 1 knock out mice
show no perturbations in the hypercapnic ventilatory response (Mulkey et al., 2007b).
Thus the search for an acid sensing cation permeable channel continues. Importantly
ionotropic purinergic receptors are non-selective cation channels. With many
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chemosensitive nuclei located close to the surface of the brain, containing purinergic
receptors and being sensitive to ATP, may be Cx26 is what we have all been looking
for; Cx26 acts as the chemosensor and purinergic receptors convey chemosensitivity
to the neuron.
5.12 ATP and pH regulation
Now that I have discussed the properties of Cx26, its location and its
involvement in ATP release, I would like to discuss how pH regulation may effect
ATP release and how ATP release may affect pH regulation (for a reminder of pH
regulation in the medulla please see chapter 1.9).
When CO2 diffuses out of blood vessels it will cause the release of ATP
through Cx26 from sub-pial astrocytes (figure 7(i)). This will activate P2Y receptors
on the dendrites of surrounding neurons leading to their subsequent depolarisation
(figure 7(ii)). In a similar time frame CO2 will cause intracellular acidification in
chemosensitive neurons again leading to their depolarisation (figure 8(i)). The effects
of one should work to amplify the other, thus leading to a heightened response. The
removal of bicarbonate from the cytosol of the neuron acts to alkalise the extracellular
space (figure 8(ii)). The alkalisation of the extracellular space will aid the transport of
ATP through Cx26 hemichannels (figure 8(iii)): this will act to amplify the sensitivity
of these cells to CO2. The increased release of ATP will thus provide a positive feed
back loop with the neuron.
As the neuron fires, extracellular potassium levels increase causing the
depolarisation of the sub-pial astrocytes and the subsequent reversal of NBC
transporters (figure 9(i)). This will cause an influx of HCO3- ions causing intracellular
alkalisation (figure 9(ii)), which should a taurine analogue be present, unblocks the
pore of the channel and leads to enhanced ATP signalling (figure (9iii)). Thus the
increased firing of the neuron will provide a positive feedback loop with the sub-pial
astrocytes.
In conjunction the release of other neurotransmitters in the vicinity of the
superficial medulla will also increase pHe thus creating an environment that enhances
not only their own affinity for their receptor but the affinity of ATP to its receptors
(figure 10(i) and (ii)). Once ventilation has corrected PCO2 levels in the blood ATP
signalling decreases, by this point pHi recovery mechanisms present in the neurons
have brought its pHi back to normal (as is seen in with isohydric hypercapnia: figure
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10(iii)). Thus with no intracellular or extracellular signalling it ceases firing. This
would reduce extracellular potassium and thus reverse the NBC transporter, so that it
returns glia pHi back to normal levels and thus the system returns back to its starting
point. Therefore it creates a system where each component works to increase the
efficiency of all the other components in the system. In conjunction the system
communicates with each other via positive feedback to provide a well coordinated
response.
Figure 7: The effect of CO2 entering the ECF of the superficial medulla on the Cx26 positive cells
that reside there. As Cx26 positive cells are closer to the surface and the mechanism of ATP release
occurs extracellularly, they will respond first.
(i)
(ii)
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Figure 8: The effect of CO2 entering the ECF of the superficial medulla on neurons of the
medulla and the subsequent amplification of ATP release through Cx26 hemichannels.
Figure 9: Feedback loop created from the neuronal depolarisation causing the reversal of NBC
transporters on glia.
(i)
(ii)
(iii)
(i)
(ii)
(iii)
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Figure 10: Increased transmission caused by alteration in extracellular pH, caused by the release
of neurotransmission.
In terms of glia this would account for: the localisation of NBC transporters on
glial cells, which stand no chance of altering pHe in the face of neuronal firing; the
need for glial cells to depolarise in response to hypercapnia, by the exact amount
required to reverse this transporter; the need for glial to increase their pHi during
hypercapnia. In conjunction it also explains why neurons continue to fire during
hypercapnia once pHi returns to control levels; once the system begins, it is the
release of ATP from glia that propagates the system and not the pHi of the neurons.
During metabolic or hypercapnic acidosis, even in the face of increased PCO2
ATP signalling through Cx26 will not occur, due to the effects of extracellular
(i)
(iii)
(ii)
e
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acidification on the channel. In this situation pHe and/or concomitant changes in pHi
will provide the driving force for neuronal activation, with no ATP driving the system,
were pHi to recover the neuron would cease to fire. Therefore the system continues
until pH levels return to normal upon which pHi will recover and the system will
cease.
Figure 11: Overview of chemosensory transduction at the VLM surface
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This explains the need for pH regulation during hypercapnic acidosis and
isohydric hypercapnia. Using the pH regulatory mechanisms which occur in these
cells combined with how pHe and pHi act on different chemosensory transducers the
system becomes flexible and adaptable to different physiological requirements. In
some instances the system works in tandem with each other and in others
independently, thus creating a spectrum of responses from the same neuronal
pathways.
5.13 Evidence for Cx26 mediated ATP release as a CO2 sensor for the entire brain
Cx26 expression is seen in: radial glia of mice (Bittman and LoTurco, 1999);
sub-ependymal and sub-pial astrocytes (Mercier and Hatton, 2001); the meninges
(Filippov et al., 2003); blood vessels; and ATP receptor binding is seen in the NTS,
caudal VLM, RVLM, inferior olive, the XII nucleus, lateral reticular nucleus, gracile
nucleus and cuneate nucleus in the medulla alone (Fong et al., 2002). I predict that
this mechanism must be working elsewhere in the brain. To begin with I identified the
systemic responses to hypercapnia. During hypercapnia there is an increase in
breathing rate, blood pressure, arousal/vigilance and anxiety/fear and a decrease in
heart rate and micturition. I therefore identified regions of the brain that are
responsible for causing these effects and then looked for evidence that they were:
activated by CO2, contain purinergic receptors/ are responsive to ATP and are located
in close vicinity to Cx26. From this I have identified areas where this mechanism may
be occurring. I will begin by describing targets of ATP at the VLM surface; I will
extend this to the medulla, then to the brain and finally possible targets in other
physiological systems.
5.13.1 Serotonergic raphé neurons
Serotonergic neurons of the medullary raphé, have cell bodies and dendrites
that reside within 150µm of the VLM surface (Ribas-Salgueiro et al., 2005, Richerson,
2004), directly against Cx26 positive cells of the medullary surface. Cx26 is also on
penetrating vessels of the medulla particularly at the midline, a pattern shown by
radial glia (Mori et al., 1990). The processes of these radial glia terminate at the
somata of raphé neurons in rabbits and cats (Mori et al., 1990). Other studies have
also shown that neurons expressing serotonergic markers are tightly apposed to large
arteries of the VLM, both surface and penetrating (Bradley et al., 2002, Severson et al.,
2003), and that only glial end feet separate these neurons from large blood vessels
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(Bradley et al., 2002). The close association between these neurons and Cx26 positive
cells implies that this relationship may be advantageous. Raphé neurons are important
in both the drive to breathe and adaptations to hypercapnia (Richerson, 2004, Ribas-
Salgueiro et al., 2005, Hodges et al., 2008, Bodineau et al., 2004, Li and Nattie,
2008b). These neurons are only mildly responsive in neonates whereas they are highly
sensitive to hypercapnia in adults where ATP release is observed (Wang and
Richerson, 1999). Interestingly this pattern of chemosensitivity closely matches the
expression of Cx26 protein in astrocytes (Solomon et al., 2001). As these neurons
have been shown to be responsive to ATP (Cao and Song, 2007), it would be
surprising if the development of their chemosensitivity was not due the development
of CO2-activated ATP release. In conjunction the multiple functions performed by
other raphé neurons outside of the medulla, such as increased arousal, means that this
mechanism acting through serotonergic neurons could be far reaching. Thus I propose
that in the ventral medullary raphé neurons are the primary target for ATP release.
5.13.2 The pre-Bötzinger complex
The pre-Bötzinger complex sends projections to within 50µm of the MGL
(Kawai et al 1996) and have cell bodies within 150-400µm of the ventral surface
(Kuwana et al., 2006). Since the pre-Bötzinger complex is the site of respiratory
rhythm generation any effect here will directly alter breathing (Smith et al., 1991).
This area contains purinergic receptors and is modulated by ATP (Lorier et al., 2004,
Lorier et al., 2007, Thomas et al., 2001). There is also evidence that the tonic release
of ATP provides continual excitatory drive to this nucleus (Thomas et al., 1999,
Thomas and Spyer, 2000, Gourine et al., 2003, Spyer et al., 2003). The proposed
mechanism of action for ATP in this brainstem region is shown in Chapter 1 and will
not be discussed here any further.
Interestingly the CO2-activation of hemichannels may play a subsidiary role in
the pre-Bötzinger complex; in this case one that does not involve Cx26. The
sensitivity of Cx32 to CO2 and its location in the pre-Bötzinger complex may not be
coincidental. Though not commented on at the time, it has already been seen to show
that the conductance of Cx32 in the presence of CO2 increases before it decreases in
the presence of high CO2 (Young and Peracchia, 2004); these increases could coincide
with low concentrations of CO2 before the solution fully equilibrates. When PCO2 in
the vicinity of this nucleus increases it may increase the functional conductance
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between cells connected by Cx32 gap junctions. This would serve to increase
electrical coupling and thus would increase the synchronicity of the firing patterns in
this area. Thus during hypercapnia it should serve to increase respiratory rate.
5.13.4 The nucleus tractus solitarus
The nucleus tractus solitarus (NTS) is a known site of chemosensitivity and
acts as the relay for the peripheral nervous system (Nattie and Li, 2002a) and receives
input from the pre-Bötzinger complex (Kalia et al., 1979). It is situated superficially
in the dorsal medulla (Okada et al., 2001) and surrounds the 4th ventricle, an area
where we have seen staining Cx26 expression in mice expressing LacZ reporter allele
(data not shown). Breathing either 21% or 10-15% CO2 for 1 hour increases c-Fos
immunoreactivity in this region (Sato et al., 1992, Belegu et al., 1999). Unilateral
lesions of this region in humans causes reduced responses to hypercapnia (Morrel et
al., 1999, Morrel et al., 2001). During wakefulness they have normal breathing
(Morrel et al., 2001); however during sleep they display irregular breathing (Morrel et
al., 1999, Morrel et al., 2001). This is probably due to the reliance of the response on
peripheral chemoreception during this arousal state. Conversely focal perfusion of
25% of CO2 into the NTS in rats during wakefulness and sleep, increases respiration
during wakefulness and NREM sleep but not REM sleep.
The NTS contains many sub-nuclei which project to different regions of the
brainstem (Loewy and Burton, 1978). Anatomical tracer studies show that the NTS
projects to the lateral reticular nucleus (which contains the respiratory centres) (Otake
et al., 1992, Ruggiero et al., 2000) and the dorsal raphé (Ruggiero et al., 2000), the
raphé pallidus and obscurus (Zec and Kinney, 2003, Loewy and Burton, 1978), dorsal
motor vagal complex (Loewy and Burton, 1978, Otake et al., 1992, Zec and Kinney,
2003), the retrotrapezoid nucleus (Otake et al., 1992), the nucleus ambiguus (Zec and
Kinney, 2003, Loewy and Burton, 1978), the retrofacial nucleus (in an area that
contains the pFRG) (Loewy and Burton, 1978), the A5 region of the pons, (Otake et
al., 1992) and the parabrachial nucleus (Loewy and Burton, 1978), the pressor regions
of the RVLM (Zec and Kinney, 2003, Loewy and Burton, 1978) and to spinal motor
neurons (Loewy and Burton, 1978). Thus it is poised to influence not only respiration
and chemosensitivity, but also cardiovascular control.
The NTS expresses all known P2X receptors (Yao et al., 2000) and responds
to ATP. ATP is released rhythmically in the NTS from pulmonary stretch receptor
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afferents during lung inflation and is phased locked with tracheal pressure (Gourine et
al., 2008). Here it excites pump cells and its actions are mediated through co-
transmission with glutamate, in an additive manner (Gourine et al., 2008). It has been
postulated that glutamate release triggers ATP release which feeds forward to amplify
glutamate transmission (Braga et al., 2008). In conscious animals ATP and glutamate
antagonism is required to block both pressor and bradycardiac but not tachypnoeic
responses to peripheral stimulation with KCN (Braga et al., 2007), which has been
shown to stimulate all unmyelinated axons in the carotid body and not just hypoxia
responsive cells (Alcayaga et al., 1999). Injections of ATP into the commissural NTS
evoke bradycardia and tachypnoea, although with hypotension (Antunes et al., 2005,
Braga et al., 2008). In the intermediate NTS ATP injections reduce phrenic nerve
activity (PNA) and heart rate (HR) (Antunes et al., 2005). In conjunction the NTS is
under the influence of adenosine caused by the hydrolysis of extracellular ATP
release (Spyer et al., 1997). At low doses, adenosine injections cause an increase in
blood pressure and a bradycardia (De Paul and Machado, 2001). Therefore ATP
release is likely to affect the respiratory and cardiovascular response to hypercapnia,
through the actions of ATP and adenosine (figure 12), either directly or through the
enhancement of glutamatergic transmission.
The NTS changes postnatally and action potentials in the NTS are highest in
the NTS between the ages of P11-14 (Vincent and Tell, 1997). Interestingly the same
time as Cx26 expression appears, as P2X receptors can desensitise to ATP, it may be
that after a few days from the onset of tonic ATP release the NTS lowers its
sensitivity. Cobalt an inhibitor of Cx26 hemichannels stops spiking activity in adult
rats (Vincent and Tell, 1997), though this may be through its actions on calcium
channels. Injections of carbenoxolone into the NTS reduce basal respiration and
adaptive changes in breathing associated with hypercapnia (Parisian et al., 2004).
Interestingly a cocktail of antagonists that did not include purinergic antagonists
reduced ventilation, which returned upon wash out (Parisian et al., 2004), however
synaptic block with cobalt, which would also inhibit Cx26, affected respiration for
days after the injection (Parisian et al., 2004). Intracisternal perfusion of low calcium
or high magnesium solutions that would effect only the surface of the dorsal and
ventral medulla reduced basal respiration and the hypercapnic ventilatory response
(Berkenbosch et al., 1976, Berkenbosch and Adan, 1974), though this may be due to
the effects on the VLM alone. Thus in the NTS there is at least circumstantial
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evidence that hemichannel mediated ATP release may play a role. Fascinatingly, ATP
release was not observed from the dorsal surface of the medulla (Gourine et al.,
2005a), in this preparation the dorsal surface was accessed through the removal of the
cerebellum; which would disrupt the pia mater in this region.
Figure 12: The actions of ATP and adenosine in the NTS on cardiov
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et al., 1997). Interestingly P2 receptors could modulate directly and independently the
respiratory and cardiovascular pathways via actions in the VLM (Spyer and Thomas,
2000). The RVLM is also sensitive to adenosine, which is produced by hydrolysis of
ATP and adenosine antagonists can influence the pressor response elicited by
hypothalamic stimulation (Spyer et al., 1997) .
5.13.6 The locus coeruleus (LC)
The LC in the pons supplies tonic chemosensory input (Infante et al., 2003). It
is located at the ponto-medulla border directly underneath the 4th ventricle, placing it
in direct contact with Cx26 expressing cells. Stimulation of the LC causes dopamine
and noradrenaline release in the cortex (Devoto et al., 2005) which has been linked to
arousal and increased vigilance (Devoto et al., 2005). It has also been shown to send
projections to the medial habenula (Yao-Hua, and Ku., 2002), and thus has been
linked to fear and anxiety (Li and Ku, 2002, Gorman et al., 2000, Devoto et al., 2005).
At rest the LC exhibits oscillatory behaviour (Oyamada et al., 1998, Filosa et al.,
2002), due to phase locking with respiration through glutamatergic and adrenergic
projections (Oyamada et al., 1998). Upon hypercapnic stimulation LC neurons lose
respiratory related phasic behaviour (Oyamada et al., 1998). These neurons are driven
by alterations in pHi and retain chemosensitivity during synaptic blockade (Filosa et
al., 2002).
Although unlike many of the nuclei mentioned here they do not show
maturational changes (Filosa et al., 2002), they do express P2X and P2Y (Yao et al.,
2000, Nieber et al., 1997, Sansum et al., 1998) receptors which co-localise with
catecholaminergic neurons (Yao et al., 2000). Thus ATP is likely to stimulate these
neurons leading to the release of noradrenaline and/or dopamine elsewhere in the
brain. ATP and ADP causes depolarisation and purinergic antagonists further reduce
LC currents already bathed in a cocktail of synaptic blockers (Nieber et al., 1997).
Interestingly the minimum amount of ATP release required to stimulate these neurons
is 3µM (Nieber et al., 1997) which is the same amount seen in in vivo preparations
(Gourine et al., 2005a). Suramin depresses LC neurons in the absence of agonists
implying tonic regulation through ATP (Nieber et al., 1997). Interestingly the profile
of CO2 sensitivity of these neurons (figure 13) in the rat is similar in profile to that of
ATP release or conductance changes in Cx26 in response to CO2 (see chapter 2 and 3)
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Figure 13: CO2 dose response curve for neurons in the locus coeruleus. Inset) ATP release in
response to alterations of %CO2 through Cx26 hemichannels at the VLM surface. Note the similarity of
the profile to that of ATP release and Cx26 conductance in response to alterations to CO2 seen in
chapter 1. Picture taken from Pineda Neuroscience 77, 723-743 (1997)
5.13.7 ATP and hypothalamus
The hypothalamic paraventricular nucleus (PVN) is thought to be the master
controller of blood pressure regulation. Stimulation of the PVN excites the pressor
areas of the rostral ventrolateral (RVLM) pressor areas via the release of glutamate
(Coote et al., 1998), leading to an increase in blood pressure. The PVN also projects
to the phrenic nucleus and the spinal cord (Yeh et al., 1997). Neurons projecting to the
phrenic nucleus express c-Fos during hypercapnia and thus are activated during it (Kc
et al., 2002, Berqin et al., 2000). Injections of L-glutamate into the PVN also cause an
increase in breathing frequency and amplitude and increased blood pressure (Yeh et
al., 1997). Thus the PVN is poised to influence blood pressure and respiration through
intermediate nuclei and directly through motor neurons. The PVN is excited by ATP
and has been shown to contain a heterogeneous collection of P2X receptors (Whitlock
et al., 2001). It is located next to the 3rd ventricle (Cham et al., 2005). Interestingly the
ependymal layers of the 3rd ventricle express Cx26 (Mercier and Hatton, 2001).
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In the adult cat hypercapnia reduces spontaneous bladder contractions (Barlett
Jr and Knuth, 2003). ATP injections into the PVN and supraoptic nuclei (SON) also
reduces urine outflow (Mori et al., 1992). It does so by the release of arginine
vasopressin (AVP) (Mori et al., 1992, Mori et al., 1994), which act on V2 receptors
(Nakamura et al., 2003). c-Fos studies show that AVP secreting cells in the SON and
PVN are excited by hypercapnia (Kc et al., 2002). Thus during hypercapnia the PVN
and SON release AVP into the blood in response to ATP and causes antidiuresis via
V2 receptors (Mori et al., 1992, Mori et al., 1994). The antagonism of AVP during
eucapnia had no effect on bladder contraction, only when ATP was injected into the
SON (Mori et al., 1994). Thus there must be a release of ATP in the SON, most
probably during hypercapnia. Injections of ATP did not effect blood pressure or
phrenic nerve discharge (Mori et al., 1994), however it was injected in nanomolar
concentrations and may not have been high enough to stimulate neurons of these
pathways.
Figure 14: Cx26 is located near hypothalamic nuclei that influence physiological responses to
hypercapnia. Coronal sections of the midbrain showing the location of; A) The tuberomamillary
nucleus. B) Cx26 expression Mercier and Hatton J Comp Neuro 431, 88-104 (2001). C) The PVN (blue)
and Son (green).
Thus the PVN and SON contain purinergic receptors and are excited by ATP
and hypercapnia and stimulation of this area causes responses associated with the
systemic response to hypercapnia. Therefore the hypothalamic PVN and SON are
possible sites where this mechanism is working.
5.18.8 ATP and tuberomamillary nucleus
The hypothalamic tuberomamillary nucleus (TMN) is located in the posterior
hypothalamus near the ventral surface and it is involved in alertness / vigilance and
arousal from sleep. Within the TMN there is an excitatory tone of ATP, which acts
through P2Y 1 and 4 (Sergeeva et al., 2006). Applications of ATP excite all TMN
neurons (Sergeeva et al., 2006), and enhances glutamatergic and GABAergic
a b c
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transmission from glia through P2X (Sergeeva et al., 2006). This nucleus is excited by
hypercapnia and expresses c-Fos after exposure to CO2 (Johnson et al., 2005).
Therefore the involvement of Cx26 hemichannels release in both the anterior and
posterior hypothalamus may take place. In fact preliminary studies utilising dye
loading and biosensors have implicate that this mechanism may be at work in this
brain region.
5.13.9 ATP and habenula
The medial habenula is situated in the thalamus close to the floor of the lateral
ventricles and is responsible for increasing fear / anxiety and learned helplessness and
depression (Shumakea et al., 2003, Pobbe and Zangrossi Jr, 2008). It is located in an
area where ependymal cells are stained for Cx26 (Mercier and Hatton, 2001). We
know that ATP acts as a fast neurotransmitter (Edwards et al., 1992). However P2Y
receptors in this region cause long term facilitation of glutamatergic currents (Price et
al., 2003). This facilitation was only seen when concentration of ATP were low
(<10µM) and approximately equal to what has been seen in this investigation when
the tone and released ATP are added (~7µM). This facilitation is due to the action of
P2Y receptors on pre-synaptic terminals. The lateral habenula receives inputs from
the LC (Yao-Hua, and Ku., 2002), which is excited during hypercapnia. If these
neurons are glutamatergic and if ATP release were to be released via Cx26
hemichannels in this region it may act to cause long term facilitation of neurons
originating in the LC and potentiate the response to fear.
5.13.10 ATP and vascular control
Cx26 is expressed heavily in the vascular endothelia, and these cells are
responsive to ATP. ATP increases leg blood flow and vascular conductance (Calbert
et al., 2006). Injections of ATP into the human leg cause vasodilatation (Calbert et al.,
2006), probably through the release of nitrous oxide (Bao et al., 2004). ATP causes
dilation of cerebral arteries in low concentrations and constriction in high
concentrations (Shuba and Vladimirova, 1980) through its actions on P2X and P2Y
receptors (Clifford, 2008, Burnstock et al., 1970). P2X receptor activation causes
constriction and P2Y dilation (Clifford, 2008). In the retina this has been linked to the
release of ATP from glia cells (Metea and Newman, 2006). Calcium waves in the glia
cells surrounding blood vessels, always preceded dilation of blood vessels (Metea and
Newman, 2006). Release of caged intracellular calcium in glia, to mimic endogenous
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calcium waves also caused vaso- constriction and dilation (Metea and Newman, 2006).
These vasomotor responses are inhibited by the antagonism of ATP (Metea and
Newman, 2006).
Thus an increase in CO2 in the blood vessels will activate Cx26 hemichannels,
either on glia cells or from the endothelial cells themselves. This will lead to ATP
release which acts on the endothelial cells causing vasodilatation. During hypercapnia
this will lead to increased blood supply in the ventral medulla, which would increase
CO2 to the medulla, a distinctively favourable physiological reflex. However this may
not be its only application. During increased neuronal activity the metabolic
production of CO2 increases, this would act to open Cx26 hemichannels and lead to
ATP release in the local vicinity. This would cause vasodilatation of the blood vessels
supplying this region, increasing delivery of oxygen to this region. If an area of the
brain becomes inactive, metabolic CO2 decreases leading to a reduction in tonic ATP
levels. Thus the blood vessels in this region would constrict. Therefore CO2-activated
ATP release through Cx26 hemichannels would cause regional changes in blood flow
that match the metabolic demand of discrete areas of the brain.
5.13.11 The placenta
The possible involvement of ATP release in vascular control may explain why
Cx26-/- transgenic mutations are embryonic lethal. This mechanism may also play a
vital role in utero. Cx26 is heavily expressed in embryos and the placenta of mice.
Homozygous deletion of Cx26 is embryonic lethal (Filippov et al., 2003), yet it does
not cause any morphological changes of either the placenta or the embryo, though
both appeared smaller than their wild type counterparts. Could Cx26 mediated ATP
release provide the answer. In a developing embryo the metabolic demands are high,
thus during periods growth or any enhanced metabolic activity an increase in PCO2
will occur. This would raise the level of PCO2 in the placenta. This increased PCO2
will open Cx26 hemichannels that reside there, causing ATP release. This will act
directly on foetal vasculature and may build up in the intravillous space where it could
diffuse to the maternal blood supply. This could lead to vasodilatation in the placenta
and thus an increase in blood flow on both the maternal and foetal sides. This increase
in blood flow serves two purposes; firstly it would increase the supply of oxygen and
essential nutrients to the foetus, essential for its continued growth. Secondly it will
cause the removal of any waste products that may be toxic to the foetus. In mice
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lacking Cx26, this will not occur; this would lead to anoxia (due to increased foetal
respiration and lack of O2 delivery) and a build up of toxic waste products in the
foetus, eventually leading to death. In heterozygous mice with a decreased but not
absent Cx26 mediated ATP control of vasculature, this would occur at a slower rate
and would lead to a decreased birth weight. Alternatively, it may be the opening of
Cx26 hemichannels alone without any involvement from ATP. Thus CO2 opens the
hemichannel allowing the passage of glucose from the intravillous space into the
foetal blood supply. Fascinatingly foetal mice with homozygous deletions of Cx26 but
not heterozygous or wild type foetus from the same litter, showed a 60% decrease in
glucose up take from maternal blood. This was originally suggested to mean that
Cx26 aids in the uptake of glucose directly. I suggest that it is due to a lack of
delivery of glucose to / in the placenta, which is the cause of decreased uptake. This
may or may not work in conjunction with a loss of Cx26 mediated glucose uptake.
Thus Cx26 mediated ATP release appears to be functionally active in other
physiological system as well as the physiological chemosensory reflex.
5.14 Summary
I have created a new in vitro preparation for the study of chemosensitivity in
the VLM surface, and proposed a new model for recapitulating in vivo conditions of
hypercapnia more accurately. I have identified a new intrinsically chemosensitive
target for chemosensory transduction, Cx26. This is the first record of connexin
hemichannel gating in response to a physiological stimulus, and may provide the long
sort after true physiological function of hemichannels, such as reduced coupling in the
heart or increased transmission in the pre-Bötzinger complex. I have shown a primary
role for glia in a sensory reflex, which may also provide a better understanding of acid
base regulation in these cells. Finally I have produced a novel mechanism by which
the brain may detect changes in CO2, which may be one of the fastest and simplest
cellular pathways ever described.
(Del Negro and Hayes, 2008)
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